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Abstract
Chemical exchange saturation transfer (CEST) is a novel mechanism used to generate
contrast in magnetic resonance imaging (MRI). Recently, CEST contrast was proposed to
noninvasively measure physiological parameters including temperature and pH.

Tissue

temperature and pH are known markers of pathological processes in many diseases including
stroke and cancer. CEST contrast can be generated using endogenous proteins and peptides
(endogenous CEST) or using exogenous paramagnetic lanthanide agents (PARACEST).
The general problem of optimizing applications of endogenous CEST and PARACEST
contrast to measure temperature and pH is addressed in this thesis. Highlights of the thesis
include a novel application of PARACEST contrast to measure extracellular pH and
temperature in vivo and a novel ratiometric approach that uses endogenous CEST contrast to
measure intracellular pH in vivo.
Using a Tm3+-based PARACEST agent (Tm3+-DOTAM-Gly-Lys), the PARACEST amide
peak chemical shift and linewidth were shown to depend on pH and temperature in a
deterministic manner. Quantitative temperature and pH maps were simultaneously measured
in a normal mouse leg following agent injection using empirical relations derived in vitro.
A ratio of endogenous amide and amine proton CEST effects was developed to measure
absolute tissue pH that is heavily weighted to the intracellular compartment. The technique
called amine and amide concentration-independent detection (AACID) was developed using
in vitro phantoms and numerical simulations. Following in vivo pH-calibration using 31Pmagnetic resonance spectroscopy (MRS), tissue pH measurement was demonstrated in mice
following focal cerebral ischemia. Local acidosis was measured in ischemic regions and
found to correlate with regions of tissue damage.
Finally, two endogenous CEST metrics including the AACID ratio were used to monitor
cancer treatment using an anticancer drug called lonidamine.

Lonidamine selectively

acidifies cancer cells. In vivo experiments demonstrate that endogenous CEST imaging is
sensitive to intracellular acidification by lonidamine in a glioblastoma brain tumor mouse
model.
ii

Overall, the results presented in this thesis demonstrate quantitative measurement of pH and
temperature using CEST and/or PARACEST contrast in vivo. Some of the novel techniques
developed in this thesis were demonstrated in stroke and cancer mouse models. Future work
should focus on 1) development of PARACEST agents with higher sensitivity in vivo to
improve accuracy of temperature and pH maps; 2) application of AACID for absolute pH
measurement to differentiate high- and low-grade tumors in vivo; and 3) application of
endogenous CEST measurement to monitor tumor response to different clinically approved
chemotherapy treatments.
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Chapter 1
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Introduction
This thesis investigates the use of chemical exchange saturation transfer (CEST)
magnetic resonance imaging (MRI) to produce contrast for the measurement of pH and
temperature. The purpose of this chapter is to provide an introduction and motivation to
the presented research. Section 1.1 outlines the motivation and general organization of
the thesis. A brief survey of pH and temperature homeostasis and clinical significance is
presented in Sections 1.2 and 1.3. An introduction to MRI physics is presented in Section
1.4, followed by a thorough discussion of CEST theory and applications in pH and
temperature measurement in Section 1.5.

1.1 Motivation and overview
Traditionally, MRI is used to produce high-resolution images with excellent anatomical
contrast that allows localization and differentiation between different types of soft tissue
(eg. muscle, fat and tumor tissue).

Anatomical MRI offers clinicians valuable

information and sometimes enables disease diagnosis [1, 2]. Significant advances in
molecular biology have improved our understanding of the pathophysiology underlying
many diseases [3, 4]. Detection of abnormal physiology often enables disease diagnosis
before MRI-detectable anatomical changes occur [5]. The probability of treatment
success is almost always increased with early diagnosis. Therefore, imaging physicists
are highly motivated to develop novel techniques to quantify physiological processes
such as metabolism. Recently, a new MRI technique called CEST has emerged to image
biological targets such as specific proteins and/or metabolites as well as molecular events
such as apoptosis [6] and angiogenesis [7]. CEST is a mechanism that can be used to
generate contrast based on several factors that are coupled to metabolism including
temperature [8], pH [9] and specific metabolite concentrations [10]. Two fundamental
tissue properties, pH and temperature, are correlated with energy producing metabolic
activity [9, 11]. To date, most applications of CEST to measure temperature and/or pH
focus on applications in cancer and stroke. Cancer and stroke represent two common

diseases that are characterized by significant changes in metabolism resulting in altered
pH and temperature as described in Sections 1.2 and 1.3 respectively.

Therefore,

temperature and pH are potentially valuable markers for indirect investigation of
metabolic changes in cancer and stroke. In some cases, disease diagnosis and prognosis
can be more accurate using metabolic imaging compared to anatomical MR imaging [5].
For example, the current gold-standard metabolic imaging device for cancer is positron
emission tomography (PET). Detection of the glucose analogue called

18

F-labeled

fluorodeoxyglucose (18F FDG) using clinical PET scanners enables direct measurement
of glucose uptake in tumors. Quantitative parameters describing tumor uptake of

18

F

FDG predict tumor aggressiveness and response to therapy [12]. However, metabolic
imaging using the MRI would arguably be more cost-effective, more easily accessible,
and easier to interpret because metabolic maps could be easily registered with highresolution anatomical MRI [13].
In this thesis, novel techniques are presented to measure absolute temperature,
extracellular pH (pHe), and intracellular pH (pHi) in living biological systems using
CEST MRI contrast. In all cases, the strategies are developed theoretically, tested in vitro
and finally demonstrated in vivo using mouse models.

Chapter 2 presents a novel

strategy to measure absolute pHe and tissue temperature simultaneously using a
PARACEST agent called Tm3+-DOTAM-Gly-Lys. In vivo experiments demonstrate
absolute temperature and pHe mapping after injection of Tm3+-DOTAM-Gly-Lys into a
normal mouse leg. In chapter 3, a ratiometric technique is developed to measure pHi
using endogenous CEST contrast. Quantitative pHi maps are used to detect local acidosis
in mouse brain during cerebral ischemia (ie. stroke).

In chapter 4, tumor-selective

acidification is measured using CEST contrast following injection of an anticancer drug
in a glioblastoma brain tumor mouse model. The sensitivity to drug-induced changes in
tumor pHi was compared for two different endogenous CEST metrics. Finally, chapter 5
offers a summary of the significant findings and conclusions of the work presented in this
thesis. Experimental limitations, future experiments, and clinical applications of the
novel techniques are also discussed.

2

1.2 Regulation of pH
1.2.1 What is pH?
Water molecules (H2O) naturally tend to ionize, or dissociate into a proton (H+) and a
hydroxyl ion (OH-) according to equation [1.1].

H2O ↔ H+ + OH−

[1.1]

Self-ionization of water is constant and reversible. At equilibrium, the product of ion

€

concentrations is characterized with the dissociation constant of water KW , described in
equation [1.2].

€

KW = [H+ ][OH− ]

[1.2]

At equilibrium, KW is constant for a given temperature, for example KW =10-14 M2 at
€

25oC [14].

€
€ [1.3].
The logarithmic
form of KW , known as pKW , is given in equation
[1.3]
pKW = − log( KW )
€
€
In solution, the proton is an acid since it can donate a proton (ie. itself) or accept an

€

electron pair, whereas the hydroxyl ion is a base since it can accept a proton or donate an
electron pair. A Danish chemist named Søren Sørensen developed the pH concept that is
used to quantify how acidic or basic a solution is. Solution pH is defined as:
[1.4]

pH = − log[ H + ]

where [H+ ] is the molar concentration of protons [14, 15]. Addition of other acids or

€

bases can perturb the system shown in equation [1.1] to a new equilibrium with different
+
and [OH− ] but a constant KW . For example, at 25oC an extremely acidic solution
€ [H ]

has [OH− ] = 1.0x10-14 M, [H+ ] = 1.0 M, and pH = 1; a neutral solution has [OH− ] =
€

€
€

€
€

€
3

1.0x10-7 M, [H+ ] = 1.0x10-7 M, and pH=7; and an extremely basic solution has [OH− ] =
1.0 M, [H+ ] = 1.0x10-14 M and pH = 14.
€

€

€

In biological tissue, [H+ ] in intracellular or extracellular fluid can be calculated using
equation [1.4] and pHi or pHe respectively. Furthermore, if pKW is known, then [OH− ]
may also be€calculated using both pKW and pH as shown below:

[H ][OH ] 10
[OH ] = H = 10€
[ ]
+

−

−pK w

−

+

−pH

€

= 10 pH−pK w

€

[1.5]

1.2.2 Normal pH regulation
€

Robust maintenance of pH is a fundamental homeostatic process in biological systems.
Systemic blood pH is regulated by the synchronized function of the renal system,
respiratory system and blood buffering enzymes [14]. More specifically, if the blood pH
is too acidic, ventilation increased to expire more weakly acidic carbon dioxide (CO2)
and the opposite is true when blood is too alkaline. Similarly, the renal system regulates
the removal or retention of acids or bases through the urine based on the blood pH. Also,
several enzymes act as pH buffers by catalyzing reactions that alter the acid-base balance
in blood. The pH measurement techniques developed in this thesis aim to quantify local
pHi and pHe in diseases such as stroke and cancer. In such diseases, local changes in
blood circulation, energy metabolism and ion transport membrane channels result in
much larger reductions in local tissue pH (~0.3-1.0 pH units) [16-18] compared to the
changes observed in systemic (ie. whole body) blood pH (~0.1 pH unit) [19]. Therefore,
from this point forward, pH regulation at the cellular level is discussed with a strong
focus on the role of metabolism because it changes significantly in both cancer and
stroke.
Different pH balances are maintained in the two main tissue compartments, the
intracellular and extracellular spaces [20]. The difference between pHi and pHe produces
a pH gradient across the cell membrane. Under normal conditions, pHi is slightly more
acidic at ~7.2 compared to pHe at ~7.4 [20]. Normal pH in both compartments is

4

maintained through the complex and coordinated interaction between several different
physiological systems including cellular metabolism, the cellular membrane potential,
intracellular and extracellular buffering systems, cell membrane transporters, delivery of
oxygen and glucose, and removal of acid by-products by the blood [21].
Cellular glucose metabolism (Figure 1.1) plays an important role in the acid-base
homeostasis of both intracellular and extracellular spaces. For example, the conversion of
glucose to pyruvate via glycolysis, which occurs in the cytosol and is described by
equation [1.6]. Specifically, the breakdown of one glucose molecule results in reduction
of two co-enzymes called nicotinamide adenine dinucleotide (NAD+) to their reduced
form NADH, phosphorylation of two inorganic phosphate (Pi) and adenosine
diphosphate (ADP) molecules to create two high-energy adenosine triphosphate (ATP)
molecules as well as production of two water molecules and two protons that are mostly
exported to the extracellular space by one of a variety of proton transporters located on
the cell membrane [20].

Glucose + 2NAD + + 2ADP + 2Pi →2Pyruvate + 2NADH + 2H+ + 2ATP + 2 H2O

€
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[1.6]
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Figure 1.1: Schematic diagram describing pH homeostasis. Normal cellular glucose
metabolism in normoxic (blue) and hypoxic (red) conditions contribute to proton, CO2
and lactate production. Membrane ion transport channels and pHi/ pHe-buffering enzymes
also contribute to normal pH maintenance.

In normoxic (ie. aerobic) conditions, pyruvate is transported to the mitochondrion, where
it is converted to acetyl co-enzyme A (acetyl-CoA) and CO2. Within the mitochondrion,
acetyl-CoA enters the citric acid cycle, which produces more CO2 and reduces NAD+ to
NADH. The electron transport chain then oxidizes the NADH to its oxidized form NAD+
with oxygen (O2) acting as the final electron acceptor. The net result of the electron
transport chain is a proton gradient across the mitochondrion inner membrane, which is
used to produce three high-energy ATPs per NADH through oxidative phosphorylation
[22].
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In the absence of oxygen (hypoxia), the citric acid cycle and electron transport chain are
inhibited, resulting in elevated glycolysis to meet energy demands.

Upregulated

glycolysis relies on lactic acid fermentation (equation [1.7]) to maintain a sufficient
supply of NAD+ for further glycolysis.

Pyruvate + NADH + H+ + →Lactate +NAD+

[1.7]

Lactic acid has a pKa ~3.9 and is mostly dissociated into the lactate anion and a proton as

€

shown in equation [1.8] at physiological pH values leading to acidification in hypoxic
conditions [23].
Lactic acid ⇔Lactate - + H+

[1.8]

Furthermore, during hypoxia, hydrolysis of ATP (equation [1.9]) that was produced in
€

the mitochondria also contributes to decreased cellular pH, unless the cell can export
protons quickly [23].

ATP + H2O ⇔ ADP + HPO4 + H+

[1.9]

Membrane transporters such as monocarboxylate-H+ efflux transporters (MCTs) are

€

relied upon to simultaneously remove protons and lactate from the cell to avoid acidosis
[12, 20]. Metabolic acids such as protons, lactate and CO2 that are transported to the
extracellular space diffuse into local blood vessels where they are transported to lungs
(CO2) or the kidneys for removal via the urine. Intracellular and extracellular acid
concentration may also be buffered by different biochemical buffering systems. For
example, the bicarbonate (HCO3-) buffering system regulates the CO2 and HCO3- levels.
Carbonic anhydrase (CA) is an important enzyme of the bicarbonate buffering system
that catalyzes the hydration of CO2 to form HCO3- (equation [1.10]) [20].
CA

CA

CO2 + H2O ⇔ H2CO-3 ⇔ HCO-3 + H+

[1.10]

€
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Carbonic anhydrase catalyzes the consumption or production of H+ depending on
substrate concentrations and is expressed in both intracellular and extracellular spaces.
The bicarbonate buffering system is responsible for the vast majority of the blood
buffering capacity [24-26]. Similar phosphate and ammonium (NH4+) buffering systems
are important for intracellular buffering [12, 26].
Normal human tissue is capable of maintaining a healthy acid base balance in a variety of
conditions including brief (ie. on the order of seconds) periods of hypoxia. However, in
many diseases where oxygen supply does not meet the metabolic demand, elevated
lactate and proton concentration can lead to abnormal pH. Importantly, many cellular
macromolecules, proteins and peptides have pH-dependent structures and activities [20,
27].

Therefore, in pathological tissue, pH is a fundamental marker of disease

progression.

1.2.3 Regulation of pH in cancer
Abnormal pH balance is a common trait in cancer tissue [20, 21]. Cancer cells tend to
have up-regulated glycolysis in aerobic conditions, known as the Warburg effect [12].
While the origin of the Warburg effect has not been completely elucidated, several
mechanisms have been shown to contribute to the observed effects. The most popular
hypothesis for up-regulated glycolysis in cancer cells is that Darwin selection favours
cells expressing the Warburg effect. Early in tumor progression, cancer cells proliferate
and form large cellular masses, or tumors, faster than proper vasculature can be produced.
Therefore, cancer cells in the central core of the tumor often lack proper circulation and
cells with up-regulated glycolysis tend to have an advantage [12, 20]. Cancer cells may
up-regulate glycolysis using numerous control mechanisms including pro-glycolytic
enzymes such as hexokinase or increased glucose uptake [12]. For example, epigenetic
mechanisms have been shown to cause increased anaerobic glycolysis in gastric cancers
[28]. Epigenetics is the study of chemical processes that cause chemical changes in DNA
(e.g. methylation) that alter protein expression without any change in DNA sequence
[29]. Liu et al. recently demonstrated hypermethylation of a promoter for known a
glycolysis antagonizer called fructose-1,6-bisphosphatase-1 (FBP1) in cancer cells
contributed to the observed Warburg effect [28]. Importantly, epigenetic contributions to
8

the Warburg effect suggest that the effect is not permanent. The end result is a tumor
with a relatively large population of cells favouring glycolysis. Increased glucose uptake
is a prominent phentotype in many cancers that has been observed repeatedly when
imaging regional uptake of the glucose analog 18F-labeled fluorodeoxyglucose (18F FDG)
using positron emission tomography (PET) [12].

Therefore, cancer cells have

abnormally high rates of glycolysis in both anaerobic and aerobic conditions. Anaerobic
glycolysis is an inefficient way to produce ATP compared to aerobic respiration as
described in Section 1.2.2. However, Vander Heiden et al. recently proposed that the
Warburg effect facilitates uptake of critical components for cell proliferation such as
amino acids. Therefore, the Warburg effect is used to meet energy demands while
simultaneously producing cellular building blocks [30].
Cancer cells with up-regulated glycolysis produce higher amounts of pyruvate leading to
increased proton and lactate production [12]. Paradoxically, cancer cells that produce
high levels of lactate tend to have an alkaline pHi (pHi > 7.4) compared to normal cells
[20]. Increased pHi in cancer cells is caused by increased expression of proton pumps on
cellular membranes such as H+-ATPases and Na+/H+ exchangers [20, 27]. Cancer cells
also increase expression and activity of numerous MCTs [20]. Increased lactate and H+
efflux is advantageous to cancer cell survival since it allows increased glycolysis that
serves as an important energy source for proliferation. Furthermore, increased efflux of
protons and lactate result in an acidic extracellular environment with pHe < 7.1 [20, 21].
Again, reduced pHe provides a selective advantage to tumor cells since surrounding
normal cells cannot survive in the acidic extracellular space. Consequent degradation of
neighbouring normal cells provides a significant opportunity for evasion and tumor
growth [20].
In cancer, increased pHi and reduced pHe both signal altered metabolism in cancer cells.
Measurement of pHi and/or pHe may improve accuracy of diagnosis of disease
progression in tumors. For example, noninvasive pH mapping may enable clinicians to
predict tumor metastasis. Furthermore, pH measurement will help develop treatment
strategies since many anti-cancer therapeutic agents have pH-dependent activity and
pharmacokinetics [21, 31].

Gerweck et al. recently showed that weakly acidic
9

chemotherapy agents preferentially cross the cell membrane when passing through the
acidic extracellular environment in cancer tissue. Upon entrance to the basic intracellular
space of cancer cells, the weakly acidic agents are trapped by ionization. Previous
experimental results support the use of weakly acidic chemotherapy agents when the pH
balance is altered in cancer [21, 31].

1.2.4 Regulation of pH in cerebral ischemia
Cerebral ischemia is a condition characterized by insufficient blood flow to the brain to
meet metabolic demand. The most common cause of stroke is the disruption of blood
flow to the brain by a blood clot. Loss of blood flow to the brain not only prevents
oxygen delivery to brain cells, but also inhibits removal of metabolic acids from the
extracellular space. Hypoxia inhibits aerobic respiration cycles (citric acid cycle and
electron transport chain) leading cells to up-regulate anaerobic glycolysis to meet energy
demands. During hypoxia, pyruvate molecules are preferentially converted to lactate,
resulting in both intracellular and extracellular acidosis [16]. Increased glycolysis leads
to intracellular acidosis in stroke, unlike cancer, because normal brain cells do not have
increased expression of H+ and lactate efflux transporters. It has also been shown that
cell damage is highly correlated to lactic acidosis [32, 33]. Severe acidosis occurs in the
ischemic core, which is the epicenter of the disease where damage is irreversible. Severe
acidosis (pH < 6.5) disrupts vascular membranes during stroke leading to increased
hemorrhage and edema [34].

Specifically, acidosis leads to protonation of

macromolecules and proteins causing structural changes that disrupt protein function
and/or synthesis. In addition, the dissociation of iron (Fe) from proteins and production of
oxygen radicals are both increased at low pH [16, 34, 35]. Oxygen radicals are highly
reactive species that can cause damage to proteins, DNA and lipids. A noninvasive
absolute pH measurement technique is needed to identify pH thresholds at which
irreversible tissue damage occurs.
In the clinic, quantitative pH mapping techniques will enable clinicians to identify the
ischemic core as well as the penumbra, which is composed of salvageable ischemic tissue
surrounding the core. The current standard of care for stroke patients is administration of
tissue plasminogen activator (tPA) that converts the plasminogen enzyme to plasmin,
10

which is responsible for breaking down blood clots. Clinicians may prescribe tPa to
dissolve the blood clot and facilitate reperfusion of the ischemic region. A recent metaanalysis of 12 randomized clinical trials discovered that tPA treatment within 6 hours of
ischemia onset improved overall patient survival and recovery [4]. However, the same
report also found that patients treated with tPA had a higher mortality rate in the acute
phase (ie. within 7 days of treatment) due to cerebral hemorrhage. Therefore, there is
significant risk of hemorrhage when treating some patients with tPa. Knowledge of the
size, location and metabolic status of the ischemic lesion with a pH distribution map
would help guide critical treatment decisions regarding stroke patients.

1.3 Temperature regulation
1.3.1 Normal temperature regulation
Similar to pH, tissue temperature is tightly regulated around 37 oC (+/- 1.0 oC) under
normal conditions [36]. Strict regulation of core tissue temperature is important because
the function and structure of many cellular components such as protein depends on
temperature [37]. Body heat is a by-product of energy consuming metabolic processes
occurring within cells [38, 39]. Heat flow throughout the body is controlled by blood
circulation. Blood flowing through external skin and lung tissue exchanges heat with the
external environment by conduction and evaporation [38-41]. The magnitude of heat
exchange with the external environment is controlled by regulation of blood flow via
vasodilatation and/or vasoconstriction. In diseases such as stroke and cancer, abnormal
local tissue temperature is a common symptom associated with changes in heat producing
energy metabolism and/or heat removal by blood circulation [42, 43]. Inflammation can
also cause local heating due to increased blood flow to the injury as well as increased
cellular activity to repair local cells and remove necrotic cells.

1.3.2 Regulation of temperature in cancer
Temperature is altered in cancer tissue [43, 44].

Altered blood circulation and

metabolism are hallmarks of cancer leading to changes in temperature [45, 46].
Abnormal blood circulation in tumors is attributed highly branched and dilated blood
vessels [47].

Angiogenesis must occur quickly in fast growing malignant tumors
11

characterized by rapid tumor cell replication to meet high-energy demands resulting in
disorganized and inefficient vasculature [47, 48].

As mentioned in Section 1.2.3,

abnormal metabolism is also a hallmark of cancer. Importantly, different types of cancer
express different metabolic profiles [49]. Therefore, since tumor temperature reflects
both circulation and metabolic activity, absolute temperature mapping could tumor
diagnosis, staging, and treatment strategies. Recently, Jayasundar and Singh recorded
tumor temperatures ranging from ~34 to 43oC and discovered that temperature could be
used to differentiate some tumor types [43]. Differences between different tumor types
were hypothesized to be due to differences in vasculature, metabolic rate and the
presence of necrosis. To-date, the study by Jayasundar and Singh represents the only
investigation of noninvasive absolute temperature measurement within multiple types of
tumors in humans and therefore, more research is required.
Absolute temperature mapping would also enable accurate monitoring of a new cancer
treatment technology called thermal ablation.

Thermal ablation involves focused

application of extreme heat to a tumor typically using high energy radiofrequency or
microwave pulses [50]. Ablation techniques enable noninvasive removal of small tumors
that are deemed unfit for surgery [50]. Most thermoablative techniques aim to reach
tumor temperatures of 60oC to induce cell death [50]. The most common cause of poor
patient outcome following tumor ablation is incomplete tumor coverage resulting in
tumor survival or reccurence [50-52]. Therefore, application of thermal ablation is
limited to small (< 5 cm) tumors to avoid incomplete tumor ablation. Real-time absolute
tumor temperature mapping would ensure that target temperatures are reached across the
entire tumor.

1.3.3 Regulation of temperature in cerebral ischemia
As mentioned in Section 1.2.4, cerebral ischemia is a condition caused by severely or
completely reduced blood delivery to brain tissue.

Tissue hyperthermia has been

observed in affected brain regions during the acute phase of cerebral ischemia in both
animal models and humans [42, 53, 54]. Hyperthermia during cerebral ischemia is
attributed to several factors including; 1) the loss of blood flow inhibits removal of heat
from ischemic tissue; 2) increased heat production in ischemia tissue via elevated
12

anaerobic metabolic activity; 3) a release of excitatory neurotransmitters occurs upon
ischemic infarct causing hyperactivity of local neurons; and 4) heat producing leukocyte
activity associated with inflammation within ischemic infarct. Specific contributions of
the listed factors along with a vast set of metabolic processes triggered or arrested by
cerebral ischemia are poorly understood, demonstrating a need for more research [55,
56].
While acute hyperthermia is common in stroke patients, tissue damage from
hyperthermia alone only occurs in severe cases (i.e. > 40oC) [36]. However, even mild
hyperthermia (~38oC) can significantly enhance tissue damage caused by stroke [36, 56].
Anaerobic metabolism produces lactic acidosis during ischemia, as discussed in Section
1.2.4, and metabolic activity increases in hyperthermia [56].

The combination of

hyperthermia and anaerobic metabolism leads to worse patient outcomes due to more
severe lactic acidosis [53, 57]. Furthermore, hyperthermia also potentiates release of
excitatory neurotransmitters [36, 57] and synthesis of damaging reactive oxygen radicals
[36, 58]. Therefore, high-resolution quantitative temperature maps in stroke patients will
offer valuable information regarding the metabolic status of ischemic tissue that would
identify tissue that could be rescued with treatment.
Several reports have demonstrated that inducing mild hypothermia after stroke by
reducing the core body temperature by approximately 1-6oC [42, 59] leads to improved
neurological outcomes in animals and humans [36, 42, 59, 60]. For example, a recent
clinical trial showed that reducing core body temperature to 32oC approximately 3 hours
after thrombolysis treatment with tpA and 6 hours after stroke onset led to improved
outcomes in stroke patients [60, 61]. Controlled hypothermia offers neurological benefits
to some patients however, it is difficult to induce and maintain mild hypothermia and
then re-warm a critically ill patient without encountering severe side effects that may
negate any potential benefits. There are many side effects during prolonged hypothermia
including bradycardia, increased blood pressure, shivering that reverses body cooling,
insulin-resistance that leads to hyperglycemia, as well as during re-warming including
high extracellular potassium [60-63]. Quantitative brain temperature mapping would
enable more accurate selection of patients that would benefit from hypothermia (ie.
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patients with hyperthermic lesions), and clinical monitoring of tissue temperature in the
ischemic lesion during hypothermia maintenance and re-warming. Currently, scientists
and clinicians monitor hypothermia using the core body temperature.

Whole-brain

absolute temperature maps will offer a more detailed assessment of local ischemic tissue
status and may enable the discovery of an optimal ischemic lesion temperature that leads
to the best long-term outcome in patients while minimizing adverse side effects.

1.4 Introduction to magnetic resonance imaging (MRI)
Magnetic resonance imaging (MRI) is an established diagnostic imaging tool that is used
in clinical medicine. Traditionally, clinical MRI produces high-resolution anatomical
images based upon magnetic signals from hydrogen (1H) associated with bulk water in
soft tissue. This section briefly outlines the fundamental principles underlying 1H MRI.
The purpose of this section is to offer a basic understanding of MRI, to develop the
theory for chemical exchange saturation transfer (CEST) MRI techniques described in the
following sections.

1.4.1 Magnetic moments in an external magnetic field
A hydrogen (1H) nucleus is composed of a positively charged proton and will be referred
to as a proton from this point forward. An intrinsic property called spin characterizes the
angular momentum of the proton. The nuclear spin quantum number (I) for the proton is
equal to 1/2. The angular momentum of the proton (a charged particle) gives rise to a
magnetic field, known as a magnetic moment (µ). In MRI, protons are placed into a
static external magnetic field (B0) with a fixed axis. Conventionally, the fixed axis of B0
is considered to be the z- or longitudinal axis. Magnetic moments µ experience a torque
(τ) when placed in B0, which causes them to precess about B0. The motion of a magnetic
moment µ in the presence of B0 is described by the differential equation:
d   
µ = µ × B0
dt

[1.11]

with the following solution:
€
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µ = µ0 e −iγB t

[1.12]

0

that describes the magnetic moment µ rotating about B0 in the clockwise direction with

€

an angular frequency equal to:



ω0 = γB0

[1.13]

where ω 0 represents the Larmor frequency in rads s-1 and γ is the gyromagnetic ratio in

€

radians per second tesla (106 rad s-1 T-1) and B0 is the main magnetic field strength (in T).
It is common to express the Larmor frequency in s-1, or Hz, using the following
conversion:
 ω
γ 
f0 = 0 =
B
2 π 2π 0

[1.14]

In the absence of an external magnetic field, the alignment of proton magnetic moments
€

µ are randomly distributed in all directions. This condition leads to no net magnetization
(Figure 1.2a). In the presence of an external magnetic field (B0), the distribution of
proton magnetic moments µ alignments slightly favours the direction of B0. This leads to
a net magnetization M0 in the same direction as B0 (Figure 1.2b). In a hypothetical spin
system, where the protons do not interact with each other, proton magnetic moments µ
precess at a fixed angle about B0 in one of two possible orientations [64]. Protons precess
with the z-component of µ (µ z) either parallel or anti-parallel with the direction of B0
(Figure 1.2). In reality, protons are constantly colliding with surrounding nuclei resulting
in protons aligned in every direction with slight excess in the direction of B0. The
interested reader is referred to a thorough description of the more realistic spin system
[64]. The hypothetical spin system offered here is a simple description that allows the
reader to more easily envision the production of a net magnetization in the presence of an
external magnetic field, excitation (section 1.4.1) and saturation (section 1.5.1).
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Figure 1.2: a) An ensemble of 1H nuclei with random orientations in the absence of a
magnetic field. b) In the presence of a magnetic field (B0), a hypothetical ensemble of 1H
nuclei have a slight excess of magnetic moments aligned in parallel with B0 leading to a
net magnetization M0.

The orientation of µ z with respect to B0 depends on its energy and for this reason, the
orientations have different energy states. Protons precessing with µ z parallel with B0
reside in the low energy state (EL), while protons with µ z oriented anti-parallel with B0
occupy the high energy state (EH). The energy difference between the two states is equal
to:
ΔE = γ

h 
B
2π 0

[1.15]

where h is Planck’s constant. When placed in a magnetic field, protons tend to orient in
€

the low energy state EL, in parallel with B0. However, at room temperature, the thermal
energy of the protons favours an equal distribution between energy states. In reality, a
very small excess of protons on the order of parts per million (ppm) reside in the low

16

energy state EL. The distribution of protons between the two energy states at thermal
equilibrium is calculated using the Boltzmann distribution given by:
h 
−γ B
NL
2π
=e
NH

0

kT

[1.16]

where NL and NH represent the number of protons in the lower and higher energy states

€

respectively, k is Boltzmann’s constant and T is absolute temperature. The fraction of
excess protons in the lower energy state accounts for a net polarization (P) given by:
γ

h 
B 0 kT

 N − N H e 2π
P= L
= h
γ B
NL + NH
e 2π

0

kT

−e

−γ

h 
B kT
2π 0

+e

−γ

h 
B kT
2π 0

[1.17]

Curie’s Law states that for laboratory magnetic field strengths at room temperature,
€

€

γ

h 
B kT << 1
2π 0

and consequently the polarization P is well approximated by:


 γhB0
P≈
4πkT

[1.18]

The excess protons in the lower energy state produces the thermal equilibrium net
€

magnetization M0 calculated using the following product:


 
M0 = N ⋅ µ ⋅ P

[1.19]

where N is number of proton nuclei per unit volume.

€

The ensemble of magnetic

moments µ creates a net magnetization M0 that is parallel with the fixed axis of B0 (zaxis). Therefore, at thermal equilibrium the summation of all magnetic moments µ

produces a net longitudinal magnetization denoted as M 0z , which for protons is equal to:
⎛ h ⎞ 
N ⋅ ⎜γ
⎟ ⋅ B0
0
⎝ 2π ⎠
Mz =
4kT

€

[20]


It is important to note that while the net magnetization vector M 0z is composed of
€

magnetic moments µ precessing at identical Larmor frequencies, there is no phase
17

€

coherence between the magnetic moments µ in the xy- or transverse plane. Therefore, at
thermal equilibrium, there is no net transverse magnetization. To summarize, in the
presence of a static external magnetic field B0, proton magnetic moments µ precess about
B0 at the Larmor frequency ω 0 and tend to align with B0 forming a net longitudinal

magnetization vector M 0z at thermal equilibrium.

1.4.2 Excitation
€
MRI signal detection is based upon Faraday’s Law of induction. Faraday’s law states
that rotating magnetization induces a corresponding voltage in electric radiofrequency
(RF) receive coils near the sample. RF receive coils are placed in the transverse plane and
detect rotating magnetization in the transverse plane, or transverse magnetization


M xy

.

As described in Section 1.2.1, at thermal equilibrium the proton magnetic moments µ
0
M
z aligned with B0 (Figure 1.2a). In most MRI
form a static net magnetization vector
€
0
applications, M z is excited or tipped into the transverse plane using an additional
external magnetic field B1.
€

The additional B1 field is removed once the net

magnetization vector is rotated into the transverse plane, creating a transverse
€

magnetization
induced by


M xy

M xy

(Figure 1.2b). By Faraday’s Law, RF receive coils detect a voltage

precessing about B0 at the Larmor frequency.

€
€
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Figure 1.3: A hypothetical ensemble of 1H nuclei in the rotating reference frame. a) In
the presence of a magnetic field (B0) at thermal equilibrium, the protons tend to orient in
parallel
 0 or anti-parallel with B0 leading to a thermal equilibrium net magnetization vector
( M z ). b) Immediately following application of an RF excitation pulse along the x’-axis,
the protons are equally distributed between parallel and anti-parallel orientations and in
phase along the y’-axis. This figure was motivated by Figure 1.4 in reference [65].

€
In MRI, RF coils not only receive magnetic signals by Faraday’s Law but may also
produce magnetic fields by Faraday’s Law. The RF coils are used to create a magnetic
field for short intervals, known as RF pulses, to excite spins and create transverse



magnetization M xy . RF pulses create an oscillating magnetic field with amplitude B1 and
a frequency ω RF. To achieve rotation of the net magnetization into the tranverse plane,
the applied magnetic field B1 must be 1) tuned to the Larmor frequency ω 0 (ω RF = ω 0)

€

and 2) applied perpendicular to B0. A rotating frame of reference (x’y’z’) that is rotating
in a clockwise direction at the Larmor frequency ω 0 about the longitudinal axis is often
used to demonstrate the effect of RF pulses. In such a rotating frame of reference, the
macroscopic motion of a net magnetization M in a magnetic field B can be described in
the same way as a single magnetic moment µ in a magnetic field was described in
equation [11], as shown by:
19



d 
M = M × γB1
dt

[1.21]

when off-resonance effects are ignored. In the same way that the magnetic moment µ
€

precessed about the main magnetic field B0, the net magnetization vector M rotates

around B1 (eg. x’-axis) towards the y’-axis in the transverse plane. If a rectangular RF
pulse is applied with an amplitude of B1, the angle at which the net magnetization vector

€

M rotates away from the longitudinal axis is called the flip-angle, α, and can be
calculated using:

α = γB1T

[1.22]

where T represents the RF pulse duration and B1 is the amplitude of the applied magnetic
€

field. From the classical mechanics perspective, immediately following a 90o excitation


and removal of B1 , the net transverse magnetization vector M xy is along the y’-axis and

precessing about B 0 in the laboratory frame of reference. From the quantum mechanics
perspective,
the protons are equally distributed between both orientations (eg. energy
€
€
states) and they are in phase coherence along the y’-axis. As discussed earlier in this
€

section, the rotating transverse magnetization M xy can be detected by the RF receive coil.

1.4.3 Relaxation
The previous section described how€an appropriate RF magnetic pulse could be used to
generate an applied magnetic field B1 perpendicular to the main magnetic field B0. Such
an applied magnetic field B1 causes the magnetization vector M to rotate into the



transverse plane, resulting in transverse magnetization M xy , that is detected by the RF
receive coil. However, immediately following an excitation RF pulse, the transverse



magnetization M xy immediately begins to decrease in amplitude as magnetic moments

€


dephase and the longitudinal magnetization M z begins to grow back to the thermal


equilibrium magnetization M 0z . The process, though which magnetization M returns to

€

€

€

€
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M 0z , is called relaxation. Longitudinal and transverse relaxation occurs by different
physical processes.

€

Longitudinal or spin-lattice relaxation describes the process by which the longitudinal


magnetization M z returns to M 0z after any perturbation, such as excitation by an RF
pulse. Specifically, spin-lattice relaxation is induced by dipole-dipole interactions
between neighboring protons that result in a net energy transfer from an excited magnetic
€
€
moment (spin) to its surrounding environment (lattice). The time-dependent relaxation of


the longitudinal magnetization M z can be described using an exponential re-growth
function given by:


€
M z (t ) = M z (0) ⋅ e −t T + M 0z (1− e −t T )
1

[1.23]

1



where M z ( 0) is the magnitude of the longitudinal magnetization M z at a reference time t

€

= 0 and T1 is the spin-lattice relaxation time constant.
€
€ As mentioned in the previous section, protons are in phase
coherence following a 90o RF

excitation pulse. Transverse or spin-spin relaxation describes the process by which



magnetic moments dephase and the transverse magnetization M xy decays to zero. In
contrast to longitudinal relaxation, transverse relaxation is a result of energy transfer
between neighboring protons with no loss of energy to the surrounding lattice.

€

Specifically, transverse relaxation can be defined as the loss of phase coherence resulting
from the exchange of energy between spins. For example, following excitation, high
energy spin may transfer energy to a low energy spin to cause both spins to change states



and lose their phase coherence. Spin-spin relaxation of the transverse magnetization M xy
is described using the exponential decay function given by:


M xy (t ) = M xy (0) ⋅ e −t T

€

2

[1.24]



where M xy ( 0) is the magnitude of transverse magnetization M xy at a reference time t = 0

€

and T2 is the spin-spin relaxation time constant.

€
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€



Following an excitation pulse, the transverse magnetization M xy decays more quickly
than would be explained by the T2 time constant.

This is primarily due to time-

independent variations in local magnetic field within the sample itself. The net result is

€

that all spins experience a slightly different magnetic field, resulting in a range of Larmor
frequencies from equation [1.13].

Local variation in Larmor frequencies results in

dephasing of the transverse magnetization M xy leading to additional loss of the



transverse magnetization M xy . Dephasing due to time-independent local magnetic field
inhomogeneities is described by an additional
decay constant T2’. Therefore the apparent
€
transverse magnetization relaxation is described by Equation [1.25]:

€



M xy ( t) = M xy ( 0)⋅ e− t

T2*

[1.25]

where

€

1 T2* = 1 T2 +1 T2' .

[1.26]

In summary, following excitation by an RF pulse, the magnetization vector M

€

immediately begins to re-grow in the longitudinal direction and dephase in the transverse
plane. The time-dependent motion of the magnetization vector M immediately after
excitation is described by the Bloch equations [27], which accounts for precession about
B0 and relaxation.


⎡M x ⎤ ⎡-1 T2*
d ⎢  ⎥ ⎢ 
M = −γB0
dt ⎢  y ⎥ ⎢
⎢⎣ M z ⎥⎦ ⎢⎣ 0



γB0
0 ⎤ ⎡M x ⎤ ⎡ 0 ⎤
⎥ ⎢  ⎥ ⎢
⎥
-1 T2*
0 ⎥ ⋅ ⎢M y ⎥ + ⎢ 0 ⎥


0
-1 T1 ⎥⎦ ⎢⎣ M z ⎥⎦ ⎢⎣M 0 T1 ⎥⎦

[1.27]

1.4.4 Spatial-encoding magnetization using magnetic gradients
€

In the previous section, the Bloch equations were introduced to describe both precession


and relaxation of the net magnetization vector M in the presence of B0 immediately
following an excitation RF pulse. This section describes how external magnetic fields are
used to produce magnetic gradients that spatially-encode magnetic moments. First, the
€
€
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transverse magnetization notation is defined using complex numbers to facilitate
description of the effects of magnetic gradients.



The transverse magnetization M xy can be described as a complex quantity:




M xy = M x + iM y

[1.28]

€
Combining equation [28] with the Bloch equations described in equation [27] results in:

€




⎛ 
dM xy dM x
dM y
1 ⎞ 
=
+i
= −⎜ iγB0 + * ⎟M xy
dt
dt
dt
T2 ⎠
⎝

[29]

which can be solved to:

€





M xy (t ) = M xy (0) ⋅ e −1 T ⋅ e −iγB t = M xy (0) ⋅ e −1 T ⋅ e −iω t
*
2

*
2

0

[1.30]

0

Equation [1.30] represents the signal observed immediately following a 90o RF excitation
€

pulse and is called the free induction decay (FID) signal. While the FID signal can be
used to estimate the Larmor frequency ω 0 and the apparent transverse relaxation time
constant T2*, it provides no spatial information.

In MRI, external magnetic field

gradients (eg. a magnetic field with spatially varying strength) are used to spatially



encode the transverse magnetization M xy . MRI scanners are typically equipped with
three orthogonal gradient RF coils that produce magnetic gradients in the x-, y- and z





directions, denoted as G x = dB z dx , G y = dB z dy , and G z = dB z dz .

€

For example, if an external magnetic gradient, G, is applied in the r-direction then the net
€ B becomes a function of the space
€ vector r and is represented as:
magnetic field

€




B(r ) = B 0 [ z] + G r (r )[ z]

[1.31]

The Larmor frequency ω 0 is dependent on the magnetic field strength B as was shown in
€

equation [13]. Upon the application of the external magnetic gradient, Gr, the Larmor
frequency ω 0 becomes a spatially varying function of r described by:
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ω (r ) = γB(r ) = γ B 0 + G r (r )⋅ r = ω 0 + γG r (r )⋅ r

(

)

[1.32]

Magnetic gradients modulate the Larmor frequency (equation [1.13]) and introduce an
€

accumulated frequency difference, or phase φ that is dependent on r as described by:
t 

φ (r,t ) = γ ∫ G r (r, τ )⋅ r dτ

[1.33]

0

where t is the duration of the applied magnetic gradient Gr.
€

In MRI, magnetic gradients are used to spatially encode the transverse magnetization


M xy . The spatially dependent integral of the gradient represents a point in the k-space

domain as shown for the x- and y-direction denoted by:

€

€


γ t 
∫ G ( x, τ ) dτ
k x (t ) =
2π 0 x

[1.34]


γ t 
∫ G ( y, τ ) dτ
k y (t ) =
2π 0 y

[1.35]

Therefore, the total phase φ accrued throughout application of magnetic gradients Gx and
€

Gy is expressed in terms of the kx and ky as:



φ ( x, y, z,t ) = 2π k x ⋅ x + k y ⋅ y

(

)

[1.36]

The k-space domain represents the Fourier transform of the object. In other words, the
€

two-dimensional Fourier transform of an object in the space domain (eg. xyz space)
produces the spatial frequency representation of the object in k-space. Conversely, the
inverse Fourier transform of the k-space signal generates the spatial domain
representation of the object.
Another application of a magnetic gradient used in MRI is for slice selection. The
excitation of a specific, or ‘selected’ slab is called slice selection. Slice selection is
achieved using a magnetic gradient G that spatially varies the Larmor frequency.
Magnetic moments µ precessing with Larmor frequencies that are excited by the RF
24



pulse produce transverse magnetization M xy . The slice is selected by simultaneously
applying the magnetic gradient G and an RF excitation pulse with a bandwidth equal to
BWRF. The BW of an RF excitation pulse represents the range of frequencies, Δω,

€

centered on the RF pulse frequency ω RF (for on-resonance excitation ω RF = ω 0) that are
excited by the pulse. For example, a slice in the xy-plane of thickness Δz can be selected
using an RF pulse with BWRF and a magnetic gradient Gz, with the thickness determined
by:

⎛ γ  ⎞
Δz = BWRF ⎜ G z ⎟
⎝ 2π ⎠

[1.37]

In two-dimensional MRI, the transverse signal is spatially encoded by phase- and

€

frequency-encoding gradients using the orthogonal Gx and Gy gradients. For clarity, it
helps to define the y-direction of k-space ky as the phase-direction and the x-direction of
k-space kx as the frequency-direction. Similarly, phase- and frequency-encoding gradients
will be described in the space domain along the y- and x-direction respectively.
Application of a phase-encoding magnetic gradient Gy causes the magnetic moments µ in
the system to precess at different frequencies based on position y. During the time that
the phase-encoding magnetic gradient Gy is on, the accumulated phase depends on the yposition according to equation [36].

The phase-encoding magnetic gradient Gy is

typically turned off prior to signal acquisition, which causes the magnetic moments µ to
precess at the initial frequency (ie. Larmor frequency ω 0) but the y-dependent
accumulated phase shift remains fixed. Hence, the phase-encoding gradients spatially
encode the y position of magnetic moments µ in the sample through the y-dependent
phase accumulation.

Subsequent application of a frequency-encoding magnetic gradient

Gx causes the magnetic moments µ in the system to precess at different frequencies based
on position x.
acquisition.

The frequency-encoding gradients are applied throughout the signal

Similar to phase-encoding, the frequency-encoding gradients spatially

encode the x position of magnetic moments µ in the sample through the x-dependent
phase-accumulation.

25

Application of phase- and frequency-encoding gradients alters the transverse



magnetization M xy according to [38]:





−i 2 π ( k ( t ) x+ k ( t ) y )
M xy (t ) = M xy (0) ⋅ e −1 T ⋅ e −iω t ⋅ e
*
2

0

x

[1.39]

y

€
The amplitude of the magnetization at value of kx and ky represents the inverse Fourier
€

transform of the object. The signal collected by the RF receiver coil is used to fill this kspace using a sequence of magnetic gradients, as will be discussed using a pulse sequence
in the next section.

1.4.5 Pulse sequences
Most applications in MRI employ a sequence of RF pulses and external magnetic
gradients, known as a pulse sequence, to manipulate the thermal equilibrium net

magnetization vector M 0z into the transverse plane, and generate spatially encoded
signals from the sample. Pulse sequences have several parameters including the repetition
time (TR), echo-time (TE), and the RF excitation pulse flip-angle (α), which was defined
€
in Section 1.4.2. Pulse sequences typically repeat or loop through the same pattern of RF
pulses and gradients with a specified time of repetition (TR). Pulse sequences that
generate signal echoes, defined below, at specific echo times (TE) are very common in
MRI applications.
Spin-echo pulse sequences are based on the creation of signal echoes (or spin-echo) using
180o refocusing RF pulses after an initial α=90o excitation pulse along the x-axis.



Immediately after excitation, the transverse magnetization M xy is composed of spins that
are in phase and pointing along the y’-axis. The spins immediately begin to dephase due
to T2 and T2’ decay, as described in Section 1.4.3, resulting in decay of the transverse



€

magnetization M xy . It is important to recall that the T2’ signal decay is due to local static
field inhomogeneities. After a dephase period equal to TE/2, a 180o RF refocusing pulse
inverts the spins about the y’-axis. Following the 180o pulse, spins immediately begin to

€

rephase, forming a spin-echo at a time defined as TE. The refocusing pulse does not
affect the precession frequency of the spins, however their phase angle is inverted in the
26

transverse plane. Briefly, spins that exist in a slightly higher magnetic field, due to
inhomogeneities, precess relatively fast. Conversely, spins in slightly lower magnetic
fields precess relatively slow.

Phase dispersion occurs due to magnetic fields

inhomogeneities and consequent variations in the Larmor frequency. It is the refocusing
180o RF pulse that reverses the position of the ‘fast’ and ‘slow’ frequency spins relative
to each other. The spin-echo is formed when the ‘fast’ spins catch up and re-phase with
the ‘slow’ spins. The spin-echo signal amplitude still decays due to T2 relaxation. Only
the time-independent magnetic field inhomogeneity effects (T2’) are eliminated using the
refocusing pulses. Fast pulse sequences are typically preferred to reduce MRI acquisition
times. A fast spin-echo (FSE) pulse sequence consists of multiple 180o refocusing RF
pulses that result in multiple spin-echoes. Each spin-echo is recorded and is accompanied
by a specific set of phase- and frequency-encoding gradients to fill one line in k-space.
The filling of k-space will be described for a typical gradient-echo pulse sequence below.
Like spin-echo imaging, the gradient-echo imaging pulse sequence is commonly used.
While three-dimensional pulse sequences exist, the current explanation describes the
generation of a two-dimensional image only. A typical two-dimensional gradient-echo
pulse sequence begins with slice selection using a z-direction magnetic gradient Gz and a
90o RF excitation pulse with a bandwidth equal to BWRF as described in Section 1.4.2.



The transverse magnetization M xy created in the slice volume is immediately phaseencoded using phase-encode magnetic gradients Gy for a duration τy as discussed in
Section 1.4.4. Following removal of the phase-encode gradient Gy, a negative frequency-

€

encode magnetic gradient (- Gx) is applied for a duration τx/2. During application of the
frequency-encode magnetic gradient Gx, spins dephase rapidly due to T2 and T2’ decay
along with dephasing due to the magnetic gradient Gx. After applying the negative
frequency-encode Gx gradient for duration τx/2, an equal magnitude but positive magnetic
gradient (eg. Gx = + Gx⋅x) is applied for τx. The positive gradient reverses the dephasing
caused by the negative gradient, resulting in the formations of a gradient-echo exactly

τx/2 after the start of the positive gradient. In terms of k-space, the maximum durations
τx/y and maximum magnitude Gx/y of the frequency-/phase-encode Gx/y gradients are
determined based on the desired field of view (FOVx/y) as shown by:
27

FOVx =

1
γ 
⋅G ⋅τ
2π x x

[1.40]

and

€
FOVy =

1
γ 
⋅G y ⋅τy
2π

[1.41]

1.5 Chemical exchange saturation transfer (CEST)
€

Chemical exchange saturation transfer (CEST) represents a relatively new class of MRI
contrast. CEST enables detection of small (~ mM) solute proton pools that exchange
with the bulk water proton pool (~110 M). Typical solute protons pools include protons
associated with exogenous paramagnetic (PARACEST) agents as well as protons
associated with endogenous molecules (endogenous CEST). A unique and powerful
advantage of CEST contrast is the ability to switch CEST contrast on and off, which
enables the use of multiple CEST agents (e.g. multiple PARACEST agents and/or
endogenous molecules) simultaneously for labeling.
Investigations into the effects of chemical exchange on pools of nuclei have been
ongoing for more than 50 years. McConnell and Thompson introduced a modified
version of the Bloch equations known as the Bloch-McConnell equations that include
chemical exchange effects in 1957. Balaban and Ward coined the term CEST more
recently in 2000 when they described a new class of MRI contrast agents that are
sensitive to their surrounding environment. Balaban and Ward immediately recognized
and investigated applications of CEST agents to measure tissue temperature and pH.
Fast-forward roughly 15 years and CEST remains a rapidly growing field in the MR
community. The collection of CEST applications is diverse including cell labeling,
monitoring glucose uptake, detection of the ischemic penumbra following stroke,
detection of zinc ions and many more.
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In this section, fundamental principles of CEST are presented.

Specifically, the

mechanisms leading to CEST are discussed qualitatively referencing quantum theory
followed by a mathematical description using the Bloch-McConnell equations. A
description of some marked differences between PARACEST and endogenous CEST is
followed by a review of the background theory regarding CEST dependence on pH and
temperature.

1.5.1 CEST mechanism
CEST contrast is generated by saturation of a solute (S) proton pool that is 1) chemicallyshifted from bulk water protons and 2) in chemical exchange with bulk water (W)
protons. The process of chemical exchange transfers high energy protons to the bulk
water proton pool, saturating this pool, resulting in a reduced net magnetization that leads
to a decrease (darkening) in MR image intensity. A proper description of the CEST
mechanism requires definition of chemical shift, saturation and chemical exchange.
Chemical shift is defined as the difference in Larmor frequency of two nucleus pools.
The Larmor frequency was defined in equation [1.13] as the product of the nucleus
specific gyromagnetic ratio γ and the main magnetic field B0. While the gyromagnetic
ratio γ is identical for all protons, the local magnetic field depends on a proton’s chemical
environment such as the solute molecule with which it is associated. The electron cloud
surrounding the nucleus causes changes in local magnetic field. Electron clouds shield
the nucleus from the main magnetic field B0 resulting in an effective main magnetic field
(B0’) expressed as:


B'0 = B0 (1− σ s )

[1.42]

where σ s is the solute-dependent shielding coefficient. Protons associated with a specific
€

solute molecule tend to have unique Larmor frequencies expressed as:



ω s = γB'0

[1.43]

€
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For CEST applications, the Larmor frequency of bulk water protons is set as the
reference frequency ω ref. The chemical shift, or frequency offset, of solute protons from
bulk water protons is defined in ppm according to:

 
ω s - ωref
δ= 
⋅106
ωref

[1.44]

Saturation is achieved using RF pulses. As mentioned in Section 1.4.1, the z-component

€

of the proton magnetic moments µ z tend to align parallel with the direction of B0 in the
presence of a static external magnetic field (B0). For clinical magnetic field strengths at
room temperature, there is a slight excess of protons oriented parallel with B0 in the low
energy state EL compared to protons oriented anti-parallel with B0 in the high energy
state EH. Saturation is achieved by applying an RF excitation pulse with energy equal to
the energy difference between the two proton energy states ΔE described in Section 1.4.1,
which drives enough low energy protons to the high energy state such that the
populations in each energy state are equal. More specifically, for the RF pulse to excite
protons from EL to EH, or vise versa, the pulse energy hω RF must equal the energy
required to transition between the states, which is equal to ΔE. Considering equations
[1.13] and [1.15], it is shown that the applied RF pulse frequency ω RF must be equal to
the Larmor frequency ω 0 because:





hω RF = ΔE = γhB0 = hω0

[1.45]

It is important to note that in CEST applications, an RF pulse is typically used to saturate

€

a pool of solute protons resonating at a Larmor frequency ω S that is chemically shifted
from the bulk water protons. Hence, application of an RF pulse of amplitude B1 and
tuned to the frequency offset of the solute proton pool (eg. ω RF = ω S) leads to a net
excitation of protons in the lower energy state EL into the higher energy state EH. If the
RF pulse has enough energy, the number of protons at each energy level will equalize
(eg. NL = NH) and the proton pool is saturated. A long RF pulse designed to saturate a
solute proton pool and not generate phase coherence is referred to as an RF saturation
pulse from this point forward.
30

Chemical exchange occurs when a nucleus freely passes between two different chemical
environments.

For CEST applications, the most common pathways of chemical

exchange include proton exchange, molecular exchange or a combination of both. An
example of proton exchange is when a proton from a protein amide group (NH2) moves
to bulk water (H2O). An example of molecular exchange is a water molecule moving
between free water and a paramagnetic lanthanide metal associated with a PARACEST
agent. In order to observe CEST contrast, chemical exchange must occur on the slow-tointermediate NMR time-scale defined as:


Δω s ≥ k sw

[1.46]

where ksw represents the chemical exchange rate from the solute to the bulk water pool

€

and Δω s is the frequency offset between the solute protons and bulk water protons. Note
that the chemical shift δ is the frequency offset Δω s normalized by the reference
frequency ω ref. Importantly, both the chemical exchange rate ksw and the chemical shift δ
often depend on pH and temperature.
In summary, CEST contrast is generated in a system with a chemically shifted solute
proton pool that is in chemical exchange with the bulk water proton pool. A frequencyselective RF saturation pulse is applied to saturate the solute proton pool.

During

saturation, chemical exchange transfers an increased number of high energy protons (eg.
aligned anti-parallel with B0) from the saturated solute pool to bulk water pool.
Throughout a long (eg. several seconds) RF saturation pulse, high energy protons
accumulate in the bulk water pool leading to partial saturation. Bulk water proton pool
saturation is limited by ongoing longitudinal relaxation. The simultaneous saturation and

relaxation of the bulk water proton pool drives the system to a steady state M sszw during a
long RF saturation pulse. The CEST effect is the resulting partial saturation of the bulk
water proton pool due to saturation of the solute proton pool. The proton transfer ratio
€
(PTR) is common metric used to quantify CEST effects by calculating the reduced steady


state bulk water magnetization M sszw relative to the equilibrium magnetization M 0zw as
shown by:

€

€
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M sszw
PTR = 1-  0
M zw

[1.47]

CEST contrast is measured as the reduction in the bulk water proton MRI signal
generated by saturating a much smaller solute proton pool that is exchanging with bulk
water protons. Chemical exchange acts as sensitivity amplification mechanism because
bulk water saturation accumulates throughout the long RF saturation pulse resulting in
significantly amplified bulk water reduction.
A typical CEST MRI experiment consists of the acquisition of a series of MR images that
are each preceded by a RF saturation pulse with an incrementally different frequency.


The normalized MRI signal intensity ( Msszw M0zw ) is then plotted as function of the RF
saturation pulse frequency offset relative to bulk water resonance to create a CEST
spectrum. If experimental parameters are appropriate then a reduction in MRI signal
€
intensity referred to as a ‘CEST peak’ may be observed in the CEST spectrum. A CEST
spectrum is shown in Figure 1.4 with a CEST peak at 10 ppm highlighted by the arrow
for illustrative purposes.
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Figure 1.4: A typical CEST spectrum. A CEST effect (or CEST peak) can be observed
at at 10 ppm as highlighted with the arrow. The peak at 0 ppm is due to direct saturation
of the bulk water protons by the RF saturation pulse.

1.5.2 Mathematical description of CEST
CEST contrast is the result of a complex interplay of proton pool parameters as well as
RF saturation pulse parameters and mathematical descriptions are often useful to
understand the impact of individual parameters. The Bloch-McConnell equations are
used to describe multi-pool exchange systems during the saturation pulse. In this section,
Bloch-McConnell equations are introduced for two-pool and three-pool exchange
systems. The two-pool version of the Bloch-McConnell equations describes a system
with one solute (s) dissolved in water (w) and is written as:
⎡ 1
− kws
⎢−
⎢ T2w
⎡M xw ⎤ ⎢
kws
⎢
⎥ ⎢
⎢
M
⎢ xs ⎥
⎢
⎥ ⎢ Δω rf ,w
d ⎢M yw ⎥ ⎢
=
dt ⎢M ys ⎥ ⎢
0
⎢
⎥ ⎢
⎢M zw ⎥ ⎢
⎢⎣M ⎥⎦ ⎢− 1 − kws
zs
⎢ T
⎢ 1w
⎢
kws
⎢⎣

€

k sw
−

1
− k sw
T2s
0

−

−

−Δω rf ,w

0

0

0

−Δω rf ,s

0

0

−ω 1

1
− kws
T2w

1
− k sw
T2s

Δω rf ,s

0

k sw

0

0

ω1

0

0

0

1
− k sw
T1s

−

0

⎤
0 ⎥
⎥
⎡0
⎤
⎥
⎥
0 ⎥ ⎡M xw ⎤ ⎢0
⎥
⎢
⎥ ⎢
⎥ ⎢M xs ⎥ ⎢0
⎥
⎢
⎥
0 ⎥ ⎢
⎥
⎥ ⎢M yw ⎥ ⎢0
⎥
⋅
+
⎥ ⎢M ⎥ ⎢ M 0 ⎥
ys
zw
−ω1 ⎥ ⎢
⎥
⎥ ⎢
⎥ ⎢M zw ⎥ ⎢ T1w ⎥
⎥
⎢
⎥
0 ⎥ ⎢⎣M zs ⎥⎦ ⎢ M 0zs ⎥
⎢⎣ T1s ⎥⎦
⎥
ω 1 ⎥
⎥⎦

[1.48]

M 0zi is the thermal equilibrium longitudinal magnetization and the chemical exchange
rate from pool i to j is kij . The Larmor frequency of pool i is denoted as ω0i . The

€

longitudinal and transverse relaxation time constants for pool i are T1i and T2i
respectively.

RF saturation pulse parameters include the amplitude
ω 1 = γB1 , the
€

€

frequency offset from pool i denoted as Δω rf ,i = ω rf − ω 0i , and the
€ duration€ (tsat) for a
continuous wave rectangular pulse that is assumed to be along the€x’-axis in the rotating
frame of reference.

€
Analytical steady-state solutions derived using reasonable assumptions provide insight
into the effects of proton pool and RF saturation parameters.
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Zhou and Van Zijl

introduced the weak saturation pulse (WSP) approximation that is often used to derive
analytical solutions for the steady state bulk water magnetization after a long RF
saturation pulse [66]. Briefly, the WSP approximation assumes that RF saturation pulse
acts on the solute proton pool (eg. Δωrf,s = 0) and not the bulk water pool (eg. Δωrf,w →
∞). Under WSP conditions, the two-pool system reaches a steady state and it is possible
to derive analytical solutions. At steady state, the time derivatives in equation [1.48] are
zero and the exact steady state PTR can be solved as:

PTR (Δωrf ,s ) =

k ws
⋅
R 1w + kws

ω12

[1.49]

p
ω + pq + Δωrf2 ,s
q
2
1

where,

€

p = R 2 s + k sw −

ksw kws
R 2 w + kws

[1.50]

ksw kws
R 1w + kws

[1.51]

and

€
q = R 1s + k sw −

and the rate of spin-lattice (R1) and spin-spin (R2) relaxation are defined as:

€
R 1,2 =

1
T1,2

[1.52]

The labeling fraction or saturation efficiency α is defined as:

€

α (Δωrf ,s ) =

ω12

[1.53]

p
ω + pq + Δωrf2 ,s
q
2
1

and represents the fraction of solute protons that are saturated at steady state as shown by:

€
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M sszs
= 1− α
M 0zs

[1.54]

Hence, at steady state PTR can be described as:

€
PTR (Δωrf ,s ) =

k ws
α (Δωrf2 ,s )
R 1w + kws

[1.55]

Using the WSP approximation and assuming that the solute proton pool reaches steady

€

state instantaneously Zhou et al. also derived the time-dependent PTR solutions:

PTR (t sat ) =

k wsα
− R
⋅ 1− e (
R 1w + k ws

[

1w

+kws ) t sat

]

[1.56]

The chemical exchange rates obey the rate equation:

€

kws M 0zw = ksw M 0zs

[1.57]

Using equations [1.56-1.57] a more insightful version of the time-dependent PTR

€

solutions is given as:
PTR (t sat ) =

k sw M 0zsα
− R
⋅ 1− e (
0
(R1w + kws )M zw

[

1w

+kws ) t sat

]

[1.58]

The time-dependent PTR solution in equation [1.58] is often used to highlight the effects
€

of several CEST parameters including solute concentration, bulk water T1 and the
exchange rate from solute to water pool, ksw. For example, based on equation [1.58] one
may predict that CEST contrast is linearly dependent on the solute concentration since

M 0zs M 0zw ∝[solute protons] [water protons].
The fundamental relations identified in the analytical steady state solutions are a useful

€

theoretical platform for designing optimal CEST experiments by modeling changes in
specific sample parameters such as concentration or pH-dependent exchange rate.
However, it is important to understand the limitations of the WSP assumption and the
two-pool model. For example, the chemical shift δ of solute protons must be large (>10
35

ppm) in order avoid violation of the WSP approximation by perturbing the bulk water
protons during RF saturation. Whereas, endogenous CEST contrast is typically generated
using solute protons less than 5 ppm away from bulk water protons and therefore the
WSP approximation is not reasonable for typical RF saturation pulse amplitudes B1 (~2
µT) with adequate durations to achieve steady state.
In order to avoid restrictive assumptions, Woessner et al. introduced numerical
simulations using the Bloch-McConnell equations. Briefly, the Bloch-McConnell
equations (equations [1.48]) are given in the form:


dM
= A⋅ M + B
dt

[1.59]

and therefore have the time-dependent analytical solution:
€
 ⎛
B ⎞
B
M = ⎜M0 + ⎟exp( At ) −
A ⎠
A
⎝

[1.60]

Woessner and colleagues used numerical solutions to investigate effects of the chemical
€

exchange rate on CEST contrast [60] in order to optimize CEST contrast and improve the
application of pH-dependent chemical exchange rates for pH measurement. It was shown
that an optimal RF saturation amplitude B1 exists for a given exchange rate ksw, and is
equal to 2πB1 = ksw [60]. The time-dependent analytical solutions numerical solution
approach is more powerful and applicable since they do not require any assumptions or
approximations.
Numerical solutions can be used to simulate CEST spectra for a range of parameters to
identify a parameter set that generates optimal PTR. For example, after setting all
chemical and RF saturation pulse parameters, the effect of varying the solute
concentration on the CEST spectrum and PTR can be numerically simulated as shown in
Figure 1.5a,b. Similarly, the effects of varying the bulk water longitudinal relaxation
time constant T1w = 1/R1w (Figure 1.5c,d), the solute proton exchange rate ksw (Figure
1.5e,f) and finally the RF saturation pulse amplitude (Figure 1.5g,h) are also shown.

36

a) "!!

b)

&!

%!

09;/8<:

&!

F

!

E GE /8<:

>&

#&

!
"&

!
!

="&

c) "!!

#!

"!

"!!/5E
#&!/5E
&!!/5E
"!
&
!
=&
="!
'()*+(),-./?+3@*3.AB/CDD23)/8665:

$!

d)

"!!
#!!
$!!
%!!
'-1*)3/N-.A3.)+(),-./85E:

&!!

"
#
$
%
K*1L/M()3+/9"/9,53/N-.2)(.)/823A:

&

$!

>&

09;/8<:

&!

F

!

E GE /8<:

#!

"!
#&

!
"&

e)

!H&/2
"H!/2
#H!/2
&H!/2
"!
&
!
=&
="!
'()*+(),-./?+3@*3.AB/CDD23)/8665:

!
!

="&

f)

"!!

&!

%!

09;/8<:

&!

F

!

E GE /8<:

>&

#&

!
"&

g)

&!/IJ
"!!/IJ
&!!/IJ
$!!!/IJ
"!
&
!
=&
="!
'()*+(),-./?+3@*3.AB/CDD23)/8665:

!
!

h)

"!!! "&!! #!!!
OPAQ(.R3/;()3/8IJ:

#&!!

$!!!

09;/8<:

"&

&!

F

!

E GE /8<:

&!!

#!

>&

#&

!
"&

#!

"!

="&

"!!

$!

"!

&
!H"/µ9
"H&/µ9
&H!/µ9
"!
&
!
=&
="!
'()*+(),-./?+3@*3.AB/CDD23)/8665:

!
!

="&

37

"
#
$
%
'()*+(),-./0*123/4561,)*73/8µ9:

&

Figure 1.5: Numerically simulated CEST spectra (a,c,e,g) and proton transfer ratios
(PTRs) (b,d,f,h) using the time-dependent analytical solutions of the two-pool version of
the Bloch-McConnell equations. The effects of varying solute proton concentration (a,b),
bulk water T1 relaxation time constant (c,d), solute proton exchange rate (e,f), and RF
saturation pulse amplitude (g,h) were investigated by varying the parameter of interest.
For all simulations, unless otherwise stated: T1w=2.0 s, T2w = 50ms, T1s=1.0 s, T2s =
50ms, ksw = 50 Hz, [solute proton] = 100 mM, Δω s = 10 ppm, saturation pulse
amplitude = 1.5 µT, saturation duration = 10 s).
Two-pool steady state solutions may only be used to simulate very simple CEST
€
experiments with aqueous solutions in vitro. In vivo CEST experiments are more
accurately described by incorporating the presence of magnetization transfer (MT)
processes between bulk water protons and protons associated with endogenous
macromolecules (m). For example, RF saturation pulse amplitudes that generate optimal
contrast in aqueous solutions in vitro are typically not optimal in vivo because significant
contrast is loss in vivo due to MT effects. Therefore, a three-pool or four-pool version of
the Bloch-McConnell equations is generally used to describe CEST effects and inherent
macromolecule effects MT effects. The macromolecules represent the semi-solid
component of tissue, which is modeled using very short transverse relaxation.

To

simulate the endogenous macromolecular MT effect, the macromolecule proton pool is
described mathematically using a super-Lorentzian line shape across a very broad range
of frequencies (~200 ppm) centered at bulk water protons. Specifically, the superLorentzian line shape is used since Li et. al found that the super-Lorentzian line shape
simulates the endogenous macromolecule MT effects observed in biological tissue better
than the Lorentzian or Gaussian line shape. The interested reader is referred to [67, 68]
for a comprehensive explanation of mathematical descriptions of macromolecular MT
effects. Since the macromolecule and solute proton pools are very small compared to the
bulk water pool, chemical exchange between the solute and macromolecule pools is
negligible and ignored. The three-pool version of the Bloch-McConnell equations is:
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[1.61]
using identical parameter definitions as the two-pool version and the super-Lorentzian
line shape g defined as:
⎧ ⎛
⎞ 2 ⎫
⎪ ⎜ Δω rf ,m T2 m ⎟ ⎪
⎨ −2
⎬
2
⎪ ⎜⎝ 3cos θ −1 ⎟⎠ ⎪
⎩
⎭

2π2
T2 m
∫ sinθ
g (Δωrf ,m ) =
e
π 0
cos2 θ −1

(

)

dθ

[1.62]

It is not possible to derive exact equations for the three-pool version of the Bloch-

€

McConnell equations. However, again the Bloch-McConnell equations are of the form
shown in equation [1.59] leading to the time-dependent analytical solution shown in
equation [1.60]. The analytical solutions derived using the three-pool model provide a
more accurate description of CEST contrast in vivo. The effect of incorporating the
macromolecule pool in a simulated CEST experiment is demonstrated in Figure 1.6. It is
important to note that a fourth pool may be added in cases where two CEST generating
solutes are simultaneously modeled in vivo, as was done in chapter 3.
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Figure 1.6: Three CEST spectra were numerically simulated using the three-pool version
of the Bloch-McConnell equations with different macromolecule concentrations
expressed in % of macromolecules (% MT) . The impact of magnetization transfer (MT)
effects from macromolecules on CEST effects is evident when comparing CEST spectra
simulated with 0% MT (a), 5% MT (b) and 10% MT (c). For all simulations, T1w=2.0 s,
T2w = 50ms, T1s=1.0 s, T2s = 50ms, T1m=100ms, T2s = 15µs, ksw = 50 Hz, kmw = 50 Hz,
[solute proton] = 100 mM, Δω s = 10 ppm, Δω m = 10 ppm, saturation pulse amplitude =
1.5 µT, saturation duration = 10 s).

€

€

1.5.3 Endogenous CEST and PARACEST
The work presented in this thesis focuses on two different types of CEST known as
endogenous CEST and PARACEST. Endogenous CEST contrast is generated using
protons associated with endogenously expressed solutes such as proteins and peptides, or
metabolites such as glucose, glutamate, and creatine. Specifically, work reported in this
thesis uses amide (Δω = 3.50 ppm) and amine protons (Δω = 2.75 ppm) that are
associated with proteins and peptides (Chapters 2 and 3). Exchangeable endogenous
solute protons typically have frequency offsets within 5 ppm of bulk water protons.
Therefore, CEST contrast can only be generated using exchangeable protons with
exchange rates slower than 2000 Hz at 9.4 T, determined using the slow-to-intermediate
exchange condition in equation [1.46]. PARACEST contrast is generated using protons
40

associated with exogenous paramagnetic lanthanide complexes. In 2001, Aime et al. [69]
and Zhang et al. [70] separately discovered that protons associated with Europium (Eu3+)
bound water molecules could be detected at a frequency offset ~ 50 ppm away from
water. Europium bound water molecules exchange with bulk water at an exchange rate of
2630 Hz, which is well within the slow-exchange regime due to the large chemical shift.
Other lanthanide metals such as Tm3+ and Yb3+ have bound water molecules with
chemical shifts greater than 200 ppm, which is outside of the endogenous macromolecule
MT range [71]. Hence, the large chemical shift of lanthanide PARACEST agents offers
two important advantages that should theoretically improve sensitivity.

First, the

increased chemical shift away from bulk water enables detection of protons with much
faster exchange rates while still satisfying the slow-to-intermediate exchange condition
and the CEST contrast increases with exchange rate ksw, according to equation [1.46].
Second, the large chemical shift enables CEST detection in the presence of endogenous
MT effects, which was shown to significantly reduce CEST contrast in Figure 1.6.
Zhang et al. used the Bloch-McConnell equations to demonstrate that PARACEST agents
with large chemical shifts and optimal exchange rates could generate detectable CEST
contrast at µM concentrations [71]. While theoretical models suggest that PARACEST
agents could have greater detection sensitivity than typical Gd3+-based relaxivity contrast
agents, PARACEST agents have suffered from low-detection sensitivity due to a severe
loss of contrast as a result of bulk water saturation from endogenous macromolecules,
which reduces the dynamic range of the CEST experiment. Furthermore, as previously
mentioned very fast exchange rates require high amplitude B1 saturation RF pulses to
achieve optimal CEST contrast, which can exceed clinical specific absorption rate (SAR)
limits. Currently, several groups are exploring the addition of different ligands (eg. side
arms) to lanthanide complexes to alter both the chemical shift and proton exchange rate.
For example, the DOTAM-Gly ligand was first introduced by Aime et al. in 2002 [72].
Lanthanide complexes with DOTAM-Gly ligands have exchanging bound water protons
and amide protons giving rise to two different chemical exchange sites. A lanthanide
complex developed by Hudson and colleagues [73] called Tm-DOTAM-Gly-Lys is used
in Chapter 4 to measure pH using the amide proton CEST effects in vivo.
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1.5.4 Proton exchange rate and pH measurement
The proton exchange rate affects the magnitude of the CEST effect as was shown in
figure 1.5e,f. Importantly, the proton exchange rate kex is pH-sensitive for several types
of exchangeable protons including amine and amide groups. The proton exchange rate kex
depends on pH according to equation [1.65]:
kex = k0 + ka [ H + ] + kb [OH − ] = k0 + ka 10 − pH + k b 10 pH−pK

w

[1.65]

where k0 is the rate constant of the spontaneous proton exchange reaction between water
€

and the amide nitrogen nucleus, ka is the rate constant of the acid-catalyzed protonation
of the amide nitrogen nucleus, kb is rate constant of the base-catalyzed proton exchange
reaction between hydroxyl ion (OH-) and the amide nitrogen nucleus, and pKw is the
ionization constant of water (pKw = 15.4 at 37 oC) from equation [1.3] in Section 1.2.1.
However, proton exchange is predominantly base-catalyzed for amide and amine protons
and the expression for proton exchange rate is often simplified as:

kex = k b 10 pH−pK

[1.66]

w

The pH-dependence of proton exchange has been known since before the origin of CEST

€

imaging in 2000 [74, 75]. Since CEST contrast is dependent on proton exchange rate it is
inherently sensitive to pH.

However, CEST contrast also depends on other factors

including: solute proton concentration, temperature, B1 amplitude, as well as bulk water
relaxation time constants (T1 and T2). The difficulty in quantitative pH measurement
using CEST contrast is isolating the pH contribution to the CEST contrast effects on
CEST measurements. For example, in some cases, increasing pH will cause the CEST
contrast to increase. However, an increase in solute proton concentration could also
induce an identical increase in CEST effect. Therefore, it is tedious and difficult to
properly measure pH without contamination from other concurrent effects. Isolation of
pH effects on CEST contrast is further complicated in vivo by the endogenous
macromolecule MT effects and because the exact solute proton concentration is
unknown. Different strategies to measure pH with CEST have been developed for
endogenous CEST and PARACEST.
42

1.5.4.1

Using endogenous CEST to measure pH

Endogenous CEST contrast generated using amide protons resonating at 3.50 ppm
downfield (ie. higher frequency) from bulk water protons has been used to measure pH
[33]. The amide protons visible at 3.50 ppm are associated with mobile proteins and
peptides. Approximately 90% of proteins and peptides originate from the intracellular
compartment and consequently, pH measured using amide proton CEST effects is
considered to be heavily weighted to the intracellular space and is referred to as
intracellular pH. Zhou et al. first developed a method to measure intracellular pH using
amide proton transfer (APT) imaging, however this APT pH measurement required
several limiting assumptions [33]. First, Zhou et al. subtracted the macromolecule MT
effects from the CEST contrast using the asymmetric magnetization transfer ratio
(MTRasym) curve by subtracting the negative frequency offsets from the positive
frequency offsets of the CEST spectrum with bulk water proton frequency referenced to 0
ppm using equation [1.67].

MTR asym (Δω ) =

M Z (Δω ) − M Z (−Δω )
M Z (−Δω )

[1.67]

where MZ(Δω) represents the bulk water magnetization after saturation at the frequency

€

offset ∆ω. Furthermore, Zhou et al. defined the MTRasym curve as the combination of an
inherent and pH-insensitive MTRasym curve defined as MTR’asym and a pH-sensitve amide
proton transfer ratio (APTR) as shown by:

APTR (tsat ) =

kex [amide proton]α

[water proton]R

⋅ [1− e −R

t

1 w sat

]

[1.68]

1w

Equation [1.68] is clearly derived from the time-dependent steady state solutions from

€

equation [1.58], which was derived from the two-pool exchange model using the WSP
approximation. Using water exchange filter spectroscopy (WEX) experiments, Zhou et
al. measured amide proton exchange rates in rat brains in different physiological states
including healthy, during cerebral ischemia and post mortem, and also measured
intracellular pH using the chemical shift between inorganic phosphate (Pi) and
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phosphocreatine (PCr) obtained by 31P NMR. The proton exchange rates and pH values
were fit to the theoretical equation [1.69] giving the in vivo relationship described by:

kex = 5.57 ×10 pH−6.4

[1.69]

Quantitative pH measurement using APT imaging is quite limited because the pH-

€

sensitive parameter APTR is also affected by amide proton concentrationa, cellular water
content, and longitudinal relaxation.

Also the MTRasym measurement may be

contaminated by nuclear Overhauser effects (NOEs) that occur between -2.0 and -4.0
ppm, directly opposite to the amide protons at 3.50 ppm. Therefore, pH measurement
using APT is susceptible to error.
Recently Cai et al. demonstrated that amine protons associated with glutamate have pHsensitive exchange rates [76]. Similarly, several groups showed that hydroxyl protons
associated with glucose exchange with water in a pH-dependent manner [13, 77, 78].
However, these CEST effects are also affected by changes in longitudinal relaxation and
concentration limiting their utility for absolute pH measurement.

1.5.4.2

Using PARACEST to measure pH

In 2000, Ward and Balaban demonstrated absolute pH measurement using PARACEST
contrast in vitro [75]. A novel ratiometric approach was developed to measure pH
independent of agent concentration or longitudinal relaxation using two different basecatalyzed exchange sites.

Briefly, two pH-sensitive effects can be observed from

solutions containing either a single agent with two chemically shifted exchange sites or a
mixture of two agents, each with one chemically shifted exchange site. When using a
single agent, the ratio of the two CEST effects was shown to be independent of agent
concentration and longitudinal relaxation. When using a mixture of two PARACEST
agents, the ratio of both agents’ concentration is assumed to be constant, which is only
appropriate if the two PARACEST agents have identical pharmacokinetic properties.
Recently, Sheth et al. demonstrated extracellular pH measurement in a mouse tumor
model using a ratiometric approach with a single PARACEST agent that possessed
exchangeable amine protons resonating at 10 ppm and amide protons resonating at -10
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ppm relative to water [79-81]. In Chapter 4, we developed a novel method to measure
extracellular pH using a PARACEST agent using the line shape of the CEST effect. This
approach is independent of agent concentration and T1 relaxation.

1.5.5 Chemical shift: pH and temperature effects
The chemical shift (δ) of protons associated with lanthanide PARACEST agents can be
sensitive to both pH and temperature [82, 83]. As mentioned in Section 1.3.1, the
chemical shift is determined by the distribution of the electron clouds. The chemical shift
is often divided into the diamagnetic component and the paramagnetic component, with
the latter describing the effects of the unpaired electrons. Importantly, the paramagnetic
component of the chemical shift of a nucleus is often much larger than the diamagnetic
component [83]. The paramagnetic chemical shift depends on the position of unpaired
electrons relative to the nucleus, which in turn depends on temperature and sometimes pH
[83].

Zhang et al. first introduced the idea of measuring the chemical shift using

PARACEST contrast to measure temperature [82]. Our group recently developed a Eu3+based PARACEST agent called Eu3+-DOTAM-Glycine(Gly)-Phenyalanine(Phe) with a
temperature-dependent and pH-independent bound water chemical shift. Using in vitro
and ex-vivo phantoms, the chemical shift was shown to be independent of agent
concentration, local pH, and endogenous macromolecule MT effects within
physiologically relevant ranges [84]. In Chapter 4, the bound water proton chemical shift
of a new Tm3+-based PARACEST agent is shown to depend on pH and temperature.
Temperature and pH we calculated simultaneously by first obtaining pH using the
linshape of the CEST effect and then the temperature using both the pH and the chemical
shift.
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Chapter 2

2

Simultaneous in vivo pH and temperature mapping using a
PARACEST-MRI contrast agent
Nevin McVicar, Alex X. Li, Mojmir Suchy, Robert H.E. Hudson, Ravi S. Menon, and
Robert Bartha
Magnetic Resonance in Medicine. November 2012. DOI: 10.1002/mrm.24539

Abstract: Altered tissue temperature and/or pH is a common feature in pathological
conditions where metabolic demand exceeds oxygen supply such as in tumors and
following stroke. Therefore in vivo tissue temperature and pH may become valuable
biomarkers for disease detection and the monitoring of disease progression or treatment
response in conditions with altered metabolic demand. In the current study, pH is
measured using the amide protons of a thulium (Tm3+) complex with a DOTAM-GlycineLysine (ligand: Tm3+-DOTAM-Gly-Lys). The pH was uniquely determined from the
linewidth of the asymmetry curve of the chemical exchange saturation transfer (CEST)
spectrum, independent of contrast agent concentration or temperature for a given
saturation pulse. pH maps with an inter-pixel standard deviation of less than 0.1 pH units
were obtained in 10 mM Tm3+-DOTAM-Gly-Lys solutions with pH ranging from 6.0 to
8.0 pH units at 37 oC. Temperature maps were simultaneously obtained using the
chemical shift of the CEST peak. Temperature and pH maps are demonstrated in the
mouse leg (N=3), where the mean and standard deviation for pH was 7.2 ± 0.2 pH unit
and temperature was 37.4 ± 0.5 oC.

2.1 Introduction
Contrast agents for magnetic resonance imaging (MRI) are often used in clinical
medicine. Most MRI contrast agents are gadolinium-based compounds that enhance
image contrast by shortening the bulk water longitudinal relaxation time through rapid
exchange of inner-sphere water molecules with bulk water [1, 2]. However, most
gadolinium-based agents have limited responsiveness to their environment. In contrast,
MRI contrast agents based on chemical exchange saturation transfer (CEST) [3, 4] may
be used to measure pH [5-8], track genetically altered glioma cells expressing lysine-rich
protein [9], and track the metabolism of glycogen in mammalian tissue [10].
Furthermore, paramagnetic CEST (PARACEST) contrast agents may be used to measure
physiological parameters [11-26], including tissue pH based on the pH dependence of the
exchange rate of amide protons with bulk water protons [11-15, 27], and tissue
temperature using the linear dependence of the exchangeable proton chemical shift on
temperature [16, 17]. PARACEST agents can also be made sensitive to enzymatic
activity [18, 19], proteins [20], and metabolites [21-23].
Altered tissue pH is a common feature in pathological conditions such as stroke and
tumors when metabolic demand for oxygen exceeds supply. The reduced buffering
capacity of tumor interstitial fluid, reduced tumor perfusion, and the increased lactic acid
secreted by tumor cells results in an acidic pH (i.e. 6.4 ~ 7.0) that is lower than normal
tissue pH (i.e. 7.0 ~ 7.4) [5, 6, 28-31]. Therefore in vivo tissue pH may be a valuable
biomarker of disease progression and/or a predictor of treatment response. Extracellular
pH could also be used to measure physiological changes due to radiation treatment and
chemotherapy. Accurate in vivo pH measurements could significantly improve cancer
and stroke treatment strategies.
Several methods to measure pH using PARACEST agents [11-15] have been
demonstrated based on the pH dependence of the CEST effect of amide protons. Initial
attempts were based on the CEST peak amplitude [13, 14, 32]. However, the amplitude
of the CEST effect depends on many factors including the saturation pulse power, and
duration, which are controlled, but also agent concentration, temperature, and pH, which
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are typically unknown in vivo.

Therefore, direct application of the CEST effect

amplitude for in vivo pH measurement is difficult.
To overcome the concentration dependence, Aime et. al. [11] proposed the use of
ratiometric methods developed by Ward et. al. [3] using a PARACEST agent with a
bound water and an amide proton exchange site, or utilizing the bound water exchange
site from one PARACEST agent and the amide proton exchange site from another. This
approach is possible because the CEST effect arising from bound water is unaffected by
changes in pH over the physiological pH range (i.e. 6 - 8), but the CEST effect from the
amide protons is sensitive to pH changes. Therefore the ratio of the amide proton CEST
effect to the bound water CEST effect provides a concentration independent method to
measure pH. However the CEST effect from these two pools is acquired in two separate
experiments using different saturation powers because the exchange rate of bound water
with bulk water is significantly different than that of amide protons. A limitation of this
approach is the assumption that endogenous magnetization transfer (MT) effects will not
affect the ratio of the measured CEST effects from bound water and amide protons.
Since the MT effect is typically different at the chemical shifts of the amide proton and
bound water protons, regional differences in MT could alter the measured ratio of the
CEST peaks. Altered temperature is also a property of pathological tissues [17, 33].
Therefore pH measurements must be independent of temperature.

Temperature has

negligible effects on pH measurements calculated using ratiometric methods within
physiological temperature ranges [34, 35]. The method presented in the current study is
expected to be less sensitive to temperature since linewidth measurements are
independent of chemical shift.

Recently in vivo extracellular pH maps were

demonstrated based on the ratiometric method [32, 36].
Another method to measure pH using only the amide proton site of a PARACEST agent
was proposed by Wegh et. al. [27]. The approach involves taking the ratio of the CEST
effect at the resonance frequency of the amide protons and a frequency several parts per
million (ppm) closer to the water frequency [37]. This ratio was pH-sensitive and
concentration independent.

However, the method assumed that the temperature

dependent resonance frequency of the amide protons was constant.
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In the current study, a novel method was developed to measure pH using the glycine
amide proton site of a thulium (Tm3+) complex with a DOTAM-Glysine-Lysine (ligand:
Tm3+-DOTAM-Gly-Lys) [38].

With this compound, pH was determined from the

linewidth of the asymmetric magnetization transfer ratio (MTRasym) curve, independent of
agent concentration and temperature for a given saturation pulse. Temperature was
measured simultaneously using the dependence of the CEST peak chemical shift on
temperature. This novel method is demonstrated in vivo in the murine leg muscle
following intramuscular injection.

2.2 Theory
CEST contrast is generated by the saturation of the exchangeable chemically shifted
amide proton pool associated with a PARACEST agent using a long continuous wave
radio frequency pulse [39]. These saturated protons then transfer to the bulk water pool
by chemical exchange. The net transfer of high-energy protons to the bulk pool leads to a
reduction of the bulk water net magnetization and produces negative contrast in MRI.
The proton transfer ratio (PTR) (equation [2.1]) is used to quantify CEST contrast. The
steady state bulk water magnetization following a presaturation pulse of frequency "#
and M 0Z is the equilibrium bulk water magnetization.
is given by MSS
Z ( Δω )

PTR(Δω ) =

M0Z - MSSZ (Δω )

!

[2.1]
€ M
To model the effect of pH on the PTR, we consider a two-site exchanging system with
€

0
Z

protons occupying the bulk water pool (W) and the solute/CEST pool (S).

€

At

equilibrium, protons within the bulk water and CEST pool have a net magnetization of

MW0 and M 0S , respectively. The Bloch equations, modified with exchange terms, describe
such systems of exchanging magnetic spins [39, 40 , 41]. Under appropriate conditions,

€

€

it can be assumed that steady state is achieved upon irradiation to derive analytical
solutions [26]. Using the analytical solutions, Zaiss et al. described the PTR with respect
to presaturation pulse frequency (Δω) [42]. Assuming steady state, it was derived that

kWS
PTR( Δω ) =
⋅
R 1W kWS

ω 12

[2.2]

q
ω + pq + Δω
p
2
1

2
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with:
kSW kWS
R 2W + kWS

[2.3]

kSW kWS
R 1W + kWS

[2.4]

p = R 2S + k SW −
q = R 1S + k SW −
€

where ω 1 is the saturation pulse power, kSW is the exchange rate of protons from the
agent-bound proton pool to bulk water and kWS = kSW

€

€

M0S
MW0

is the exchange rate in the

reverse direction, and R 1/ 2,W/S 1 T1/ 2,W/S are the relaxation rates of the proton pools [42].
The Lorentzian line shape of the PTR
€ curve implies a linewidth measured as the fullwidth half maximum (FWHM) given by:

€

Linewidth = 2 ω 12

p
+ p2
q

[2.5]

Rearranging Eqs. 3 and 4, gives,

€

€
€

p = R 2S +

R 2W k SW
,
R 2W + kWS

[2.6]

q = R 1S +

R 1W k SW
R 1W + kWS

[2.7]

The exchange rate (kSW) of amide protons bound to Tm3+ agents is approximately ~2500
Hz [13]. Thus, at a concentration of 10 mM it follows by definition that kWS ≈ 0.182 Hz.
Relaxation rates of PARACEST aqueous solutions are on the order of R 1W R 2W = 1/10
Hz and R 1S R 2S = 10/10 Hz [41, 43]. Based on these estimates, we can assume that (1)

kSW >> kWS , (2) kSW >> R1S ,2S and (3) R1W ,2W >> kWS . Under such
€ conditions, p and q are
€ approximately equal to kSW and
€

2
Linewidth = 2 ω 12 + kSW

€

[2.8]

€

Recently, Van Zijl et. al. and coworkers [5] introduced the magnetization transfer ratio
€

asymmetry curve (MTRasym), defined by equation [2.9], as a practical measure of PTR.

MTR asym ( Δω ) =

€

MSSZ ( −Δω ) − MSSZ ( Δω )
MSSZ ( −Δω )

≈ PTR( Δω )
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[2.9]

The MTRasym curve is created by subtracting the positive frequencies from negative
frequencies of a CEST spectrum, with water referenced to 0 ppm to remove the effect of
the direct saturation of bulk water [5]. Hence, MTRasym linewidth is linearly proportional
to exchange rate as shown in equation [2.8]. Furthermore, when the CEST pool consists
of protons coordinated with an amide group, the exchange rate is base-catalyzed and
sensitive to pH [5]. With respect to pH, a base-catalyzed exchange rate is described as:

kSW = k 0 + kb × 10 pH − pK w

[2.10]

where k0 is the spontaneous exchange rate, kb is the base-catalyzed exchange rate, and

€

pKW is the ionization constant of water (pKW=15.4 at 37 oC) [5, 44]. Hence, MTRasym
linewidth has an exponential relation with pH as shown in equation [2.11] and described
by

Linewidth ∝ k SW = k0 + k 0 × 10 pH − pK w

[2.11]

2.3 Methods
€

2.3.1 PARACEST Agent Synthesis
The synthesis method of Tm3+-DOTAM-Gly-Lys has been previously described [38].
Briefly, the DOTAM-Gly-Lys was synthesized by tetraalkylation of cyclen with the
corresponding iodoacetyl dipeptide sequence (C-terminal ester). After hydrolysis of the
ester groups, Tm3+-DOTAM-Gly-Lys was prepared by mixing an aqueous solution of
ligand and TmCl3 in a 1:1 molar ratio. The reaction mixture was treated with NaOH (2.5
M solution) to adjust the pH to 9 and was stirred for 18 hours at room temperature
followed by size exclusion chromatography to purify the compound. The formation of the
complex was confirmed using high-resolution mass spectrometry (found: 1311.5773,
calculated: 1311.5750 for C48H86N16O16Tm) and high-resolution proton NMR
spectroscopy. The structure of Tm3+-DOTAM-Gly-Lys is given in Figure 2.1.
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Figure 2.1: Molecular structure of the thulium (Tm3+) chelate with ligand DOTAM-GlyLys and bound water.

2.3.2 Bloch Simulations
Using the two-pool modified Bloch equations, the effect of pH on the MTRasym linewidth
was studied. Simulations were performed using MATLAB (MATLAB release 14; The
MathWorks Inc., Natick, MA, USA). CEST spectra were simulated by modeling the
bulk water signal intensity as a function of presaturation frequency using the parameters
listed in Table 2.1. Parameters remained constant for all simulations with the exception
of the pH dependent exchange rates (kSW, kWS). Exchange rates were calculated using
equation [2.9] with varying pH (6.0 - 8.0 pH units). MTRasym curves were created using
the simulated spectra and fitted to a Lorentzian function in MATLAB to determine the
linewidths. Linewidth was defined as the Full Width at Half Maximum (FWHM). A
base-10 exponential function was fitted to the resulting linewidth-pH curve using the
MATLAB lsqcurvefit function.
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Simulation parameters (Units)

Values

T1W/T2W (s)
T1S/T2S (s)
Concentration (mM)
# Amide proton sites
Chemical shift (ppm)
Spontaneous exchange rate (Hz)
Base-catalyzed exchange rate (Hz)

1.0/0.03
0.01/0.01
10
4
-46
100	
  
200 x 109
15.4
6.0, 6.5, 7.0, 7.5, 8.0
14
3

Ionization constant of water (pKW)
pHs
Saturation power (µT)
Saturation duration (s)

Table 2.1: Stimulation Parameters Used for Aqueous Solutions Containing Tm3+DOTAM-Gly-Lys at 37 oC.

2.3.3 In vitro Experiments
To study the effect of pH on the linewidth of the CEST effect, a series of 10 mM
solutions (600 µL) of Tm3+-DOTAM-Gly-Lys were produced with pH ranging from 6.0
to 8.0 pH units in steps of 0.5 pH units. Sample pH was controlled by dissolving Tm3+DOTAM-Gly-Lys into 600 µL of 20 mM phosphate buffer solution (NaH2PO4 +
Na2HPO4) with different pH (6.0, 6.5, 7.0, 7.5, and 8.0). The pH value of the buffer
solution was confirmed with a standard pH electrode (Cole-Parmer, QC, Canada). To
study the effect of agent concentration on the linewidth of the CEST effect, a series of pH
7 solutions (600 µL) of Tm3+-DOTAM-Gly-Lys were produced with concentrations
ranging from 5 to 20 mM. Finally, to study the effect of endogenous MT on the linewidth
of the CEST effect, a series of pH 7 solutions (600 µL) of Tm3+-DOTAM-Gly-Lys were
produced with 10% bovine serum albumin (heated to cross-link) with concentrations
ranging from 5 to 20 mM.
CEST spectra were acquired on a 9.4 T horizontal bore Agilent MRI scanner equipped
with a 30 mm millipede radio frequency coil (Agilent, Palo Alto, CA). All in vitro
measurements were made in triplicate unless stated otherwise.
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The pulse sequence

consisted of a continuous wave presaturation pulse (B1) followed by a hard 90o pulse.
Presaturation time (TS = 3s) and power (B1 = 14 µT) were constant for all experiments,
unless stated otherwise. Images were acquired using a two-dimensional fast spin echo
(FSE) pulse sequence (FOV = 25.6 × 25.6 mm2, data matrix: 64 × 64, TR = 500 ms, ESP
= 10 ms, ETL = 16, ETE = 10 ms, 2 dummy scans, 3 averages) preceded by a continuous
wave presaturation pulse. CEST spectra were obtained from the images by varying the
frequency of the presaturation pulse from -60 to 60 ppm with 1-ppm steps. Temperature
was controlled by blowing warm air over the phantoms using a Model 1025 Small
Animal Monitoring and Gating System (SA Instruments Inc., Stony Brook, NY) and
monitored using a fiber optic probe placed adjacent to the phantoms. A heating time of 15
minutes was allowed for the experimental temperature to be achieved.
Linewidth was studied as a function of several experimental conditions. To study the
effect of temperature, CEST spectra from a series of 10 mM Tm3+-DOTAM-Gly-Lys
solutions (pH: 6.0, 6.5, 7.0, 7.5, 8.0) were obtained at 35, 36, 37, 38, and 39 oC. To study
the effect of concentration, CEST spectra from a series of pH 7.0 Tm3+-DOTAM-GlyLys solutions with concentrations of 5, 10, 15 and 20 mM were obtained at 37 oC. To
study the influence of the inherent MT effect, the CEST spectra of a series of pH 7 Tm3+DOTAM-Gly-Lys solutions with 10% bovine serum albumin (BSA) and different
concentrations (5-20 mM) were acquired at 37 oC. Relaxation rates were measured for
both the aqueous and BSA phantoms to study the effects of relaxation on linewidth
measurements. To study the effect of presaturation power, CEST spectra of a 10 mM pH
7 Tm3+-DOTAM-Gly-Lys solution were acquired at 37 oC with different presaturation
powers (8, 10, 12, and 14 µT). Finally, to study the effect of pH, CEST spectra of a series
of 10 mM Tm3+-DOTAM-Gly-Lys solutions (pH: 6.0, 6.5, 7.0, 7.5, 8.0) were acquired at
37 oC.
For each pixel, the MTRasym curve was fitted to a Lorenztian lineshape to measure the
linewidth and chemical shift. An empirical exponential equation was derived to describe
the relationship between linewidth and pH. The method used to produce temperature
maps from the chemical shift of the MTRasym curve has been previously published [16,
17, 43].

Briefly, the chemical shift changes linearly with temperature (0.268oC/ppm)
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[16]. However, the y-intercept of the linear relationship was observed to be pH-sensitive.
Therefore, an empirical quadratic equation was derived to describe the relationship
between the y-intercept of the chemical shift response and pH. The MTRasym curve was
fitted to a Lorenztian lineshape, and the temperature was determined from the chemical
shift of the peak using the chemical shift and the pH-calibrated linear relation.
The spin-lattice (T1) and spin-spin (T2) relaxation time constants were measured for each
aqueous and BSA solution at 36 oC. The T1 time constant was measured using an
inversion recovery pulse sequence (repetition time (TR) = 10 s, inversion time (TI) = 0 to
3 seconds in 10 steps, 3 averages). The T2 time constant was measured using a spin-echo
sequence (TR = 10 s, TE = 5 to 60 ms in 5ms increments, 3 averages).

2.3.4 In vivo Experiments
For in vivo demonstration, C57BL/6 mice (8 months of age, weighing ~ 30 g, N=3) were
anesthetized (induced using 4% isoflurane in oxygen and maintained using 1.5 - 2.5%
isoflurane in oxygen).

Each mouse was secured on a MRI-compatible stage.

Temperature was monitored with a rectal temperature probe, and respiration was
monitored with a respiratory sensor pad, which was connected to a pressure transducer,
placed over the thoracic/abdominal region. Following the acquisition of pre-injection MR
anatomical and CEST images, 50 µL of 100 mM Tm3+-DOTAM-Gly-Lys dissolved in
phosphate buffered saline (PBS) was injected directly into the left leg muscle [45], with
the mouse secured to the MRI compatible stage. Using a 27-gauge needle, injection was
performed at a rate of 12.5 µL/min at a tissue depth of 2mm. In vivo CEST image
acquisition began within 15 minutes of injection. The animals were recovered following
imaging. The animal procedure was performed according to a protocol approved by the
Western University Animal Use Subcommittee.
In vivo imaging was performed on the same 9.4 T MRI scanner used for in vitro studies
equipped with a custom-built 3 cm diameter radio frequency surface coil.

Body

temperature was maintained at 37 oC during the imaging procedure by blowing warm air
over the animal using a model 1025 small-animal monitoring and gating system (SA
Instruments Inc., Stony Brook, NY, USA). At baseline, a high-resolution T2-weighted
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image was acquired for localization using a fast imaging with steady state precession
pulse sequence (FOV = 25.6 × 25.6 mm2, data matrix = 256 × 256, TR = 6 ms, echo time
= 3 ms, excitation flip angle = 70o, 1 slice, 1 mm thickness, 20 prescans, 1 average, total
acquisition time = 1 min and 46 s). CEST images were acquired from the same slice preand post-injection. To maximize the signal to noise ratio in vivo, a fast spin echo pulse
sequence was used for CEST imaging (FOV = 25.6 × 25.6 mm2, data matrix = 64 × 64,
TR = 5000 ms, ETL = 32, effective echo time = 10 ms, 2 mm thickness, and 1 average,
total acquisition time = 10.2 s) preceded by a continuous wave presaturation pulse (B1 =
14 µΤ, TS = 5s). For in vivo CEST images, presaturation pulse frequency was varied in
ascending order beginning with -1000 ppm and included the following frequencies:
±1*(1000, 60 to 30ppm with 1-ppm steps along with 30, 20, 10, 5, 3, 2, 1ppm) and 0 ppm
(total CEST acquisition time = 26 min 36s). All in vivo CEST images were spatially
smoothed using a 2 x 2 filter. The temperature and pH maps were created using the CEST
spectra on a pixel-by-pixel basis.

For each pixel, the contrast to noise ratio was

calculated. To achieve a 95% probability that a real CEST signal was observed, only
pixels with contrast to noise ratio ≥ 2 2 were used to map temperature and pH [46, 47].
To correct B0-inhomogeneity effects, the water peak of all in vitro and in vivo CEST
spectra were fitted to a €tenth-order polynomial on a pixel-by-pixel basis following
interpolation of the spectrum to a resolution of 1 Hz. The water resonance was assumed
to be at the frequency where the interpolated fitted polynomial was lowest.

Each

interpolated spectrum was shifted so that the fitted water resonance was positioned at
0ppm [5].

2.4 Results
Simulated CEST spectra for different pH values are plotted in Figure 2.2a.
Corresponding linewidths are plotted with pH in Figure 2.2b with a fitted exponential
function. The pH-dependence of simulated linewidths agrees well with the theoretical
relation shown in equation [2.11].
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Figure 2.2: a) Simulated MTRasym curves derived using the modified Bloch equations.
Agent parameters used are listed in Table 1. The MRI parameters included B0 = 9.4T, B1
= 14uT, TS = 3 s. pH-dependent exchange rates (kSW, kWS) were calculated using Eq. 2.9
with k0 = 100 Hz, kb = 200 x 109 Hz and pKW = 15.4. b) Linewidths plotted with pH. The
exponential function (Linewidth = 3.25 + 100.99pH-7.44) is superimposed on the simulation
linewidths (R2 = 0.9999). The linewidths increase monotonically and logarithmically
with pH as predicted by the steady state analytical solutions.

A typical CEST spectrum of a 10 mM pH 7 Tm3+-DOTAM-Gly-Lys solution acquired at
37 oC is shown in Figure 2.3. The corresponding MTRasym curve is displayed on the
baseline with the position of the linewidth measurement indicated. Both temperature and
agent concentration had only a small effect on the CEST peak linewidth. The effect of
temperature on the linewidth of the CEST peak is given for a series of 10mM Tm3+DOTAM-Gly-Lys aqueous solutions with different pH values (6.0, 6.5, 7.0, 7.5, and 8.0)
in Figure 2.4a. The linewidths were constant from 36 to 38 oC for pH ≤ 7.5 solutions
(pH: mean linewidth ± std. dev., 6.0: 4.3±0.2, 6.5: 4.6±0.1, 7.0: 5.5±0.2, 7.5: 8.9±0.6,
8.0: 14.1±0.7). The effect of temperature on the linewidth of the CEST peak is given for
Tm3+-DOTAM-Gly-Lys at pH 7.0 in aqueous solution in Figure 2.4b.
The effect of agent concentration on the linewidth of the CEST effect in aqueous
solutions and in 10% BSA is shown in Figure 2.4c. BSA simulates the endogenous MT
effect from protons bound to macromolecules in vivo. The linewidths (Aqueous: 5.3±0.2,
BSA: 4.9±0.1) were independent of agent concentration within the concentration range
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expected to be necessary for in vivo PARACEST detection (5-20mM) [48]. Overall, the
relative insensitivity of linewidth to temperature, agent concentration and MT effect
suggests these conditions did not significantly modify the exchange rate between the
amide and the bulk water protons. Relaxation rates of the aqueous and BSA solutions are
listed in Table II. Figure 2.4c also demonstrates that linewidth is relatively independent
of relaxation rates. The effect of saturation power (ω1) on the linewidth of the CEST
peak is given for ω1 = 8, 10, 12 and 14 µT values in Figure 2.4d. Linewidth increased
linearly with power as expected from equation [2.8]. Specifically, at pH 7.0 and 37 oC,
for ω1 = 8 to 14 µT:
[2.12]

Linewidth = 0.19ω 1 + 2.7

MTRasym curves for a series of 10 mM Tm3+-DOTAM-Gly-Lys solutions (pH: 6.0, 6.5,

€

7.0, 7.5, 8.0) at 37 oC are given in Figure 2.5a, and the dependence of the linewidth of the
MTR asymmetry curve on pH is shown in Figure 2.5b. A transformation of the data to
log-linear format is shown in Figure 2.5c.

A linear fit of the log-linear data is

superimposed. The linewidth of the CEST effect clearly increases with pH. The rate of
increase is greater at pH≥7 as expected since amide proton exchange is base-catalyzed
[5]. pH can be determined uniquely from the linewidth of the CEST effect. The base-10
exponential relationship determined empirically between the MTRasym linewidth and the
pH given in Figures 2.5b and 2.5c can be expressed as equations [2.13] and [2.14]
respectively, and can be used for pH measurement.
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Figure 2.3: A typical CEST spectrum of a 10 mM pH 7 solution of Tm3+-DOTAM-GlyLys acquired on a 9.4 T MRI scanner at 37oC using a 14 µT 3 s saturation pulse. The
linewidth of the CEST effect is defined as the full width at half maximum of the
asymmetry curve generated by the subtraction of the halves of the CEST spectrum (pH =
7.0, B0 = 9.4 T, B1 = 14 µT, TS = 3 s, 37oC).
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Figure 2.4: a) The dependence of MTRasym linewidth on temperature for a series of 10
mM solution Tm3+-DOTAM-Gly-Lys (pH: 6.0 (—), pH: 6.5 (---), pH: 7.0 (-•-•-), pH: 7.5
(• • •), pH: 8.0 (—)). B) Close-up of dependence of the MTRasym linewidth on temperature
for pH 7 solution shown in 4A. C) The dependence of the MTRasym linewidth on
concentration for the pH 7 solution of Tm3+-DOTAM-Gly-Lys at 37oC in the absence and
presence of MT effect. D) The dependence of the MTRasym linewidth on saturation
power for the pH 7 solution of Tm3+-DOTAM-Gly-Lys at 37oC (B0=9.4 T, B1 = 14 µT,
TS = 3 s for a,b,c,d). Error bars are equal to one standard deviation.

Linewidth = 3.59 +10 0.69pH−4.49
pH =

[2.13]

log(Linewidth − 3.59) + 4.49

[2.14]
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€
Figure 2.6 shows the in vitro phantom pH distribution maps generated from each pixel’s
€

MTRasym linewidth and using equation 2.14. The measured pH within each 600 µL, 10
mM phantom was (Phantom pH: mean pH ± std. dev; 6.0: 6.2±0.2, 6.5: 6.5±0.1, 7.0:
6.9±0.04, 7.5: 7.6±0.03, 8.0: 8.0±0.03).
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Similarly, the equation describing the relation between chemical shift and temperature
was measured (data not shown) and is given by equations [2.15] and [2.16].
Chemical Shift = 0.268 × Temperature( o C) + y − intercept

[2.15]

y − intercept = 0.3738 × pH2 - 4.7824 × pH - 40.679

[2.16] 	
  

€

Applying equations [2.15] and [2.16], Figure 2.7 shows the in vitro temperature

€

distribution maps generated using the chemical shift of the MTRasym curve from each
pixel in a series of 600 µL, 10 mM phantoms with different pH at 37 oC. Average
phantom temperature measurements were: (Phantom pH: mean temperature ± std. dev.)
6.0: 37.2±0.2, 6.5: 37.2±0.2, 7.0: 37.3±0.2, 7.5: 36.7±0.2, 8.0: 37.3±0.3).
Figure 2.8a shows the average pre-injection and first post-injection CEST spectra
obtained in a single mouse leg muscle, from pixels achieving 95% probability of CEST
detection post-injection. Similar results were obtained in the other two mice. Both CEST
spectra were normalized to the mean signal intensities measured following the ± 1000
ppm saturation pulses. From the average first post-injection spectrum, a clear CEST
effect was observed along with slightly lower endogenous MT effect compared to preinjection. The pH and temperature maps measured using PARACEST on a pixel-bypixel basis are superimposed on the pre-injection high-resolution T2-weighted image in
Figures 2.8b and 2.8c respectively. The mean (± std. dev.) in vivo pH and temperature
measured within each mouse (N=3) was: Mouse 1) pH=7.2 (± 0.2) and temperature=37.5
(± 1.1) oC (shown in Figure 8), Mouse 2) pH=7.3 (± 0.1) and temperature=36.9 (± 1.2)
o

C, and Mouse 3) pH=7.0 (± 0.2) and temperature=37.8 (± 0.5) oC.

The temperature and pH measurements were calculated using the first post-injection
CEST spectrum for each mouse. The region exhibiting CEST effect was largest in the
first post-injection spectra, with an average CEST effect of approximately 3%. The
detected CEST region size decreased by more than half in the second CEST experiment
and no CEST effect was detected in the third post-injection CEST experiment. The
decreased CEST effect suggests that a large fraction of the agent had cleared the leg
region within the imaging plane within the first hour following injection.
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Agent
concentration
5 mM
10 mM
15 mM
20 mM

Aqueous solution

10% BSA solution

T1 (ms)

T2 (ms)

T1 (ms)

T2 (ms)

1880 ± 10
1180 ± 10
980 ± 10
770 ± 10

38.0 ± 1.0
18.0 ± 1.0
15.0 ± 1.0
10.0 ± 1.0

610 ± 10
530 ± 10
540 ± 10
630 ± 10

7.0 ± 1.0
5.7 ± 1.0
6.0 ± 1.0
7.0 ± 1.0

Table 2.2: Relaxation Rates of Aqueous and 10% BSA pH 7 Solutions of Different
Concentrations of Tm3+-DOTAM-Gly-Lys (pH = 7.0, B0 = 9.4 T, 37oC, Conc. = 5, 10,
15, 20 mM).
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Figure 2.5: a) The dependence of MTRasym line shape on pH and b,c) the dependence of
the MTRasym linewidth on pH of a 10 mM solution of Tm3+-DOTAM-Gly-Lys at 37oC
(B0 = 9.4 T, B1 = 14 µT, TS = 3 s, 37oC).

2.5 Discussion
A novel method is presented for in vivo extracellular pH measurement using only the
amide proton site of PARACEST agent Tm3+-DOTAM-Gly-Lys. Specifically, the
linewidth of the CEST effect of the amide protons was uniquely related to pH. Highresolution in vitro pH maps were achieved with accuracy within 0.2 pH units of the
expected value and with an inter-pixel standard deviation of less than 0.2 pH units in the
range of pH 6 - 8 at a constant physiological temperature. In vitro temperature maps
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were also achieved with accuracy within 0.3 oC of the expected value with an inter-pixel
standard deviation of less than 0.3 oC. Following direct injection into the left mouse leg
muscle, extracellular pH and temperature maps were produced in vivo.

Figure 2.6: pH maps produced in phantom containing five tubes of solution of 10 mM
Tm3+-DOTAM-Gly-Lys with different pH at 37oC (pH = 6.0, 6.5, 7.0, 7.5, 8.0, B0 = 9.4
T, B1 = 14 µT, TS = 3 s, 37oC). The pH maps calculated using the CEST peak linewidth
agree well with the actual pH measurements (white labels).

The use of the linewidth of the CEST effect represents a novel approach to pH
measurement. The linewidth of the CEST effect is modulated by the proton exchange
rate, which in turn depends on the sample temperature and pH. The current study
demonstrated that the linewidth of the CEST effect for Tm3+-DOTAM-Gly-Lys was
relatively constant around body temperature (36-38 oC). Linewidth was markedly more
sensitive to temperature for pH 7.5 and pH 8.0 phantoms for temperatures above 37 oC.
This temperature dependence can be predicted based on temperature-dependent increases
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in the base-catalyzed exchange rate [5] and increased sensitivity as pH increases
(equation [2.10]).

Most clinical applications, including stroke and tumors, require

measurement of extracellular pH between 6.0-7.5.

Thus, our data suggests that

temperature has negligible effects on exchange rate within the temperature range likely to
be encountered in vivo (36-38 oC) without deliberate tissue heating or cooling. The
insensitivity of linewidth to temperature is important for measuring pH under
physiological conditions where temperature may be altered.

Figure 2.7: Temperature maps produced in phantom containing five tubes of solution of
10 mM Tm3+-DOTAM-Gly-Lys with different pH at 37oC (pH = 6.0, 6.5, 7.0, 7.5, 8.0, B0
= 9.4 T, B1 = 14 µT, TS = 3 s, 37oC). The temperature maps calculated using the CEST
peak linewidth and chemical shift agree well with the actual temperature measurements
(white labels).
Additionally, the linewidth was insensitive to agent concentration in both aqueous
solution and when mixed with 10% BSA, although the endogenous MT effect in the 10%
BSA did reduce measured linewidths slightly. This result is expected as previous work
has demonstrated the MTRasym curve lineshape changes in the presence of MT effects
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[43]. However, within a constant medium, such as brain tissue, only subtle changes in
MT effect are expected and would cause negligible effects on linewidth measurements.
The differences in linewidth observed between aqueous and 10% BSA solutions are not
expected within tissue regions in vivo. Different tissues may require separate calibration
of linewidth and pH to account for differences in endogenous MT effects. Ratiometric
methods proposed by Ward et. al. are also independent of concentration. However, the
application of ratiometric methods to CEST, as proposed by Aime et. al. requires two
experiments with different saturation powers and must account for endogenous MT
effects under both conditions [34, 49, 50].

Figure 2.8: a) Average preinjection and postinjection CEST spectra, MTRasym curves on
the x-axis. All curves and maps were generated using only pixels that exhibited
significant PARACEST contrast (probability ≥ 95%) following injection. b) In vivo pH
map superimposed onto a preinjection anatomical image. c) In vivo temperature map
superimposed onto a preinjection anatomical image. The temperature and pH maps
calculated in vivo agree well with normal temperature and pH measurements.

The linewidth of the CEST effect was dominated by the local pH and consequently, the
linewidth of the CEST effect of the amide protons of Tm3+-DOTAM-Gly-Lys was
effective for pH mapping. The benefit of this method is that prior knowledge of in vivo
tissue temperature or agent concentration is not necessary. The insensitivity of linewidth
to temperature and concentration also means that the calibration of linewidth to pH
established in vitro is directly applicable in vivo. The measured linewidth could be
influenced by B0-inhomogeneities. The current study fit a high-order polynomial to the
73

water peak to measure B0 and correct CEST spectra on a pixel-by-pixel basis. However,
this technique is susceptible to error for in vivo experiments using large B1 amplitudes
due to the inherent asymmetry of the endogenous MT effect. Future in vivo studies
should employ the water saturation shift referencing (WASSR) technique to accurately
measure B0 in each pixel [51]. The modest sensitivity of linewidth to ω1 is another
important consideration when using linewidth to measure the pH.

Typically, ω1-

inhomogeneities are on the order of 5-20% in vivo [52-54]. However, this sensitivity is
not a significant limitation as in vivo ω1 mapping is easily achieved [52-55] and must be
used in combination with the linewidth response to ω1 (equation [2.12]) to correct pH
maps. The greatest limitation of this method is that a significant portion of the CEST
spectrum must be acquired to create an accurate asymmetry curve, which increases
acquisition time.

Assuming local B0 variations of ~1000 Hz, acquisition of

approximately 50 saturation offsets points are required. Since numerous images must be
acquired consecutively, the power and duration of the presaturation pulse must be
minimized to avoid directly heating the sample. Such saturation pulse limits may make it
difficult to achieve steady state conditions and detect the CEST contrast. In the current
study, in vitro experiments were preceded with a 3 second, 14 µT presaturation pulse to
ensure that the results could be applied in vivo. This saturation pulse nearly achieved a
steady state condition resulting in the measurement of linewidth effects that agreed well
with the theoretical model presented.
Within physiological ranges, the measurement of pH described in the current study using
the MTRasym linewidth was independent of temperature. An alternative method proposed
by Wegh et. al. was independent of agent concentration, but sensitive to temperature
fluctuations [27]. Specifically, the ratio of the CEST effect at the resonance frequency of
the amide protons to the CEST effect at a frequency several ppm closer to the solvent
water frequency was pH sensitive. This method does not require two different saturation
experiments but is sensitive to temperature because of the dependence of amide proton
chemical shift on temperature. The ratio of the CEST effects acquired at these two
frequencies will also be different in vivo due to the endogenous MT effect. So it is also
difficult to use this method directly in vivo even if the temperature is known. All
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previous methods that use the CEST sensitivity of the PARACEST agent amide protons
to measure pH must be carefully calibrated to ensure that the relationship established in
vitro between the pH and CEST effect is applicable in vivo.
Noninvasive methods for temperature measurement using MRI have been developed
recently [33, 56, 57]. The most common methods are based on the temperature
dependence of the T1 relaxation time, chemical shift, or diffusion coefficient of bulk
water protons. However, the low temperature sensitivity (~ 0.01 ppm/oC) of such
methods limits their application to situations where a large temperature variation occurs.
Previous studies have proposed MRI thermometry methods based on the measurement of
the bound water chemical shift of PARACEST agents [16, 17]. Such methods provide the
possibility for greater temperature sensitivity (~0.5 ppm/oC or higher). Like the bound
water associated with PARACEST agents, the chemical shift of amide protons within
PARACEST agents is also temperature dependent and can be used for temperature
measurement with similar temperature sensitivity. In the current study, it was shown that
the amide proton chemical shift of Tm3+-DOTAM-Gly-Lys could be used to accurately
measure temperature in the pH range of 6.0-8.0, using a pH-calibrated linear relation
between chemical shift and temperature.
The current approach improves on previous pH mapping methods using PARACEST
agents by utilizing the linewidth of the CEST effect, which was shown to be insensitive
to agent concentration and temperature (36-38 oC).

Using this approach pH and

temperature measurement was achieved in the leg of a mouse around the site of
intramuscular injection of Tm3+-DOTAM-Gly-Lys. The average measured pH (7.2 ± 0.2
pH units) and temperature (37.4 ± 0.5

o

C) were both consistent with expected

physiological values. Uncertainties of the empirical constants derived for equations
[2.13-2.16] are expected to contribute some small error in measured pH and temperature
maps.
The linewidth of the bulk water peak was narrower in post-injection CEST spectra and
the MT effect was lower, compared to pre-injection spectra.

Several factors may

contribute to these changes including a decrease in the T1 relaxation time constant of the
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bulk water and/or bound protons, and an increase in local tissue water content following
injection. Future work will investigate the role of these mechanisms in defining the
shape of the CEST spectrum post injection. However, the linewidth measurements made
in BSA phantoms with different agent concentrations (Figure 2.4c) indicate that both
water content and T1 relaxation have minimal impact on the linewidth of the CEST peak,
which is required for pH mapping.
More in vivo work is needed to determine which tissues are amenable to pH mapping
using this approach.

However, the current study demonstrates in vivo pH and

temperature mapping independent of agent concentration. This technique will likely be
applicable to novel agents developed in the future with greater amide proton chemical
shifts that reduce the loss in sensitivity from the endogenous MT effect.

2.6 Conclusion
A novel approach was developed to measure in vivo extracellular pH using the linewidth
of the amide proton CEST effect of the PARACEST agent Tm3+-DOTAM-Gly-Lys.
Linewidth was found to be insensitive to agent concentration and changes in temperature
between 36-38 °C. The amide proton chemical shift could also be used to measure
temperature.

High-resolution in vitro pH and temperature maps were successfully

produced as well as in vivo maps of the mouse leg muscle. This work demonstrates the
possibility for simultaneous measurement of in vivo temperature and pH using
PARACEST agents.
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Quantitative tissue pH measurement during cerebral
ischemia using amine and amide concentration-independent
detection (AACID) with MRI
Nevin McVicar, Alex X. Li, Daniela Gonçalves, Miranda Bellyou, Susan Meakin, Marco
A.M. Prado and Robert Bartha
A shortened version of the manuscript below has been published in the Journal of
Cerebral Blood Flow & Metabolism (April 2014. :10.1038/jcbfm.2014.12).
Abstract: Tissue pH is an indicator of altered cellular metabolism in diseases including
stroke and cancer. Ischemic tissue often becomes acidic due to increased anaerobic
respiration leading to irreversible cellular damage.

Chemical exchange saturation

transfer (CEST) effects can be used to generate pH-weighted MRI contrast, which has
been used to delineate the ischemic penumbra after ischemic stroke. In the current study,
a novel magnetic resonance imaging (MRI) ratiometric technique is presented to measure
absolute pH using the ratio of CEST-mediated contrast from amine and amide protons:
amine/amide concentration independent detection (AACID).

CEST effects were

observed at 2.75 ppm for amine protons and at 3.50 ppm for amide protons downfield (ie.
higher frequency) from bulk water. Using numerical simulations and in vitro MRI
experiments, we showed that pH measured using AACID was independent of tissue
relaxation time constants, macromolecular magnetization transfer effects, protein
concentration and temperature within the physiological range. Following in vivo pHcalibration using

31

P-MRS, local acidosis is detected in mouse brain following focal

permanent middle cerebral artery occlusion.

In summary, our results suggest that

AACID represents a noninvasive method to directly measure the spatial distribution of
absolute pH in vivo using CEST MRI.

3.1 Introduction
Cerebral tissue pH is normally regulated at ~7.0-7.2 pH units by the cooperative action of
a multitude of sensors and regulators within cellular compartments.[1] Deviation from
pH-homeostasis is an indicator of disease and occurs in stroke when metabolic demand
for oxygen exceeds supply. Lactic acidosis leads to irreversible cellular damage in
ischemic tissue.[2] Therefore, pH is a potentially important and sensitive fundamental
measure of metabolic state and disease progression. However, few methods measure
absolute pH in vivo.[3] Even noninvasive magnetic resonance imaging (MRI) methods,
which have had the greatest success to date, either suffer from low spatial and temporal
resolution[4] or require assumptions that limit their clinical application.[5]
Several MRI observable parameters are sensitive to in vivo pH.[3] For example, the
chemical shift between inorganic phosphate (Pi) and phosphocreatine (PCr) observed
with phosphorus (31P) magnetic resonance spectroscopy (31P-MRS) is directly related to
pH.[4] However 31P-MRS is limited by low signal to noise ratio resulting in low spatial
and temporal resolution. Recently, Zhou et al. proposed a novel technique called amide
proton transfer (APT) to measure pH using the chemical exchange saturation transfer
(CEST) effects from amide protons associated with mobile peptides and proteins.[5]
Amide protons freely exchange with bulk water protons at a rate that is pH-dependent.
However, APT contrast is also affected by cellular water content, amide content, the bulk
water spin-lattice (T1) relaxation time constant, and macromolecular exchange-relayed
nuclear Overhauser effects (NOEs).[5-7] Therefore, APT pH measurement is susceptible
to error in conditions that cause appreciable changes in protein concentration and/or
water content. Consequently, groups have successfully employed APT contrast to acquire
pH-weighted MR images that correlate well with lactic acidosis.[8, 9] CEST effects
derived from various metabolites including glutamate [10] and creatine [11] are also
sensitive to pH however quantitative pH measurement using these CEST effects is
limited by concurrent concentration and T1 dependence.
To overcome limitations associated with concentration dependence, Ward and Balaban
developed a ratiometric approach that was applied to exogenous compounds using the
CEST effects at two distinct frequencies to measure quantitative pH independent of bulk
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water T1 and exchange site concentration.[12] Desmond et al. recently proposed a similar
ratiometric approach to measure pH using endogenous CEST effects from amide (3.5
ppm) and amine (2.0 ppm) protons.[13] Here, we describe a novel method to measure
absolute pH using the CEST effects of both amine (2.75 ppm) and amide (3.50 ppm)
protons associated with endogenous mobile peptides and proteins: amine/amide
concentration independent detection (AACID). AACID produces quantitative pH maps
with markedly higher spatial resolution compared to

31

P-MRS, and eliminates the

assumptions of constant water content and protein concentration that limit APT. AACID
is also independent of NOE and requires a simple pH-calibration step for in vivo
application.
Amine and amide proton CEST effects are often considered to originate from mobile
intracellular proteins and peptides.[5, 13-15] Recently, pH changes measured using
endogenous amide CEST effects were considered to be of intracellular origin[5] because
nearly 90% of total protein content exists in the intracellular space.[16] However, it is
more accurate to consider the pH to be an average cerebral tissue pH that is heavily
weighted to the intracellular compartment. Regardless, the pH resolution achieved using
CEST effects (~0.2 pH units)[5] does not appear to be sufficient to distinguish the
physiological differences between intracellular and extracellular spaces (~0.1 pH unit).
Therefore, the measured pH is described as the cerebral tissue pH.
In the current study, numerical simulations were used to investigate the dependence of
AACID measurements on pH, macromolecular magnetization transfer (MT), direct
saturation and relaxation times.

In addition, the pH, protein concentration and

temperature dependencies of the AACID method were characterized in vitro. The,
AACID pH measurement was then calibrated in mouse brain using

31

P-MRS pH as the

standard measurement. Finally, high-resolution in vivo pH maps were acquired in the
mouse brain following permanent middle cerebral artery occlusion (MCAO) and
compared to cellular damage identified histologically. The assumptions required for
absolute pH measurement using AACID, the impact of CEST effects from other
metabolites on AACID, and potential applications of AACID at lower magnetic field
strengths are discussed.
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3.2 Methods and materials
3.2.1 CEST theory
CEST MRI contrast can be detected following the selective saturation of solute protons
that exchange with bulk water protons. Solute protons resonate at specific frequencies
that are chemically shifted (Δω) from bulk water. Figure 3.1a illustrates the distribution
of different solute proton pools based on their resonant frequencies relative to bulk water.
To observe CEST contrast, the chemical shift (Δω) of the exchanging solute protons must
satisfy the slow-intermediate exchange condition (Δω > k), where k is the exchange rate
between solute and bulk water.[17] During frequency-selective saturation of the solute
protons, a net transfer of irradiated high energy protons to the bulk water pool ensues by
chemical exchange producing a reduction in the net magnetization of the bulk water
leading to negative contrast in MRI. Figure 3.1b demonstrates the CEST effects on the
bulk water following frequency selective RF saturation of the amide protons (3.50 ppm),
and the amine protons (2.75 ppm).

During saturation, longitudinal (T1) relaxation

simultaneously drives both pools toward their equilibrium population (Boltzmann)
distribution leading to a steady state condition.[17] Following a long saturation pulse of

(

W
frequency ω, the bulk water steady state magnetization ( M SS ω ) ) is described by

equation [3.1], where M W0 is the bulk water magnetization without saturation preparation,
k is the solute proton exchange rate, and f is the mole fraction of solute protons as

€
W
W
described by
€ equation [3.2].[12, 17] A plot of M SS (ω ) M 0 as a function of the
saturation pulse frequency is called a CEST spectrum (Figure 3.1c). CEST effects are
often quantified using the magnetization transfer ratio (MTR) defined by equation [3.3].

€
M WSS (ω ) M W0 = 1 (1+ kfT1W)

€

€

€

[3.1]

f = [ solute protons] [ water protons]

[3.2]

CEST (ω ) =1 − M WSS (ω ) M W0

[3.3]
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The chemical exchange rate of protons from the solute pool to bulk water is both
temperature- and pH-dependent. Within the narrow physiological temperature range (3539 oC), the chemical exchange rate is dominated by modulations in pH.[5, 18] The pHdependence of the solute proton exchange rate is described by equation [3.4] where kb is
the base-catalyzed exchange rate, and pKW is the ionization constant of water (pKW=15.4
at 37 oC).[19, 20]

k = k b 10 pH − pK

[3.4]

W

Amide and amine protons associated with peptides have been shown to have different kb

€

and therefore have a differential response to pH changes.[5, 13, 14] As pH increases,
amine (kamine = 10pH-4.2) and amide (kamide = 5.57x10pH-6.4) base-catalyzed exchange rates
increase. As expected from equations [3.1] and [3.4], saturation of the amide proton pool
(ie.
€

ω

(

W
W
= 3.50 ppm) causes M SS ω ) M 0 to decrease as pH increases (Figure 3.1c)

producing an increase in the amide CEST effect (equation [3.3]). Paradoxically, the
amine proton CEST effects appears to decrease as pH increases (Figure 3.1c), apparently

€

defying equations [3.1] and [3.3]. However, the apparent decrease in CEST effect occurs
because the amine proton exchange rate increases into the fast-exchange regime (k >Δω)
when pH increases above ~6.5 pH units. Since the amide and amine CEST effects
change in opposite directions with increasing pH, the ratio of these two effects is
expected to be sensitive to pH.
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Figure 3.1: Illustration of chemical exchange saturation transfer (CEST) principles
and the effect of pH on amine and amide CEST signal: a) Schematic diagram of
relevant solute proton pools that resonate at frequencies chemically-shifted by parts per
million (ppm) from bulk water. b) Irradiation of amide (top) or amine (bottom) protons
using a frequency-selective saturation pulse. Chemical exchange transfers amide (top) or
amine (bottom) magnetization to bulk water, resulting in indirect saturation of the bulk
water ( MWSS). c) CEST spectra (vertically offset for clarity) measured at different pH (6.0,
6.5 and 7.0). The red and green portions of the curve illustrate the pH dependent
response of the amide and amine protons.

€

3.2.2 AACID pH measurement
AACID is based on the CEST MRI experiment. Direct measurement of pH using the
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CEST effect amplitude of a single solute proton pool is difficult due to the concomitant
effects of solute concentration, saturation pulse amplitude and duration, and T1
relaxation. Ward and Balaban first proposed a ratiometric approach to measure pH using
the CEST effects from two different exchange sites on one CEST agent.[12] Briefly, a
single solute may have two different proton exchange sites (ie. Site 1 and Site 2).
Rearranging equation [3.1] combined with equation [3.2] for both sites results in equation
[3.4].

(M

- M S)
1,2
M Site
S

Site 1,2

0

=k

Site 1,2

⎛[ solute protons] ⎞Site 1,2
⎟
T1W ⎜
⎝ [ water protons] ⎠

[3.4]

Taking the ratio of equation [3.4] for two different sites produces equation [3.5],[12]

€

where T1W effects and solute concentration effects cancel leaving only a ratio of pHdependent exchange rates.

⎛ [ solute protons] ⎞ Site 1
⎟
k T1W ⎜
⎝ [ water protons] ⎠
=
⎛ [ solute protons] ⎞ Site 2
Site 2
⎟
k T1W ⎜
⎝ [ water protons] ⎠
Site 1

2
M Site
( M 0 - M S)
S

Site 1

1
M Site
( M 0 - M S)
S

Site 2

[3.5]

In the present study, amine protons resonating at 2.75 ppm and amide protons resonating

€

at 3.50 ppm on endogenous proteins were considered to be Site 1 and Site 2 respectively.
The bulk water magnetization following saturation at 6.0 ppm was used as a common
reference point for both amine and amide CEST measurements (equation [3.6]). This
approach minimizes endogenous macromolecule MT related signal loss while avoiding
contamination from NOE effects, which occur between -2.0 and -4.0 ppm.[6, 7, 21] The
common reference point also reduces the number of CEST images required for pH
measurement.

AACID =

€

M Z( 3.50 ppm) × ( M Z( 6.0 ppm) − M Z( 2.75 ppm))
M Z( 2.75 ppm) × ( M Z( 6.0 ppm) − M Z( 3.50 ppm))
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[3.6]

The reference point was chosen to be 6.0 ppm because there are no observed CEST or
NOE effects at 6.0 ppm in tissue or BSA phantoms and the 6.0 ppm CEST image is
unaffected by CEST effects at 3.5 ppm and 2.75 ppm. The use of a single reference point
for both CEST effects is justified when using a ratiometric method since any significant
signal modulations at the reference frequency (ie. due to T2 relaxation or MT) will cancel.
All CEST contrast measurement methods are sensitive to inhomogeneities in the main
magnetic field (B0) because the CEST effects are measured at specific frequencies.
Therefore, it is essential that B0 maps are measured and a B0-correction is applied. The
effects of the amplitude of the applied magnetic field (B1) on CEST measurement are
complex due to the B1-dependence of saturation efficiency, direct saturation, and MT.
Hence, it is also important to measure and correct for B1-inhomogeneities using B1
calibration curves.

3.2.3 Numerical Simulations
The Bloch-McConnell equations [22] were used to numerically simulate CEST spectra
based on a four-pool exchanging system (bulk water, macromolecular, amine, and amide
protons) using specific saturation pulse parameters. First, to simulate the relationship
between AACID values and pH, CEST spectra were generated for different pH using
previously reported pH-dependent base-catalyzed exchange rates of the amide and amine
protons.[5, 13, 19] Ratiometric AACID values, calculated using equation [3.6] adopted
from Ward and Balaban,[12] were measured directly from simulated spectra. In addition,
macromolecular concentration was varied (9, 10 and 11%) to model potential changes in
MT following ischemia.[23] Finally, normal tissue (NT) and ischemic tissue (IT) were
modeled by incorporating tissue specific relaxation time constants and exchange rates for
each pool (Table 3.1). AACID-pH relationships were simulated for both tissue types to
study the cumulative effects of differences in water content, relaxation times and
consequent changes in direct saturation.

89

Simulation Parameters
Proton Pools

Bulk water

Macromolecule

Amine

Amide

0

0

2.75

3.50

NT: 1.844a
IT: 1.992a
NT: 0.045a
IT: 0.054a
NT: 39.1 Md
IT: 51.8 Md

0.1b

1.0c

1.0c

0.000015b

0.05

0.05

0, 9, 10, 11
%-by-weight

10.0 mM

71.9 mM

-

50b

10pH-4.2e

5.57x10pH-6.4f

Chemical Shift (ppm)
T1 (s)
T2 (s)
Concentration
Exchange rate (s-1)
a

From ref. [24], b From ref. [22], c From ref.[10], d From ref. [25], e estimated from refs.

[19] [13], and f From ref. [5].
Table 3.1: Simulation parameters used to simulate CEST spectra for normal (NT) and
ischemic (IT) cerebral tissue.

3.2.4 In vitro solutions
To study the AACID pH measurement, a series of solutions containing 10% (by weight)
bovine serum albumin (BSA, Sigma-Aldrich, St. Louis, Missouri) dissolved in 600 µL of
phosphate buffered saline (PBS) were produced with pH ranging from 6 to 8 pH units.
Solution pH was adjusted using 1M HCl and 1M NaOH and confirmed with a standard
pH electrode (Cole-Parmer, Montreal, Canada).

To study the effect of protein

concentration on AACID, a series of pH 7 solutions (600 µL) were produced with 6, 8,
10, 12 and 14% BSA. All phantoms were prepared in 5 mm NMR tubes. Physiological
total protein content has been previously shown to be approximately 10% by weight in
both rodent and human brains.[26] To measure potential contributions of CEST contrast
from common brain metabolites, we prepared phantoms with each metabolite dissolved
into pH 7.0 phosphate buffered saline (PBS) solutions at physiological concentrations
(Sigma-Aldrich). We used the identical metabolites and concentrations as Cai et. al. to
allow direct comparisons (Table 3.2).[10]
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Metabolite Concentrations
Metabolite
Concentration (mM)
Creatine (Cr)
10
Myo-inositol (MI)
10
N-acetyl aspartate (NAA)
10
Glutamine (Gln)
2
Taurine (Tau)
2
Aspartate (Asp)
2
Glutamate (Glu)
10
γ-aminobutyric acid (GABA)
2
Table 3.2: Metabolite concentrations used for in vitro measurement of potential
contaminant CEST effects.

3.2.5 MR experiments
All phantom and animal MRI studies were performed in an Agilent 9.4T small animal
MRI scanner (Agilent, Palo Alto, California). The bore of the magnet is 31 cm and the
maximum gradient strength is 400 mT/m. A long 4s continuous wave radio frequency
(RF) saturation pulse with a B1 amplitude of 1.5 µT was introduced prior to a RF spoiled
two-dimensional fast spin echo (FSE) pulse sequence for all phantom and animal CEST
MRI studies.

3.2.5.1

In vitro magnetic resonance imaging

All solutions were scanned using an Agilent 30 mm millipede volume coil (Agilent). All
CEST images were acquired using the modified FSE pulse sequence (slice thickness = 4
mm, TR = 7000 ms, TE = 7 ms, ETL = 32, effective TE = 7 ms, 3 averages, 2 pre-scans,
field of view = 25.6 x 25.6 mm2, matrix size = 64 x 64, and a 4s long continuous wave
RF saturation pulse with a B1 amplitude of 1.5 µT). Total image acquisition time was
22s.

CEST images were acquired with preceding saturation pulses at different

frequencies.

The saturation pulse frequencies, expressed in ppm relative to water,

include -1000 ppm, -6.4 to -5.6 ppm (in 0.1 ppm steps), -3.9 to -1.6 ppm (in 0.1 ppm
steps), -0.4 to 0.4 ppm (in 0.1 ppm steps), 1.6 to 3.9 ppm (in 0.1 ppm steps), 5.6 to 6.4
ppm (in 0.1 ppm steps), and 1000 ppm.
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3.2.5.2

General animal procedures

All animal protocols conform to the guidelines established by the Canadian Council on
Animal Care and were approved by The University of Western Ontario Animal Use
Subcommittee. For in vivo studies, C57BL/6 male mice (3-5 months old, 24-28g) were
used. Anesthesia was induced using 4% isoflurane in oxygen and maintained with 1.5%–
2.5% isoflurane in oxygen. The mouse was secured on a custom built MRI-compatible
stage. Temperature was monitored with a rectal temperature probe, and respiration was
monitored with a respiratory sensor pad connected to a pressure transducer that was
placed on the thoracic region. Body temperature was maintained at 37-37.5 oC throughout
imaging by blowing warm air over the animal using a model 1025 small-animal
monitoring and gating system (SA Instruments Inc., Stony Brook, New York). Three
animals were used for in vivo pH calibration and five different animals were used for
MCAO demonstration. Two of the five animals used for MCAO demonstration were
used for histology. Four different animals were used to measure the percent reduction in
cerebral blood flow (CBF) obtained by permanent MCAO using laser Doppler
flowmetry.[27]

3.2.5.3

In vivo proton magnetic resonance imaging animal
procedures

All 1H MRI scans were performed with a custom-built 3.0-cm-diameter RF surface coil.
CEST images were acquired using the modified FSE pulse sequence (slice thickness = 2
mm, TR = 7000 ms, TE = 7 ms, ETL = 32, effective TE = 7 ms, 3 averages, 2 pre-scans,
field of view = 25.6 x 25.6 mm2, matrix size = 64 x 64, and a 4s long continuous wave
RF saturation pulse with a B1 amplitude of 1.5 µT). Total image acquisition time was
22s.
CEST images were acquired with preceding saturation pulses at different frequencies.
The saturation pulse frequencies, expressed in ppm relative to water, include -1000 ppm,
-0.4 to 0.4 ppm (in 0.1 ppm steps), 1.6 to 4.2 ppm (in 0.1 ppm steps), 5.6 to 6.4 ppm (in
0.1 ppm steps), and 1000 ppm. For the pH calibration procedure, a larger slice thickness
of 6 mm was used to measure whole brain average pHi and match the 31P MRS field of
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view. T1-weighted images were acquired using a FSE pulse sequence (slice thickness = 2
mm, TR = 500 ms, TE = 10 ms, ETL = 4, effective TE = 10 ms, 4 averages, 2 pre-scans,
field of view = 25.6 x 25.6 mm2, matrix size = 128 x 128, total image acquisition time
was 1 min 5s). T2-weighted images were acquired using a FSE pulse sequence (slice
thickness = 2 mm, TR = 3000 ms, TE = 10 ms, ETL = 4, effective TE = 40 ms, 1
average, 2 pre-scans, field of view = 25.6 x 25.6 mm2, matrix size = 128 x 128, total
image acquisition time was 1 min 42s). Diffusion-weighted images were acquired using
a multislice spin-echo pulse sequence (slice thickness = 2 mm, TR = 1000 ms, TE =
35.49 ms, b-value = 1100 s/mm2 in the readout direction, 4 averages, field of view = 25.6
x 25.6 mm2, matrix size = 128 x 128, total image acquisition time was 8 min 32s).

3.2.5.4

In vivo phosphorus magnetic resonace spectroscopy

Similar to endogenous CEST pH measurement,

31

P-MRS pH measurement mainly

reflects intracellular pH because >75% of inorganic phosphate is intracellular.[28]
Therefore,

31

P-MRS provides an appropriate standard for pH-calibration of AACID

measurements in vivo. All
31

31

P-MRS data were acquired with a custom-built 2.5 cm

1

diameter dual-tuned ( P/ H) RF surface coil. The 6 mm thick slices used for 1H CEST
images contained a large portion of the brain. Following the acquisition of 1H CEST
images in vivo, the 1H surface coil was replaced with a

31

P/1H dual-tuned surface coil

without changing the animal’s position. Using the dual-tuned coil, anatomical 1H MRI
scout images were acquired to confirm that the animal position was unchanged and to
choose a 5 x 10 x 6 mm3 voxel location. The 31P voxel location was chosen such that the
6mm thick voxel was centered on the 6mm thick 1H CEST slice in the z-direction.
Furthermore, the 5 x 10 x 6 mm3 voxel was placed inside the brain to produce negligible
skull and skin contributions. After switching to the 31P frequency, the 31P MRS spectrum
was acquired. Localized brain

31

P spectra were acquired using image selected in vivo

spectroscopy (ISIS, Excitation = 100 µs hard pulse, TR = 5s, spectral width = 12 kHz,
768 averages, 4 pre-scans, 512 complex points, field of view = 5 x 10 x 6 mm3 corresponding to 6 mm thick field of view used for 1H CEST images).[29] All 31P spectra
were fitted using in-house software (fitMAN[30, 31]) to measure the chemical shift
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difference (δ) between inorganic phosphate and phosphocreatine. pHi measurements
were made using pHi = 6.75 + log[(δ-3.26)/(5.70-δ)].[4, 32]

3.2.5.5

B0 and B1 corrections to CEST spectra

B0 and B1 field maps were generated for the image slice of interest prior to all CEST
experiments. CEST data were frequency shifted to account for B0 variations using the
water saturation shift referencing (WASSR) technique.[33] Specifically, a B0 field map
was generated by acquiring a CEST spectrum using a FSE sequence (slice thickness = 2
mm, TR = 7000 ms, TE = 7 ms, ETL = 32, effective TE = 7 ms, 3 averages, 2 pre-scans,
field of view = 25.6 x 25.6 mm2, matrix size = 64 x 64, and a 100 ms long continuous
wave RF saturation pulse with a B1 amplitude of 0.2 µT, saturation frequencies = -0.5 to
0.5 ppm in 33 steps). The 33 WASSR points were interpolated to 401 points (1 Hz
resolution) and fit to a 10th order polynomial. A B1 field map was created using an actual
flip-angle imaging (AFI) pulse sequence (TR = 20 ms, TE = 3.47 ms, # echoes = 2, flipangle = 70o, 1 average, field of view = 25.6 x 25.6 mm2, matrix size = 64 x 64, total
image acquisition time was 2 min 13 s).[34] For each pixel, B1 was calculated using B1 =
B1ref * (actual flip-angle/ 70o) incorporating the flip angle map and B1ref = 1.5 µT. Both
B1 and B0 corrections were applied to all CEST images.[35]

3.2.5.6

CEST data processing

All acquired CEST MR data were loaded into MATLAB (version 7.5, R2007b) for
analysis. Using custom MATLAB programs, B0 and B1 corrections were performed on a
pixel-by-pixel basis and all CEST spectra were smoothed using the ‘smooth’ algorithm
from the MATLAB curve fitting toolbox.

3.2.6 Middle cerebral artery occlusion
Focal cerebral ischemia was induced in 24-28g, C57BL/6 mice by middle cerebral artery
occlusion (MCAO) using a filament technique as previously described.[36] Briefly,
anesthesia was induced by inhalation of 4% isoflurane in a 100% O2 mixture and
maintained using 1.5% isoflurane. Under an operating microscope, the left common
carotid was exposed through a midline neck incision. Then, a silicone rubber-coated
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monofilament (701956PK; Doccol Company, Redlands, California) was inserted through
the left common carotid artery into the internal carotid artery to occlude the middle
cerebral artery (MCA).

The monofilament remained in the MCA until sacrifice

(permanent occlusion). Body temperature was maintained at 37±0.5°C by using a heating
pad.

MCAO induced ischemia was confirmed based on the T1, T2 and diffusion-

weighted MR images following surgery, as well as histology. The percent reduction in
cerebral blood flow (CBF) obtained by permanent MCAO was measured using laser
Doppler flowmetry[37] in four different 24-28g, C57BL/6 mice.

3.2.7 Histology
Animals (N=2) were removed from the MRI scanner and sacrificed immediately after
completion of MRI imaging. Animal brains were dissected and stained within 5 minutes
after sacrifice. After decapitation, the brain was quickly removed and sectioned into 2
mm slices. The slices were immersed into 37 °C solutions of 2% TTC dissolved in
normal saline.[27] After approximately 30 minutes, all brain slices were fixed in 10%
phosphate-buffered formalin for photography.

Brain slices corresponding to CEST

imaging slices were identified using multi-slice scout MR images as a reference.

3.2.8 Statistical Analysis
Cerebral tissue pH measurements were made from pathological and contralateral regions
within each mouse brain and expressed as mean ± s.d. Differences in mean pH between
stroke and contralateral brain regions (n=5 mice) were tested using the Student’s t-test
with p < 0.05 considered to be significant.

3.3 Results
3.3.1 Numerical Simulations
Bloch-McConnell simulations demonstrated that as pH increases within the physiological
pH range (ie. pH = 6.0 to 8.0 pH units), the CEST contrast associated with amine protons
and amide protons changes in opposite directions (Figure 3.2a-c). These changes are
most easily observed in Figure 3.2c, where amide and amine CEST effects, as defined by
equation [3.3] are displayed with varying pH. Specifically, as pH increases from 6.0 to
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8.0, the CEST effect increases for the amide protons at 3.50 ppm. Conversely, the CEST
effect associated with amine protons at 2.75 ppm decreases from pH 6.5 to ~7.5. The
resulting AACID values decrease linearly as pH increases (Figure 3.2d). Numerical
simulations also demonstrate that pH-dependent exchange rate effects dominate AACID
measurements in brain tissue when considering expected variations in macromolecule
concentration, water content and relaxation times in tissue following ischemia. First,
varying macromolecular concentrations (9, 10 and 11 %) modeled potential changes in
MT following ischemia[23] (Figure 3.2e) and confirmed negligible effects on the
simulated AACID-pH relationship. Second, the AACID-pH relationship was simulated
for both normal and ischemic brain tissue to study the cumulative effects of differences in
water content, relaxation, and consequent changes in direct saturation. Known changes
in water content, and T1 and T2 relaxation [24] also produced negligible changes in
AACID measurement (Figure 3.2f).

3.3.1.1

In vitro studies

Solutions with varying pH were produced containing different concentrations of bovine
serum albumin (BSA) dissolved in phosphate buffered saline (PBS). Although these
solutions did not replicate all in vivo conditions (e.g. T1 and T2 relaxation time constants,
and macromolecule MT), they provided a physical model of an exchanging system
containing both amide and amine protons similar to that found in vivo. These solutions
demonstrated the effects of changing pH, protein concentration, and temperature on
CEST, and consequently AACID measurements. CEST spectra of 10% BSA dissolved in
PBS solutions with varying pH demonstrate three distinct CEST effects (Figure 3.3a,b).
Amide proton CEST effects are centered at ~3.50 ppm and two different amine proton
CEST effects are centered at ~2.0 and ~2.75 ppm. Incrementally increasing solution pH
from 6.0 to 8.0 caused the amide CEST effect to increase and the amine CEST effect at
~2.75 ppm to decrease. The amide and amine CEST effects at ~2.75 ppm are plotted
separately with varying solution pH in Figure 3.3c. Ratiometric AACID values decreased
linearly when increasing pH from 6.5 to 8.5 (Figure 3.3d) as predicted by numerical
simulations.

AACID measurements were nearly identical for pH 7.0 phantoms
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containing 6, 8, 10, 12 and 14% BSA (Figure 3.3e). AACID pH measurements obtained
in a pH 7.0 10% BSA phantom were unaltered between 35-39 oC (Figure 3.3f).
Amine and amide CEST effects are also dependent on saturation pulse amplitude (B1)
and duration (tsat) (Figure 3.4a,b). Similar to Cai et al., CEST effects were measured in
vitro for eight metabolite solutions (Table 3.2) at 37 oC.[10]

The CEST contrast

produced by these brain metabolites was measured at 3.50 ppm and 2.75 ppm at
physiological concentrations to determine the magnitude of contaminant contributions to
AACID pH values (Figure 3.4c,d). Glutamate was the only metabolite to generate a
significant contaminant CEST effect at 3.50 ppm (Glutamate CEST ≈ 2.3% compared to
CEST from 10% BSA ≈ 9.2%) and 2.75 ppm (Glutamate CEST ≈ 3.0% compared to
CEST from 10% BSA ≈ 19.4%). Note that the CEST effects from the amine protons
associated with glutamate are optimal at ~1.0-3.0 ppm at physiological pH.[10]
However, glutamate CEST contributions to AACID pH values are expected to be less
than 5% due to ratiometric cancellation when using a 4s, 1.5 µT saturation pulse at 9.4T.
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Figure 3.2: Numerical simulations of AACID Dependence on pH, Macromolecule
Concentration, and Relaxation Time Constants in Brain: a) Simulated CEST-spectra
for varying pH in normal brain tissue. b) Figure 3.1a magnified to highlight the amine
and amide pH dependent CEST effects. Note: MZ and M0 represent the region of interest
MRI signal acquired with and without a saturation pulse, respectively. c) Amine and
amide CEST values measured directly from 2a using equation [3.3]. d) AACID values
measured directly from 3.2a using equation [3.6]. e) AACID-pH relationships simulated
for a range of macromolecular concentrations (% by-weight) using a 4s, 1.5 µT saturation
pulse. f) AACID-pH relationships simulated for normal and ischemic brain tissue using a
4s, 1.5 µT saturation pulse. Numerical simulations predict that AACID values decrease
approximately linearly with pH within the physiological pH and temperature range.
Independence of physiological changes in MT and relaxation times during cerebral
ischemia suggests that AACID can be used to calculate absolute pH in vivo.
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Figure 3.3: Amine and Amide CEST Dependence on pH, Protein Concentration and
Temperature: a) CEST-spectra of 10% (by weight) BSA dissolved in PBS with varying
pH at 37 °C. b) Figure 3.2a magnified. c) Amine and amide CEST values measured
directly from 3.3a using equation [3.3]. d) AACID values measured directly from 3.3a
using equation [3.6]. e) AACID values measured in solutions containing a range of BSA
concentrations at 37 oC using a 4s, 1.5 µT saturation pulse. f) AACID values measured
in a pH 7.0 10% BSA solution for a range of physiologically relevant temperatures using
a 4s, 1.5 µT saturation pulse. In vitro AACID measurements decrease linearly with pH
as predicted by numerical simulations. AACID independence of protein concentration
and tissue temperature suggests that AACID values can be used to calculate absolute pH
in vivo.

3.3.2 In vivo AACID pH-calibration
Numerical simulations indicate that significant differences in macromolecular MT and
proton exchange rates [5, 10, 22] between BSA solutions and brain tissue necessitated a
separate in vivo AACID pH-calibration.

31

P-MRS (Figure 3.5a) and CEST (Figure 3.5b)

99

spectra were acquired in vivo and postmortem in normal healthy mice (n=3).

pH-

calibration was achieved by fitting a linear model to mean whole brain in vivo and
postmortem AACID values plotted against corresponding

31

P-MRS pH measurements

(Figure 3.5c). The calibration is valid assuming the Pi and PCr metabolites used to
measure pH by 31P-MRS exist in the same physical environment as the amide and amine
protons used to produce the AACID value [5] and the pH-dependence of the AACID
measurement is linear in vivo, as it was in both numerical simulations and in vitro. The
resulting linear relation obtained by 31P-MRS calibration described in equation [3.7] was
used to produce quantitative pH maps in vivo.
[3.7]

pH = -4.0× AACID + 12.8
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Figure 3.4: Amine and Amide CEST Dependence on Saturation Pulse Amplitude,
Duration, and Metabolite Contributions: Amine and amide CEST effects from 10%
(by weight) BSA dissolved in pH 7.0 PBS at 37 °C measured following a) a 4s
continuous wave RF saturation pulse with amplitudes ranging from 0-3 µT, and b) a 1.5
µT continuous wave RF saturation pulse with duration ranging from 0-6s. CEST values
measured at c) 2.75 ppm and d) 3.50 ppm for major brain metabolites at physiological
concentrations (37 oC using a 4s, 1.5 µT continuous wave RF saturation pulse) compared
to 10% BSA. Amide and amine CEST effects approach steady state after a 4s, 1.5 µT
saturation pulse. Protein is shown to be the dominant contributor to AACID values
compared to other brain metabolites, which suggests that AACID measurements are
independent of changes in metabolite concentrations and can be used to calculate
absolute pH in vivo.
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3.3.3 Acute acidosis following MCAO
Following the pH-calibration of AACID measurements in vivo, high-resolution pH maps
were produced in mice following permanent middle cerebral artery occlusion (MCAO).
Several studies have reported local cellular acidosis after induction of ischemia.[5, 38,
39] Therefore, a MCAO mouse model[40] was used to establish the feasibility of in vivo
pH measurement using AACID across the range of pH values encountered in ischemic
conditions.
Following ischemia, anaerobic metabolism causes cellular acidosis.[5, 38, 41]
Quantitative pH maps produced at two (Figure 3.6d) and five hours (Figure 3.6i)
following permanent MCAO (n=5) showed a localized pH decrease that corresponded
anatomically to changes observed in T1-, T2- and diffusion-weighted MR images (Figure
3.6a,b,c,f,g,h). Regions of interest (ROIs) containing the ischemic core and contralateral
brain are shown in Figures 3.6d,i. Figure 3.6e shows the CEST spectrum from the
contralateral brain ROI (blue) superimposed onto the spectrum from the ROI containing
the ischemic core (red). At 3.50-3.70 ppm, the CEST spectra do no overlap, indicating a
distinct difference in amide CEST effects (red arrow). Whereas, at 2.75 ppm, the CEST

101

spectra nearly overlap, indicating very little change in amine CEST effects (green arrow).
This pattern of change was expected based on numerical and in vitro studies that also
showed only small changes in amine CEST effect between pH 6.5-7.0 (Figures 3.2a,b
and 3.3a,b). Regions of significant acidosis in pH maps were consistently larger 5 hours
after surgery compared to 2 hours. For example, in the mouse shown in Figure 3.5, the
region of significant acidosis (pH ≤ 6.6) within the imaging slice was approximately 15
mm3 two hours after occlusion and increased to 29 mm3 at five hours. At five hours post
occlusion the pH values [mouse #: stroke mean ± s.d., contralateral tissue mean ± s.d.]
calculated using the pH maps were: [mouse 1: 6.76 ± 0.19, 6.93 ± 0.14], [mouse 2: 6.57 ±
0.13, 6.90 ± 0.13], [mouse 3: 6.67 ± 0.22, 7.02 ± 0.13], [mouse 4: 6.64 ± 0.17, 7.04 ±
0.15], [mouse 5: 6.54 ± 0.16, 6.94 ± 0.16]. Ischemic and contralateral tissue pH mean
values were calculated using all pixels in the entire ischemic and contralateral sides
respectively. The average ischemic tissue pH (6.64 ± 0.09) was significantly lower
(p<0.01 by t-test, n=5 mice) than the average contralateral tissue pH (6.97 ± 0.06). While
pH maps were fairly consistent among different animals, specific quantitative
measurements such as ischemic volumes and mean pH may vary with slice location. A
series of molecular events initiated by cerebral ischemia lead to increased intracellular
water content (i.e. edema) and consequently reduced water flow, leading to increased
brain tissue water T1 relaxation time constants.[24, 42] However, the numerical
simulations and in vitro results from the current study, demonstrate that these
physiological changes have negligible effect on the ratiometric AACID pH measurement.
Following MR imaging animals were immediately sacrificed and histology was
performed (N=2). Brain sections corresponding to the acquired pH maps were stained
with 2,3,5-triphenyltetrazolium chloride (TTC) and demonstrated that regions of
decreased pH corresponded to regions of low oxidative metabolism indicated by a lack of
TTC staining (white, Figure 3.6j). The mean (± std. dev.) percent reduction in CBF
measured with laser Doppler flowmetry [27] in healthy C57BL/6 mice was 87% ± 7%
(N=4).
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Figure 3.6: Cerebral Ischemia: Representative MR images of a mouse brain two hours
(a-e) and five hours (f-j) following permanent middle cerebral artery occlusion (MCAO)
in radiological orientation. a,f) T1-weighted image, b,g) T2-weighted image, c,h:
diffusion-weighted image, d,i: pH map with ischemic (left) and contralateral (right)
regions of interest (ROIs) drawn, and e) CEST-spectra measured from ischemic (red) and
contralateral (blue) ROIs at 2 hours with CEST effects located at arrows (red arrow:
amide CEST, green arrow: amine CEST), f) histology TTC-stained for mitochondrial
cellular respiration (i.e. red stained tissue has functional mitochondrial and white unstained tissue does not).

3.4 Discussion
The current study demonstrates a novel method to noninvasively quantify in vivo pH
using CEST-MRI contrast. The ratiometric approach called AACID is insensitive to
variations in tissue T1, T2, macromolecule concentration, and temperature over the
relevant physiological ranges following ischemia. Since the AACID measurement is a
relative measure that compares two CEST effects, it is also insensitive to changes in the
concentration of amine and amide protons relative to water protons that can be caused by
changes in water content, protein content and diffusion.[12, 43] However, chemical shift
corrections must be made to account for B0 variation and CEST amplitude corrections
must be made to account for B1 variation on a pixel-by-pixel basis. Using AACID pH
measurement, high-resolution maps of brain tissue pH were obtained in mice following
permanent MCAO. Regions of significantly decreased pH at two and five hours after
MCAO corresponded to regions of cellular damage.
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Previous studies have shown that changes in pH can be measured by noninvasive MRI
techniques.[5, 8, 9] Although the AACID technique avoids several sources of error
associated with previous CEST-based methods to measure pH, three assumptions were
required to measure quantitative pH using AACID. These assumptions were that: 1) the
ratio of exchangeable amide and amine proton populations remain constant throughout
the brain and during ischemic conditions, 2) the relation between AACID values and pH
is linear in vivo, as it was found to be in numerical and in vitro studies, and 3) direct
water saturation has a negligible effect on the AACID ratio.

The validity of each

assumption is discussed below.
First, the AACID technique assumes that the ratio of exchangeable amide to amine
proton populations is constant throughout the brain, even in regions with different protein
concentration. Consider that the measured CEST signals are from exchangeable amine
and amide protons on mobile peptides and proteins, with the vast majority existing within
the cell. There are 21 standard amino acids that constitute the structural units of peptides
and proteins in eukaryotes,[44] along with many other less abundant amino acids that are
formed by post-translation modifications. Of the 21 amino acids, only lysine has
exchangeable amine protons on its side arm. Although each amino acid contains an
amine functional group, when peptide bonds form between amino acids, the amine is
transformed to an amide group. Therefore peptides and proteins may contain from one to
hundreds of exchangeable amide protons, while only proteins with lysine-rich regions
contain significant amounts of exchangeable amine groups. The average occurrence of
lysine in proteins is ~6%.[44] In the current study, pH maps did not show any significant
contrast between gray and white matter in mouse brain (Figure 3.6d) suggesting that the
amine to amide ratio is the same in both gray and white matter. However, we cannot
exclude the possibility that the ratio of amine and amide proton populations changes in
disease, which would result in inaccurate pH measurements.
Accurate quantitative pH measurement also requires a linear relationship between
AACID and pH in vivo. This assumption is reasonable considering a linear relationship
was observed in both numerical simulations and in vitro.

Numerical simulations

provided a convenient theoretical model to investigate complex exchange systems.
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Simulation of the AACID response to altered pH demonstrated a linear relationship under
both aqueous (i.e. no endogenous macromolecule MT) and tissue (i.e. with endogenous
macromolecule MT) conditions. However, the simulations also showed that endogenous
macromolecule MT significantly shifted the AACID response to pH, necessitating a
separate in vivo pH-calibration.

Additional numerical simulations revealed that

physiologically relevant regional changes in endogenous macromolecule MT effects (<
10%) do not significantly affect the linear AACID-pH relationship.

AACID

measurements were also insensitive to changes in water content, and variations in T1 and
T2 relaxation, suggesting that direct saturation has negligible effects at 9.4T.
The CEST sensitivity of both the amide and amine protons depends on the chemical
exchange rate. In order to detect CEST contrast, the exchange rate must be within the
slow-to-intermediate exchange regime at 9.4T. At physiological pH and temperature,
amide protons associated with endogenous protein have slow exchange rates of 10-300 s-1
and APT contrast has been detected when using a low amplitude (~1.2 µT) saturation
pulse.[5] Conversely, amine protons associated with free amino acids and metabolites
have much faster exchange rates (500-10000 s-1).[10, 19] However due to the significant
CEST effects observed at 2.75 ppm from 10% BSA solutions (Figures 3.3a,b) using a 4s,
1.5 µT continuous wave RF saturation pulse, the authors suspect that amine protons
associated with peptides and proteins are in the slow-to-intermediate exchange regime
(e.g. 100-1500 s-1) at pH ≤ 7.0.[17] In vitro results indicate that at 9.4T, amine proton
exchange rates pass through the slow, intermediate and fast exchange conditions as pH
increases from 6.0 to 8.0. Exchangeable amine protons associated with endogenous
peptides and proteins resonating at ~2.75 ppm were also recently detected by spinlocking techniques using a 5s saturation pulse with amplitudes as low as ~2 µT.[45]
Therefore, in the current experiment, a saturation pulse with a low amplitude (1.5 µT)
and a long duration (4s) was used to selectively saturate the relatively slowly exchanging
amide and amine protons and avoid contaminant CEST contrast from fast exchanging
amine protons associated with common brain metabolites such as glutamate and
creatine.[10, 11]
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Since chemical exchange rate is sensitive to pH and temperature, the effects of
temperature modulation of the system must also be considered. Zhou et al. recently
showed an increase in amide proton exchange rate of ~1% per 1 oC compared to a ~76%
increase in exchange rate following an increase in pH of only 0.4 pH units.[5] These
results suggest that base-catalyzed exchange rate effects mediated by pH dominate
temperature (Arrhenius) mediated exchange rate effects within the physiologically
relevant range. Theoretical modeling of temperature effects is difficult,[5] therefore in
vitro verification was performed in the current study (Figure 3.3e). Using in vitro protein
solutions containing amine and amide protons, AACID values were measured at different
temperatures (35, 36, 37, 38, 39 oC). As expected from Zhou et al., the amide and amine
CEST effect is more sensitive to physiologically relevant changes in pH than to
physiologically relevant changes in temperature and AACID values did not change
significantly across the measured temperature range (Figure 3.3e). Within the range of
temperature variation expected in cerebral ischemia,[46] amine and amide CEST effects
were negligibly altered in comparison to the magnitude of the changes observed when pH
was altered within the physiological range.
The use of CEST-MRI contrast to measure pH has evolved over the last several years.
The first approach to measure CEST effect was to divide the NMR signal intensity
following a saturation pulse by the signal intensity without saturation. However, this
measurement is contaminated by endogenous macromolecule MT effects, direct water
saturation, and blood oxygen level dependent (BOLD) effects.[5] Therefore Zhou et al.
introduced the novel MTRasym curve to maximize CEST sensitivity, while eliminating the
mentioned interferences.[5] However when using MTRasym, APT contrast is modulated
by changes in tissue pH, as well as amide content, water content, T1 relaxation time
constants, and macromolecular NOEs; therefore, quantitative pH measurement using
APT should be used cautiously.[5-7] AACID pH measurement avoids NOE
contamination by normalizing the amide and amine signal intensities following saturation
to the signal intensity at 6.0 ppm following saturation.

Normalization to 6.0 ppm

decreases CEST sensitivity at 2.75 and 3.50 ppm compared to MTRasym methods because
the endogenous macromolecule MT effect is not completely removed.

However,

normalizing both 2.75 and 3.50 ppm to 6.0 ppm allows the measurement of two different
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CEST effects while acquiring only three images. The 6.0 ppm point is not influenced by
amine or amide CEST effects, or NOE effects, and it provides a good indicator of local
T1 related signal loss, BOLD effects, and macromolecule MT for normalization. Similar
results are possible when using any reference at ∆ω > 6.0 ppm, however CEST sensitivity
decreases as ∆ω increases away from the water resonance because contributions from
macromolecule MT will begin to dominate measured AACID values.

The current

normalization at 6.0 ppm provided a linear AACID-pH relation that ensured a
straightforward in vivo calibration.
While CEST effects have been detected at 3.50 ppm at clinical field strengths (1.53T),[47] further work is required to assess the feasibility of measuring the 2.75 ppm
amine CEST effect at these lower magnetic field strengths. The AACID method is
expected to have lower sensitivity to pH at lower magnetic fields because the amine
proton exchange likely approaches the fast exchange rate condition and because direct
saturation of water will be increased. However, the method would remain independent of
NOE and would require less saturation power than at higher magnetic field strengths. The
AACID technique is immediately applicable in humans using current 7T and 9.4T human
MRI systems, although an initial pH-calibration would be required. In addition, three
dimensional AACID pH maps can be generated with significantly higher spatial and
temporal resolution using steady state CEST acquisition methods.[48] Application of the
AACID technique to measure pH in other diseases such as cancer is possible with proper
in vivo pH-calibration.[49]
The quantitative resolution, or the uncertainty in a determined value (e.g. pH value) is a
useful parameter when comparing different measurement techniques. Using methods
described by Pardue et al., quantitative resolution is defined as the ratio of the uncertainty
in measured response to the sensitivity of a measurement system.[50] In the current
study, the quantitative resolution is determined using the in vivo pH-calibration data
(Figure 3.5). Results in Figure 3.5c, reveal a measured response uncertainty of 0.036 (i.e.
standard deviation of AACID values from the linear fit in Figure 3.5c) and an AACID
pH-sensitivity of 0.253 pH-1. Therefore the quantitative resolution of pH measurements is
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0.14 pH units. Zhou et al. report a slightly lower quantitative resolution, stating that pH
changes of ~0.2 pH units or greater can be detected using amide proton CEST effects.[5]

3.5 Conclusion
AACID represents a novel technique to quantify in vivo pH using endogenous CEST
contrast.

Using AACID, CEST-MRI can provide noninvasive, high-resolution pH

distribution maps within animal models and could be extended to human subjects.
Quantitative pH measurement using AACID is independent of protein concentration,
water content, temperature, and NOEs at 9.4T. In vitro results indicate that glutamate
may contribute ~5% to the AACID measurement in vivo.

Following in vivo pH-

calibration, pH was measured by AACID in a mouse model of MCAO. Decreased pH
was observed on the ischemic side of the brain at two and five hours after the start of
cerebral ischemia. The tissue region showing decreased pH increased in size between two
and five hours. Absolute in vivo pH measurement could provide an indicator of disease
progression, severity and treatment response.
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Abstract:
Increased lactate production through glycolysis in aerobic conditions is a hallmark of
cancer. Some anticancer drugs have been designed to exploit elevated glycolysis in
cancer cells.

For example, lonidamine (LND) inhibits lactate transport leading to

intracellular acidification in cancer cells. Chemical exchange saturation transfer (CEST)
is a novel MRI contrast mechanism that is dependent on intracellular pH. Amine and
amide concentration-independent detection (AACID) and apparent amide proton transfer
(APT*) represent two recently developed CEST contrast parameters that are sensitive to
pH. The goal of this study was to compare the sensitivity of AACID and APT* for the
detection of tumor-selective acidification after LND injection.

Using a 9.4T MRI

scanner, CEST data were acquired in mice approximately 14 days after implanting 105
U87 human GBM cells in the brain, before and after administration of LND (dose: 50
mg/kg or 100 mg/kg). Significant dose dependent LND-induced changes in measured
CEST parameters were detected in brain regions spatially correlated with implanted
tumors. Importantly, no changes were observed in T1- and T2- weighted images acquired
before and after LND treatment. The AACID and APT* contrast measured before and
after LND-injection exhibited similar pH-sensitivity.

Interestingly, LND-induced

contrast maps showed increased heterogeneity compared to pre-injection CEST maps.
These results demonstrate that CEST contrast changes after administration of LND could
help localize brain cancer and monitor tumor response to chemotherapy within one hour
of treatment. The LND-CEST experiment uses an anticancer drug to induce a metabolic

change detectable by endogenous MRI contrast and therefore represents a unique cancer
detection paradigm that differs from other current molecular imaging techniques that
require injection of an imaging contrast agent or tracer.
Abbreviations used: GBM, glioblastoma multiforme; pHi, intracellular pH; CEST,
chemical exchange saturation transfer; LND, lonidamine; RF, radiofrequency; MTRasym,
asymmetric magnetization transfer ratio; NOE, nuclear Overhauser effect; MT,
magnetization transfer; AACID, amine and amide concentration-independent detection;
APT*, apparent amide proton transfer; PBS, phosphate-buffered saline; FSE, fast spinecho; ETL, echo train length; WASSR, water saturation shift referencing; AFI, actual
flip-angle imaging; ROI, region of interest; H&E, hematoxylin and eosin;
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4.1 Introduction
Primary brain glioma is a rare form of cancer accounting for < 2% of all cancers,
however it represents the second leading cause of death among neurological diseases in
the United States [1, 2]. Glioblastoma multiforme (GBM) is the most lethal and most
common form of glioma [2-4]. The current standard of care of GBM tumors includes
surgical resection of the primary tumor followed by aggressive concurrent radiation and
chemotherapy [2-4].

Despite advances in therapeutic strategies coupled with

neurological imaging throughout treatment, mean GBM patient survival time is
approximately one year after diagnosis [1-4]. Over 90% of GBM tumors recur due to
migratory cancer cells that evade treatment [4].
Currently, clinicians rely on standard anatomical 1H MRI to detect tumors and monitor
treatment response [2, 4], yet morphological changes caused by treatment are often
difficult to detect and quantify especially during radiation therapy when pseudoprogression markers may exist [3, 5]. Using anatomical MRI techniques, clinicians often
require several weeks to conclude that a GBM tumor is unresponsive to therapy before
prompting a change in treatment [4]. Since GBM tumors are among the most aggressive
human tumors, there is a need to develop imaging techniques that are able to detect tumor
response within days or even hours after initial treatment. For example, Zhou et al.
recently showed that tumor response to radiation therapy (ie. radiation necrosis) could be
detected within 3 days of treatment using used a novel 1H MRI contrast mechanism
called chemical exchange saturation transfer (CEST) [5]. The ability to quantify tumor
response immediately after therapy will enable clinicians to quickly tune and optimize
therapy, improving patient outcome.
Malignant cancer cells undergo genetic mutations that result in increased aerobic
glycolysis, known as the Warburg effect [6]. The Warburg effect leads to higher lactic
acid production but cancer cells adaptively increase expression of intracellular pH (pHi)
regulators (e.g. ion transport channels and pHi-buffering enzymes) to maintain a
relatively alkaline pHi [7]. Alkaline pHi enables increased proliferation and evasion of
apoptosis by cancer cells [7]. A class of chemotherapy agents target increased glycolysis
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in tumors by inhibiting key pHi-buffers and/or glycolytic enzymes such as hexokinase or
by blocking ion transport channels [6]. Consequently, many chemotherapy agents cause
changes in physiological properties such as pHi almost immediately after starting
treatment [8-11]. Monitoring immediate tumor pHi response to metabolic stressors could
provide a measure of tumor aggressiveness and predict tumor response to treatment [12].
For example, Sagiyama et al. recently used a pH-sensitive CEST MRI contrast to monitor
tumor response to chemotherapy with temozolomide [3]. It was found that CEST MRI
contrast changed significantly in orthotopic GBM tumors 7 days after a single course of
temozolomide treatment compared to untreated tumors. Since no changes in tumor
volume, cell density or apoptosis were observed in treated tumors, Sagiyama and
colleagues hypothesized that the observed changes in CEST contrast may be attributed to
a decrease in pHi caused by temozolomide.
The purpose of the current study was to evaluate the sensitivity of pH-dependent CEST
contrast for the detection of changes in tumor pHi induced by a single dose of the drug
lonidamine (LND), which has been used to treat cancer in Europe and Canada [10]. LND
is an anticancer agent that exploits the Warburg effect to target and destroy malignant
cancer cells [6, 10]. More specifically, LND limits aerobic respiration in cancer cells by
blocking pyruvate transport from the cytoplasm [13]. Due to the Warburg effect, cancer
cells have a greater reliance on pyruvate produced by glycolysis in the cytoplasm
compared to normal cells.

Inhibition of pyruvate transport impedes oxidative

phosphorylation in tumors leading to energy depletion [10, 14]. Furthermore, LND
blocks lactate efflux from cells by inhibiting the monocarboxylic acid transporter [10].
Cancer cells produce significantly more lactate compared to normal cells [6] and
consequently, we hypothesize that tumor-selective intracellular acidification occurs [10,
11, 14] following lonidamine treatment that will produce CEST MRI contrast.

4.2 Theory
CEST contrast is generated using protons associated with endogenous mobile proteins
and peptides that are 1) chemically-shifted by Δω from bulk water protons and 2) freely
exchanging at a rate kex with bulk water protons.
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To generate CEST contrast,

exchangeable protons associated with specific molecules can be saturated using a
frequency-selective radiofrequency (RF) saturation pulse.

The process of chemical

exchange transfers saturated protons to the bulk water proton pool leading to a decrease
(darkening) in MR image intensity. CEST effects from amide protons resonating at Δω =
3.50 parts per million (ppm) downfield (i.e. higher frequency) from bulk water protons
(referenced to 0 ppm) or amine protons resonating at Δω = 2.0 and Δω = 2.5-2.75 ppm
have been used by several groups to generate CEST contrast [15-19]. Amide and amine
proton CEST effects are pH-dependent since their chemical exchange rates kex are basecatalyzed [20]. The majority of mobile proteins and peptides reside in cells and therefore
amide and amine CEST effects are considered to be pHi-dependent. Cerebral ischemia
animal models have been used to demonstrate a local decrease in amide CEST effects at
3.50 and increase in amine CEST effects at 2.5 ppm in regions of intracellular acidosis
[15-17].
CEST effects may be observed using a z-spectrum. A z-spectrum is a plot of the
normalized bulk water magnetization
frequency, where

Msat M0 as a function of the saturation pulse

Msat and M0 are the bulk water magnetization measured after and

without saturation respectively [21]. Traditionally, CEST effects are quantified using the
asymmetric magnetization transfer ratio (MTRasym) that was first introduced by Zhou et al
[16]. MTRasym measurements are calculated using equation [4.1]:

[4.1]

where

is the bulk water magnetization measured after saturation at the

frequency ∆ω. However some groups have found that nuclear Overhauser effects (NOEs)
at frequency offsets Δω between -2.0 to -4.0 ppm and asymmetric macromolecular
magnetization

transfer

(MT)

effects

can

significantly

contaminate

MTRasym

measurements [22, 23]. Therefore, it is difficult to quantify CEST effects using the
MTRasym technique [22]. Recently, two novel techniques were introduced to enable
quantification of amide and amine CEST effects in vivo while avoiding upfield NOEs and
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asymmetric MT effects. Our group developed a CEST technique called amine and amide
concentration-independent detection (AACID) that uses the ratio of CEST effects of
amide and amine (Δω = 2.75ppm) protons to generate pHi dependent contrast
independent of tissue macromolecule concentration and temperature [17]. Also, Jin et al.
recently demonstrated a novel three offset measurement technique to measure a
parameter named apparent amide proton transfer ratio (APT*) [23]. Both AACID and
APT* techniques are sensitive to pHi and have been used in vivo to detect acidosis in
cerebral ischemia models [17, 23]. In the current study, we compare the sensitivity of
AACID and APT* for the detection of LND-induced pHi changes in tumors.

The

magnitude of single-dose LND-induced CEST contrast could help predict tumor response
to treatment.

4.3 Experimental
4.3.1 Subjects
Nine mice were included in the current study including six NU/NU mice with U87 GBM
brain tumors that were used to evaluate the effect of injecting 50 mg/kg (N=3) and 100
mg/kg (N=3) of LND. C57BL/6 male mice (N=3) were used to study the effects of LND
on normal brain tissue. All animal procedures were performed according to a protocol
that was consistent with guidelines established by the Canadian Council on Animal Care
and was approved by the University of Western Ontario Animal Use Subcommittee.

4.3.2 Lonidamine
LND (C15H10C12N2O2) was purchased from Lancrix Chemicals (Shanghai, China). The
drug (37.5 mg) was dissolved in 3 mL of pure dimethyl sulfoxide (DMSO) and vortexed
until the solution was clear. LND was administered intraperitoneally (i.p.) at a dose of 50
mg/kg or 100 mg/kg with a syringe pump (Harvard Apparatus, Holliston, MA, USA)
over the course of 2 min.
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4.3.3 Animal tumor preparation
GBM brain tumors were induced in 21-25g, NU/NU mice (N=6) using U87 GBM cells
established from a human GBM (ATCC; Rockville, MD, USA) as described previously
[24]. Briefly, U87 GBM cells were grown in Dulbecco’s modified Eagles’s medium
supplemented with 10% fetal bovine serum (Wisent Inc., St-Jean-Baptiste, QC, Canada)
at 37 oC in a humidified incubator with 5% CO2 and passaged twice a week. On the day
of injection, U87 GBM cells were washed and dissociated with versene solution
(phosphate-buffered saline (PBS) plus 0.5 mM EDTA), then washed twice with PBS,
counted and re-suspended to a final concentration of 1 x 105 cells in 2 µL PBS. Prior to
injection, mice were anesthetized by inhalation of 4% isoflurane and maintained using
1.5% isoflurane. The mouse was placed in a stereotactic head frame (Stoelting
instruments, Wood Dale, IL, USA). The scalp was swabbed with betadine and an
incision was made in the scalp to expose the bregma. A 1 mm diameter hole was drilled
at coordinates measured from the bregma (1 mm anterior and 2 mm lateral). U87 GBM
cells (2 ml) were injected at a rate of 0.5 µL/min, at a position 3 mm deep from the
bregma into the right frontal lobe using a Hamilton (Reno, NV, USA) syringe with a 27gauge needle attached.

4.3.4 General mouse preparation for in vivo imaging
Anesthesia was induced using 4% isoflurane in oxygen and maintained with 1.5%–2.5%
isoflurane in oxygen. The mouse was secured on a custom-built MRI-compatible stage
and the head was secured using surgical tape to limit motion due to respiration.
Temperature was monitored with a rectal temperature probe, and respiration was
monitored with a respiratory sensor pad connected to a pressure transducer that was
placed on the thoracic region. Body temperature was maintained at 36.9-37.1oC
throughout imaging by blowing warm air over the animal using a model 1025 smallanimal monitoring and gating system (SA Instruments Inc., Stony Brook, NY, USA).
Following pre-injection imaging, the MRI-compatible stage was removed from the
scanner without altering the animal position with respect to the stage. The mouse was
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replaced in the scanner immediately after LND injection.

Animals were sacrificed

immediately after MR imaging.

4.3.5 In vivo imaging parameters
All animals were scanned using an Agilent (Palo Alto, CA, USA) 9.4 T small animal (31
cm horizontal bore) MRI scanner using an Agilent 30 mm millipede volume coil. The
maximum gradient strength is 40 mT/m. Tumors were initially detected using multi-slice
standard anatomical T1-, T2- and diffusion-weighted MRI. Upon tumor detection, a slice
of interest was selected with maximal tumor coverage and single-slice T1-, T2- and
diffusion-weighted MR images were acquired. T1-weighted images were acquired using
a standard fast spin-echo (FSE) pulse sequence (TR/TE = 500/10 ms, echo train length
(ETL) = 4, the time between excitation and the echo at the center of k-space (effective
TE) = 10 ms, 4 averages, 2 pre-scans, FOV = 19.2 x 19.2 mm2, matrix size = 128 x 128,
slice thickness = 2 mm, TA was 1.1 min). T2-weighted images were acquired using a
FSE pulse sequence (TR/TE = 3000/10 ms, ETL = 4, effective TE = 40 ms, 1 average, 2
pre-scans, FOV = 19.2 x 19.2 mm2, matrix size = 128 x 128, slice thickness = 2 mm, TA
= 1.7 min). Diffusion-weighted images were acquired using a multislice spin-echo pulse
sequence (TR/TE = 1000/35 ms, b-value = 1100 s/mm2 in the readout direction, 4
averages, FOV = 19.2 x 19.2 mm2, matrix size = 128 x 128, slice thickness = 2 mm, TA
= 8.5 min). CEST MR images were acquired for the slice of interest using a FSE pulse
sequence (TR/TE = 7000/7 ms, ETL = 32, effective TE = 7 ms, 3 averages, 2 pre-scans,
FOV = 19.2 x 19.2 mm2, matrix size = 64 x 64, slice thickness = 2 mm, TA = 0.4 min,
preceded by a 4 s long continuous wave RF saturation pulse with a B1 amplitude of 1.5
µT). Z-spectra were obtained by acquiring 57 CEST MR images, each with different
saturation frequencies (in ppm) including -0.6 to 0.6 (Δ = 0.1), 1.6 to 4.5 (Δ = 0.1), and
5.4 to 6.6 (Δ = 0.1) and 1000. In each animal, a B0 field map was generated for the image
slice of interest immediately prior to each CEST experiment. A separate B0 map was
acquired pre- and post-injection. B0 distribution maps were measured using the water
saturation shift referencing (WASSR) technique [25]. Specifically, a WASSR spectrum
was acquired using a FSE sequence (TR/TE = 7000/7 ms, ETL = 32, effective TE = 7 ms,
3 averages, 2 pre-scans, FOV = 19.2 x 19.2 mm2, matrix size = 64 x 64, slice thickness =
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2 mm, TA = 0.4 min and a 100 ms long continuous wave RF saturation pulse with a B1
amplitude of 0.2 µT, saturation frequencies = -0.5 to 0.5 ppm in 16 linearly spaced steps).
The 16-point WASSR spectrum was interpolated to 401 points (1 Hz resolution) and fit
to a 10th order polynomial. Z-spectra data were frequency shifted to account for B0
variations. A B1 field map was created using an actual flip-angle imaging (AFI) pulse
sequence (TR = 20 ms, TE = 3.47 ms, # echoes = 2, flip-angle = 70o, 1 average, FOV =
19.2 x 19.2 mm2, matrix size = 64 x 64, TA = 2.22 min) [26]. For each pixel, B1 was
calculated using B1 = B1ref * (actual flip-angle/ 70o) incorporating the flip angle map and
B1ref = 1.5 µT. B1 variation was less than 5% throughout the brain and no B1 correction
was necessary.

4.3.6 CEST data processing
All acquired CEST MR data were loaded into MATLAB (Mathworks, Natick, MA,
USA) for analysis. Using custom MATLAB programs, B0 corrections were performed
on a pixel-by-pixel basis and all z-spectra were smoothed using the ‘smooth’ algorithm
from the MATLAB curve fitting toolbox. Pre- and post-injection images were coregistered using custom MATLAB programs.

4.3.7 CEST and contrast calculations
Using B0-corrected and smoothed z-spectra, AACID values were measured on a voxelby-voxel basis. AACID represent the ratio of CEST effects of amine protons resonating
at 2.75 ppm and amide protons at 3.50 ppm, normalized by MT effects measured after
saturation at 6.0 ppm and is calculated using equation [4.2] [17].

[4.2]
The bulk water magnetization following saturation at 6.0 ppm (ie. MZ (6.0 ppm) ) serves
as a common reference point for both amine and amide CEST effects. As previously
described in detail, the 6.0 ppm normalization point may slightly reduce CEST sensitivity
compared to asymmetry methods, however it avoids contamination from NOEs that occur
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between −2.0 to −4.0 ppm and it reduces the total number of MR images required [17].
Furthermore, the common reference point at 6.0 ppm represents a good estimate of the
endogenous MT contribution.
APT* measurement of CEST effects from the amide protons resonating at 3.50 ppm were
also quantified using the simple three offset measurement technique according to
equation [4.3].

⎛ M (3.0 ppm) − M (4.0 ppm)
⎞
Z
Z
⎜
APT* = ⎜
− MZ (3.50 ppm)⎟⎟ MZ (1000 ppm)
2.0
⎝
⎠

[4.3]

Contrast to noise ratio (CNR) was measured as described by equation [4.4] where

€

CESTBaseline represents the CEST parameters (AACID or APT*) measured at baseline and
CESTLND represents the same parameter after LND treatment. The background noise (
) was approximated as the standard deviation of the CEST parameters within
normal tissue at baseline.

[4.4]

4.3.8 Statistical Analysis
Mean AACID and APT* measurements were made from tumor and contralateral regions
of interest (ROIs) for each mouse brain in quantitative CEST maps acquired before and
after LND injection as well as LND-induced contrast maps. Differences in mean CEST
values measured in tumor ROIs before and after LND injection were tested using
Student’s paired t-test with MATLAB statistics toolbox with p < 0.05 considered to be
statistically significant.
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4.4 Results
4.4.1 CEST imaging of normal brain tissue after LND treatment
A representative set of CEST images acquired from a healthy control animal (C57BL/6
male mouse) is presented in Figure 4.1. For each control mouse, CEST data were
collected at baseline (ie. immediately before LND injection) (Fig. 4.1a,d) and ~50 min
after i.p. bolus administration of 100 mg/kg LND (Fig. 4.1b,e). LND-induced contrast
maps (Fig. 4.1c,f) show the spatial distribution of CNR calculated from the AACID (Fig.
4.1c) and APT* (Fig. 4.1f) distributions maps using equation [4.4].

Some small

variations in LND-induced CNR is visible in the brain in both AACID and APT* contrast
maps. Much of the variation in the contrast maps is spatially correlated to fine brain
structures such as ventricles and may be attributed to motion between acquisitions. Some
heterogeneity may also be attributed to variations in LND effects and delivery within
normal brain tissue. Mean CEST values measured before and after injection of 100
mg/kg LND treatment and LND-induced contrast are summarized for all control mice
(N=3) in Figure 4.2. There was no significant difference between AACID whole brain
mean values acquired at baseline and after LND treatment. Similarly, no significant
LND-induced change was measured using APT*.
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Baseline
a)

After LND
b)

Contrast
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Figure 4.1: Representative set of CEST data from a healthy C57BL/6 mouse brain:
CEST images acquired immediately before (a, d) and 50 min after (b, e) i.p. injection of
100 mg/kg LND. AACID and APT* values were calculated from the same z-spectra.
Contrast maps (c, f) were calculated using CEST maps acquired at baseline and after
LND treatment using equation [4.4].
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Figure 4.2: Summary of CEST and contrast values from healthy C57BL/6 mice
(N=3): a) Mean AACID and b) APT* values acquired at baseline and ~50 min after 100
mg/kg LND treatment. No significant differences were observed before and after LND
treatment in both the AACID and APT* values. As a result the average LND-induced
contrast was equal to background noise.
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4.4.2 CEST imaging of U87 GBM brain tissue after LND treatment
Figure 4.3 presents a set of anatomical MR images for a representative NU/NU mouse 14
days after U87 GBM cancer cell implantation. For all brain tumor mice, regions of
interest (ROIs) containing tumor (dashed line) and normal contralateral (solid line) tissue
were drawn based on anatomical changes observed in T2-weighted images as shown in
Figure 4.3a. The relatively low tumor contrast observed in the T2-weighted anatomical
MR images (Figure 3) is attributed to a combination of partial volume effects associated
with the large (2 mm) slice thickness used and the expected similarity of the T2 relaxation
time constants in the tumor and contralateral brain tissue [27, 28]. NU/NU mice with
U87 GBM brain tumors were treated with 100 mg/kg (N=3) or 50 mg/kg (N=3) of LND.
CEST MRI data are presented in Figures 4.3-4.7 for a representative NU/NU mouse with
U87 GBM brain tumor that was treated with 100 mg/kg LND. Figure 4 shows average
baseline (blue) and post-injection (red) B0-corrected z-spectra obtained using all pixels in
the normal contralateral tissue-containing ROI (Fig. 4.4a) and tumor tissue-containing
ROI (Fig. 4.4b). Baseline amide CEST peaks consistently had larger amplitudes in
tumors compared to contralateral tissue. Although amine protons resonating between
2.50 ppm and 3.0 ppm did not generate clear CEST peaks, they also consistently
generated larger CEST effects in tumor tissue at baseline. This effect is more easily
visualized using the reference line superimposed on each baseline z-spectrum in Figure
4.4 with endpoints empirically set to MZ/M0 values at 1.6 ppm and 4.6 ppm.
Furthermore, in Figure 4.4a, normal contralateral tissue z-spectra showed no significant
change in amine CEST effect at 2.0 ppm and 2.75 ppm or amide CEST effect at 3.50 ppm
(ie. both spectra overlap) following LND injection. A small vertical offset is visible
between spectra at saturation frequencies greater than ~2.50 ppm that may be due to a
minor change in macromolecular MT effects. Conversely, more distinct changes were
observed in the z- spectrum of the tumor ROI after LND injection (Figure 4.4b). Figure
4.4b shows a marked decrease in the amide CEST effect between 3.0 and 4.0 ppm
following LND injection.

This change strongly suggests LND-induced tumor

acidification as amide CEST effects decrease in tissue upon acidosis. In tumor ROIs,
CEST spectra demonstrated a very small change in amine CEST effect at 2.0 ppm and no
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change in amine CEST effect at 2.75 ppm as expected from previous work [17]. Notably,
the minor vertical offset noted above in normal tissue spectra was not observed in tumor
spectra.

b)

a)

c)

Figure 4.3: Standard anatomical MR imaging of U87 GBM brain tumor before
injection of lonidamine: a) T2-weighted image with tumor (dashed line) and
contralateral (solid line) regions of interests (ROIs) drawn. b) T1-weighted and c)
diffusion-weighted images were also acquired using the identical slice of interest.
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Figure 4.4: Chemical exchange saturation transfer (CEST) z-spectra collected at
baseline and ~50 min after administration of lonidamine (LND): Average B0corrected z-spectra calculated from a) normal contralateral tissue-containing region of
interest (ROI) and b) tumor tissue-containing ROI with error bars equal to one standard
deviation. A reference line (gray dashed) was empirically superimposed onto baseline zspectra to aid visualization of differences between z-spectra in contralateral and tumor
tissue. These zoomed Z-spectra highlight the significant changes in the 1.6 to 4.5 ppm
frequency range.
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Figure 4.5: CEST data from a U87 GBM brain tumor model treated with 100 mg/kg
LND: CEST images acquired immediately before (a, d) and 50 min after (b, e) i.p.
injection of 100 mg/kg LND. AACID and APT* values were calculated from the same zspectra. Contrast to noise ratio maps show the change in CEST effects caused by tumor
acidification following administration of LND normalized to the background noise (c, f).
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Figure 4.6: Summary of CEST and contrast values from NU/NU mice with U87
GBM brain tumors (N=3): a,b) Mean AACID and c,d) APT* values acquired at
baseline and ~50 min after 100 mg/kg LND treatment in tumor regions of interest (ROIs)
(a,c) and contralateral ROIs (b,d) with error bars equal to one standard deviation. Mean
LND-induced contrast values are shown with error bars equal to one standard error.

Figure 4.5 shows quantitative CEST distribution maps measured on a voxel by voxel
basis using CEST data measured before (Fig. 4.5a,d) and after (Fig. 4.5b,f) injection of
100 mg/kg LND. At baseline, tumor regions consistently presented lower AACID and
elevated APT* measurements (Fig. 4.5a,d respectively) compared to normal tissue. The
average tumor CNR values (N=6) for each CEST parameter [CEST parameter: tumor
mean CNR ± standard error] calculated using CEST contrast maps were: [AACID: 4.99
± 1.11] and [APT*: 5.12 ± 0.82]. Approximately 50 min after LND injection, a marked
increase in AACID and reduction of APT* values was observed in tumor regions only
(Fig. 4.5b,e respectively). Conversely, tissue relaxation time constants and/or tissue
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water content appeared unaffected by LND treatment because no difference was observed
between T1-, T2- and diffusion-weighted images acquired before and after injection.
Contrast maps (e.g. Fig 4.5c, e) were used to locate and quantify changes in AACID and
APT* caused by 100 mg/kg LND treatment. A marked increase in spatial heterogeneity
appears in LND-induced contrast maps generated using both APT* and AACID maps
within tumor regions, which was not observed in the pre-injection CEST maps. Figure
4.6 summarizes CEST data from all brain tumor animals treated with 100 mg/kg LND
(N=3) calculated using each pixel in tumor and contralateral tissue-containing ROIs from
baseline and post-injection images as well as contrast maps. In tumor ROIs, AACID
values were consistently and significantly higher after LND injection, compared to
baseline (p<0.05 by t-test, N=3). Similarly, APT* values showed a trend toward lower
values in tumor ROIs after LND injection, compared to baseline APT* (p=0.078 by ttest, N=3). The LND-induced signal change was significantly higher in tumor regions
compared to normal tissue using either CEST measure (Fig. 4.6).

Therefore, both

AACID and APT* contrast maps produced high tumor contrast and could potentially be
used to detect tumor-specific effects of LND injection.

The LND-induced CNR

generated using AACID and APT* values were not significantly different. At ~50
minutes after 100 mg/kg LND treatment, the average CNR values (N=3) for each CEST
parameter [CEST parameter: tumor mean CNR ± standard error, contralateral mean
CNR ± standard error] calculated using CEST contrast maps were: [AACID: 4.54 ± 1.79,
1.41 ± 1.06] and [APT*: 4.82 ± 2.51, 1.81 ± 0.51].
To investigate the dose-dependence of LND-induced AACID and APT* contrast, a set of
NU/NU U87 GBM brain tumor mice (N=3) were treated with 50 mg/kg LND. The
LND-induced contrast in tumors generated with 50 mg/kg was consistently lower
compared to animals treated with 100 mg/kg LND for both AACID and APT*. No
significant difference was observed between AACID and APT* LND-induced contrast
maps in animals treated with 50 mg/kg LND.

Figure 4.7 summarizes the dose-

dependence of the mean contrast values generated using each pixel in tumor ROIs in
AACID and APT* maps following LND treatment using 50 mg/kg (N=3) and 100 mg/kg
(N=3) doses. At ~50 minutes after 50 mg/kg LND treatment, the average CNR values
(N=3) for each CEST parameter [CEST parameter: tumor mean CNR ± standard error,
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contralateral mean CNR ± standard error] calculated using CEST contrast maps were:
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Figure 4.7: Dose dependence of mean LND-induced contrast values calculated using
each pixel in tumor regions of interest (ROIs): Mean LND-induced contrast values
generated using a) AACID and b) APT* values in tumor ROIs are shown with error bars
equal to one standard error for different LND doses.

4.4.3 Histological analysis of U87 GBM tumors after LND treatment
Following MRI experiments, animals were euthanized and two brains were excised for
histology. Brain sections (5 µm thick) corresponding to the selected slice of interest were
stained for morphological identification using hematoxylin and eosin (H&E). For the
representative animal presented in Figures 4.3-4.5, H&E stained brain sections confirmed
that regions of high LND-induced CNR within CEST contrast maps corresponded to U87
GBM tumor regions, as shown in Figure 4.8. Two regions of heterogeneous H&E stain
uptake that were observed within the tumor (labeled with boxes b and c in Figure 8a) are
attributed to vasculature and/or inflammatory cells. Interestingly, regions b and c appear
to correspond spatially to regions of heterogeneity observed in the LND-induced CNR
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maps (Figure 4.5c,e). However, robust registration of the LND-induced CNR map with
the brain section is required to conclude that the regions are correlated. Some signal
variation could also be attributed to motion, as was observed in the AACID and APT*
contrast maps obtained in healthy mice (Figure 4.1).

Figure 4.8: H&E stained brain section from representative U87 GBM brain tumor
model: a) Brain section corresponding to the slice of interest used for CEST MR images
in Figure 3 with two regions of interest that display stain heterogeneity attributed to
vasculature and/or inflammatory cells labeled b and c. b-c) Magnified regions of interest
b and c respectively.

4.5 Discussion
The goal of this study was to determine whether CEST MRI contrast changes in response
to single-dose LND treatment could be used to detect treatment response in orthotopic
GBM tumor. LND is an anticancer agent that alters metabolism and pHi. The results
indicate that both the AACID and APT* CEST parameters studied are sensitive to LNDinduced pHi changes in tumors within 1 hour of treatment and that the changes observed
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in tumors are roughly 4-fold higher in tumors than in surrounding brain tissue. Both
AACID and APT* provided similar dose dependent CNR.
The use of CEST contrast has many potential clinical applications. Zhou et al. were the
first to show that exchanging protons associated with endogenous mobile protons and
peptides could be used to detect changes in pHi using amide CEST contrast [16].
Endogenous amide and amine CEST contrast has since been used to detect decreased pHi
in the ischemic penumbra after cerebral ischemia [16, 23]. Amide CEST contrast in
tumor regions has also been used to detect tumors [29]. Recently, Zhou et al. discovered
that differences in amide CEST contrast could be used to differentiate recurrent glioma
from radiation necrotic tissue [5]. Some groups have also found that amide and amine
CEST effects are sensitive to necrotic regions within tumors [18, 30]. In addition, as
already mentioned, Sagiyama et al. discovered that amide proton CEST effects could
detect temozolomide treatment effects one week after treatment [3].
Amide CEST peak amplitude is consistently larger in tumors compared to normal tissue.
Large amide CEST peak amplitudes in tumors are typically attributed to several
characteristics of tumor tissue including longer T1 and T2 relaxation time constants, a
more dilute macromolecular pool with lower magnetization transfer effects, slightly
alkaline pHi and increased mobile cytosolic protein concentration [15, 18].

Amide

protons originate from the amide groups in the backbone of endogenous proteins and
peptides. Similarly, relatively slow-exchanging amine protons resonating between 2.03.0 ppm originate from lysine amino acids in proteins and peptides.
In the current study, LND treatment caused the amide proton CEST peak to decrease
significantly in tumor regions only.

Base-catalyzed amide proton exchange rates

decrease exponentially with a decrease in pH and therefore local acidosis results in
reduced CEST effects in vivo [16, 17, 23]. Amine protons resonating at 2.0 and 2.75 ppm
also have base-catalyzed exchange, however LND treatment induced only small changes
in CEST at 2.0 ppm and no change at 2.75 ppm. The difference in pH-sensitivity is
attributed to the unique ionization constants (pKa) of the different proton pools [20]. Our
group recently showed that amine protons associated with proteins and peptides that
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resonated at 2.75 ppm exchanged in the slow-to-intermediate regime at neutral pH invitro [17]. However in vivo, consistent with the observations in the current study, we
were previously unable to detect pHi-dependent changes in CEST effects at 2.75 ppm in
acidic tissue regions after stroke [17]. The insensitivity of amine CEST effect to changes
in pHi could be predicted based on the relatively low power saturation scheme used (ie. 4
s, 1.5 µT continuous wave saturation) that is not optimally tuned to faster exchanging
amine protons (17). As Woods et al. demonstrated using numerical simulations [31],
CEST peak amplitudes measured using a non-optimal saturation scheme is less sensitive
to changes in exchange rate. Increased amine CEST contrast in tumor regions could be
attributed to increased cytosolic protein concentration in tumors.
Ward and Balaban first demonstrated that a ratiometric approach was valuable because
the ratio of two CEST contrasts is independent of exchange site concentration and bulk
water T1 [32]. Ratiometric techniques may offer improved pH-sensitivity compared to
single CEST effect approaches in cases where both CEST effects change with pH in
opposite directions. Ali et al. described another case where one pH-dependent CEST
effect is normalized by a pH-independent CEST effect that acts as an unresponsive local
control [33]. In such a case, the ratio is pH-dependent and independent of exchange site
concentration and bulk water T1 [32-34]. Based on the observed pHi-sensitive amide and
pHi-insensitive amine CEST effects at 3.50 ppm and 2.75 ppm respectively, AACID
ratios should be sensitive to changes in pHi and insensitive to local variations in protein
content, and T1 and T2 relaxation time constants, assuming that the ratio of amine and
amide groups is the same in all tissue types and does not change after LND injection [17].
Lower AACID values in GBM tumor tissue before LND treatment indicate a slightly
alkaline tumor pHi compared to normal tissue. However, further work is required to
directly relate the AACID ratio to absolute pHi within tumor tissues. Previous work by
Desmond et. al. [35] suggests that using the amine CEST effect at 2.0 ppm rather than
2.75 ppm could improve the performance of the AACID technique. In the current study,
the z-spectrum was not sufficiently sampled around 2.0 ppm to permit further
investigation of this potential alternative, however future work should compare the pHsensitivity of the AACID ratio using the different amine CEST effects at 2.0 and 2.75
ppm.
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APT* values are sensitive to pHi, but unlike AACID are also sensitive to protein content,
magnetization transfer effects from endogenous macromolecules as well as T1 and T2
relaxation time constants. Following injection of LND, T1-, T2- and diffusion-weighted
MR images did not change indicating that the observed changes in both AACID and
APT* maps are dominated by changes in pHi. The current results suggest that AACID
and APT* are equally sensitive to changes in pHi caused by LND. However, the AACID
ratiometric approach is expected to reflect changes in pHi more specifically than APT* in
applications where changes in pHi are accompanied by changes in tissue relaxation and
MT effects.
LND administration causes intracellular acidification in cancer cells by inhibiting efflux
of lactic acid.

Upon LND injection, the Warburg effect leads to tumor-selective

acidification. LND treatment did not induce significant changes in CEST values in
normal tissue regions. This result agrees with recent work by Nath et al. who used
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MRS to confirm that LND caused significant acidification within tumor tissue only [10].
Although several studies have confirmed that LND induces tumor acidification, this work
is the first application of CEST imaging to spatially map LND-induced pHi changes. In
agreement with previous results, we showed that LND-induced changes in tumor pHi
depend on LND dosage. Ben-Yoseph and colleagues used 31P MRS to show that tumor
pHi decreased 0.45 pH units after injection of 100 mg/kg LND and tumor pHi decreased
approximately 0.25 pH units after injection of 50 mg/kg LND [11]. Assuming that LND
injections in the current study generated similar changes in tumor pHi per LND dose, our
results indicate that both APT* and AACID parameters are sufficiently pH-sensitive to
detect pH changes of ~0.25 pH units as was predicted in previous work [16, 17].
The key finding of this study is that amide proton-mediated CEST effects decreased
significantly in GBM tumor regions immediately after LND treatment. Consequently,
post-injection quantitative APT* and AACID distribution maps showed differences
compared to baseline maps in tumor regions only. Tumor-specific drug effects were
evident approximately 1 hour after dosing. LND-induced contrast maps offered high
tumor contrast, consistently enabling accurate tumor detection and boundary delineation.
Primary results presented here suggest the paradigm of CEST imaging before and after
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application of a physiological stress could offer a novel technique tumor detection. To be
clinically relevant, this paradigm must be operationalized using a physiologic stress that
is well tolerated by the patient and must offer improved tumor contrast compared to
baseline images. In the current study, the LND/DMSO injection was not well tolerated
by the mice. However in some mice, LND-induced tumor contrast was higher than the
contrast between contralateral and tumor tissue in the baseline CEST maps. Further work
is required to evaluate the tolerability of alternative physiological stressors that could
further improve tumor contrast. No significant differences were found between APT*
and AACID parameters in terms of LND-induced tumor contrast.

Heterogeneity

observed in tumor regions of the APT* and AACID contrast maps correlated with
morphological variations observed in H&E stained histology images (Figure 4.8).
Morphological variations may be attributed to vasculature and/or inflammatory cells,
which should be further investigated, however this was beyond the scope of the current
work. Importantly, H&E stained histology slices consistently demonstrated minimal
necrosis throughout the solid tumors, as seen in Figure 4.8. However, since necrotic
tissue is common in humans with GBM [36], LND-induced changes in CEST effects
should also be measured in necrotic tissue. If necrotic tissue is unresponsive to LND, the
use of a physiologic stress combined with CEST imaging may offer a new approach to
differentiate necrotic tissue from tumor and normal tissue.
The single-dose LND-CEST method could be translated to lower field strength clinical
MRI scanners, which are routinely used to produce APT contrast in humans [37-39].
Several clinical trials investigating cancer treatment using LND in U.S., Canada and
across Europe reached phase II and III status [40, 41], however, high liver toxicity at 3
months of dosing led to a hold on all clinical trials in the United States in 2006 [42].
Recently, cancer-targeted LND-containing liposomes were developed and were shown to
improve adjunct chemotherapy in a small animal tumor model [42]. Importantly, the
dose of LND used in the current study was 100 mg/kg, which is considerably higher than
that used clinically in the treatment of cancer in adult humans, where the highest reported
total single-day dose was 900 mg. The main side effects associated with LND treatment
are typically mild and include myalgia, asthenia, and testicular pain [41, 43]. The dose in
the current study was chosen to replicate previous studies in the MR literature [9-11, 14].
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Similar studies [9, 10] have reported high toxicity when using high LND doses (ie. > 50
mg/kg), however Nath et al. found mortality to be completely avoided when dissolving
LND in a Tris/glycine buffer [10, 11]. In the current study, the authors were unable to
completely dissolve LND unless using pure DMSO as a solvent. DMSO is toxic at high
dosages{Kelava, 2011 #215} and future studies should aim to limit the amount DMSO
used.
The small sample size represents a limitation of the present study. In addition, absolute
pHi was not measured because the calibration between AACID CEST and absolute pH
has not been established in U87 GBM. Finally, this study was not designed to evaluate
the predictive value of LND-induced pH-dependent changes in CEST contrast with a
therapeutic outcome. Future longitudinal studies will be designed to follow animals
following treatment.
Further work is required to investigate whether other clinically approved therapeutic
agents can alter tumor pHi after single-dose administration and whether these changes are
detectable by CEST MRI. In addition, future investigations must determine whether acute
pharmacologically induced CEST contrast predicts treatment outcomes. Finally, tumorselective LND effects were so clear that safer pharmacological stressors should be
investigated in combination with CEST MRI for applications in cancer detection,
differentiation, and grading.
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Chapter 5

5

Discussion and Future Work
The aim of this thesis was to optimize the application of endogenous CEST and
PARACEST contrast to measure temperature and pH in vivo. CEST experiments involve
labeling of a very small pool of solute protons using a RF saturation pulse. CEST
contrast is achieved if the labeled (or saturated) solute protons freely exchange with bulk
water protons.

Many proton exchange events involving the transfer of RF labeled

protons to the bulk water pool (and vice versa) eventually leads to a reduction in 1H MR
image signal intensity (ie. negative contrast). In biological systems, CEST contrast may
be used to probe local temperature and pH since chemical exchange is sensitive to
temperature and pH. If CEST contrast only depended on chemical exchange rate, then it
would be relatively straightforward to measure absolute pH and/or temperature.
However, CEST contrast depends on several other factors including solute concentration,
tissue water content, local magnetic relaxation time constants, and MT effects from
protons associated with endogenous macromolecules such as cell membranes. Therefore,
isolation and quantification of pH-dependent exchange rate influences on CEST contrast
presents a significant obstacle to measuring absolute pH in vivo. Experiments presented
in this thesis led to the discovery of a novel technique to measure absolute temperature
and pHe using exogenous PARACEST MRI contrast as well as a new technique to
measure absolute pHi using endogenous CEST MRI contrast. Both new approaches were
shown to be independent of solute concentration, magnetic relaxation, and MT effects in
vitro. Quantitative pH and temperature was mapped regionally in vivo using mouse
models. All MRI experiments were performed using an ultra high magnetic field (9.4 T)
MRI scanner. In the first study (Chapter 2), the linewidth (ie. full width at the half
maximum, FWHM) of the CEST peak corresponding to the amide proton associated with
a PARACEST agent (Tm3+-DOTAM-Gly-Lys) was shown to be sensitive to RF
saturation pulse amplitude and exchange rate only using theoretical models and in vitro
PARACEST solutions.

An empirical equation was derived to describe the relation

between the amide proton CEST peak linewidth and pH and a separate set of equations
were calculated to describe the amide proton CEST peak chemical shift dependence on
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pH and temperature. Absolute pH and temperature maps were calculated in in vitro using
PARACEST solutions and in vivo immediately after direct injection into a healthy mouse
leg based on in vitro calibration curves. In the second study (Chapter 3), a novel
ratiometric approach named amine and amide concentration-independent detection
(AACID) was developed to measure absolute pHi. AACID represents a ratio of two
different endogenous CEST effects originating from amide protons and amine protons
associated with proteins and peptides resonating at 3.50 ppm and 2.75 ppm respectively.
Again, numerical simulations showed that the AACID ratio is dependent on exchange
rate only for a given RF saturation pulse. Quantitative pHi maps were used to detect local
acidosis in vivo using a mouse model of cerebral ischemia based on an AACID-pHi
calibration curve. In the third study (Chapter 4), we investigated the sensitivity of two
endogenous CEST metrics to tumor-selective acidification using an anticancer drug
called lonidamine (LND).

Specifically, the LND-induced contrast was compared

between a novel CEST parameter called apparent amide proton transfer (APT*) and
AACID. LND treatment effects on APT* and AACID were investigated in healthy
mouse brain tissue as well as glioblastoma tumor tissue. Endogenous CEST effects
originating from amide protons associated with proteins and peptides decreased
significantly in tumor regions only after LND injection. Both CEST metrics, AACID and
APT*, were equally sensitive to LND treatment and produced equal LND-induced
contrast to noise ratio.

5.1 Measuring extracellular pH and temperature using
PARACEST peak lineshape
Chapter 2 focused on the application of CEST effects originating from amide protons
associated with Tm3+-DOTAM-Gly-Lys that resonate around -46 ppm upfield (ie. lower
frequency) from bulk water protons. The chemical shift and the linewidth of the amide
CEST peak were both used to simultaneously measure tissue temperature and pHe. This
study presented a novel application of the CEST peak linewidth that was defined as the
full width at half the maximum (FWHM). Analytical steady state solutions derived using
a weak saturation pulse (WSP) approximation (described in Section 1.5.2) were
simplified and rearranged to show that the CEST peak linewidth is linearly related to RF
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saturation pulse amplitude B1 and amide proton exchange rate. A linear relation between
the CEST peak linewidth with both the B1 and amide proton exchange rate was
confirmed using numerically simulated CEST spectra, which do not require any
assumptions. Hence for a given saturation pulse (ie. fixed B1) the CEST peak linewidth
depends on amide proton exchange rate only. The amide proton exchange rate is pHdependent since it is base-catalyzed and therefore amide CEST peak linewidth is pHdependent. Amide proton exchange rate is also temperature-dependent however
temperature effects on exchange rate caused negligible change in linewidth within the
narrow physiological range.
As predicted by the Bloch-McConnell equations and base-catalyzed exchange rate
kinetics, the amide CEST peak linewidth increased exponentially with increasing pH in
vitro. CEST data derived from in vitro PARACEST solutions was used to show that the
amide proton CEST peak was independent of PARACEST agent concentration, magnetic
relaxation time constants and temperature within experimentally relevant ranges. In vitro
experiments also demonstrated that the CEST peak linewidth was insensitive to
physiologically relevant changes in endogenous MT effects. The addition of tissue-like
semi-solid component to in vitro solutions introduced significant magnetization transfer
(MT) effects that mimic inherent macromolecular MT effects observed in vivo. In the
presence of MT effects, the linewidths were consistently reduced by a constant offset.
However, the MT effects on linewidth are not expected to introduce significant error
since the magnitude of inherent MT effects is nearly constant throughout normal tissue.
It is important to note that in the presented study, pH maps were calculated using the
linewidth-pH relation derived in aqueous solutions (i.e. in the absence of MT effects).
Therefore, future applications of the linewidth to measure absolute pH should derive
empirical linewidth-pH calibration curves in vivo or using in vitro phantoms that mimic
physiological MT effects. Furthermore, future experiments should correct CEST peak
linewidth measurements for B1–inhomogeneity effects using a quantitative B1 map and a
separate in vitro calibration to determine the linewidth dependence on B1.
After injection of PARACEST agents into biological systems, the precise agent
concentration is unknown.

Similarly, tissue temperature is rarely known in tissue
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affected by stroke or cancer. Therefore, the linewidth technique overcomes two major
obstacles in absolute pH measurement using PARACEST agents since it is independent
of agent concentration and tissue temperature.

A major drawback of the linewidth

technique is that it requires acquisition of the entire CEST peak lineshape for accurate pH
measurement. However, CEST peak acquisition enables simultaneous measurement of
the chemical shift.

Using the mathematical relation between pH, temperature and

chemical shift, it is possible to measure pHe and temperature simultaneously.
Tm3+-DOTAM-Gly-Lys was injected directly into a healthy mouse leg and PARACEST
contrast was detected in vivo. Our group is among the first groups to detect PARACEST
contrast in vivo. Quantitative pH maps were acquired using the linewidth-pH calibration
curves derived using aqueous PARACEST solutions. Absolute temperature and pH
measurements agreed well with values in the literature. The CEST spectra in regions of
high PARACEST contrast (i.e. large CEST peak amplitude) demonstrated significantly
less endogenous MT effects compared to normal tissue regions. The reduced MT effects
suggest that direct injection of PARACEST agent may result in a pocket of PARACEST
fluid at the injection site.

Further investigation is ongoing to determine if the

PARACEST contrast observed in vivo is from PARACEST agent within a fluid pocket or
diffused throughout the tissue.
Linewidth analysis may be applied to any CEST peak originating from solute protons
with pH-dependent exchange rate. Proper in vitro calibration is necessary since most
amide proton pools have unique spontaneous and base-catalyzed exchange rate constants
(equation [2.10]). Development of PARACEST agents with greater detection sensitivity
would improve the overall accuracy and utility of the linewidth technique. Ongoing
experiments are focused on determining which agent characteristics offer the best
contrast to noise ratio in vivo. Ideally, new agents will generate sufficient contrast to
enable detection after intravenous (i.v.) injection in order to measure pH and temperature
across the entire tissue of interest. Two strategies to optimize PARACEST agents for in
vivo pH measurement using the linewidth technique are; 1) modify the agent such that the
amide protons resonate at very large (> 100 ppm) chemical shifts to avoid endogenous
MT effects [1] and 2) modify the agent such that the water molecule bound to the
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paramagnetic metal exhibits non-optimal exchange leading to less T2-shortening and
subsequent tissue signal loss in the presence of the agent [2, 3]. Recently, our group
developed an agent with minimal T2-shortening effects, which led to improved pH
measurement accuracy [2].

5.2 Measuring intracellular pH using AACID
The study presented in Chapter 3 focused on the development of a novel technique called
amine and amide concentration-independent detection (AACID). AACID represents a
ratio of CEST effects originating from amine and amide protons associated with
endogenous proteins and peptides. The AACID ratio is linearly dependent on pH under
physiological conditions. The vast majority of proteins and peptides originate in the
intracellular space and therefore AACID pH measurements are heavily weighted to the
intracellular compartment.

The AACID ratio was theoretically derived using the

analytical steady state solutions derived using the WSP approximation. Analytical steady
state solutions predict that the AACID ratio depends on the pH-dependent exchange rate
only. Furthermore, CEST spectra were numerically simulated using a four-pool version
of the Bloch-McConnell equations to simulate AACID ratios in the presence of
endogenous MT effects. Introduction of physiological MT effects induced a significant
change in the numerically simulated AACID-pH relation.
The AACID ratio was linearly dependent on pH for in vitro protein aqueous solutions. In
agreement with numerical simulations, in vitro AACID values were independent of
protein concentration, magnetic relaxation time constants and temperature. Initial pilot
studies concluded that a 4 s, 1.5 µT RF saturation pulse generated AACID values with
the greatest sensitivity to pH (unpublished results). The AACID-pH calibration curve
generated in vitro could not be applied to in vivo AACID measurements to calculate
absolute pH since the BSA protein solutions did not precisely mimic endogenous MT,
magnetic relaxation time constants and chemical exchange properties encountered in
vivo. Therefore, an in vivo AACID-pH calibration curve was calculated using 31P MRS
pH measurements. The AACID-pH calibration relies on a constant pHi during collection
of the AACID values and

31

P MRS data. This assumption may be susceptible to small

error in pH-calibration since the overall experiment takes approximately 2 hours for the
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in vivo measurements alone. However, AACID and

31

P MRS results were consistent

among different animals suggesting that this assumption is valid.
Importantly, AACID measurements required B1-correction since the use of a surface RF
coil resulted in significant B1-inhomogeneity across the mouse brain. Quantitative B1
maps consistently showed that most MRI voxels had actual B1 values that were below the
prescribed B1 value. Plots of CEST spectra values (ie.

MZ ( Δω ) M0 ) at ∆ω = 2.75, 3.50

and 6.0 ppm with the measured B1 values showed that CEST values were linearly
dependent on B1 within the range of B1 values encountered for in vivo experiments (1.0 –
1.5 µT). Therefore, B1-calibration curves were€derived in vivo and CEST spectra values
were corrected on a pixel-by-pixel basis using B1-maps. AACID values were then
calculated using B1-corrected CEST spectra values. The effects of B1-inhomogeneities
on CEST data were successfully accounted for and corrected in this study, however, B1correction is difficult and relies on accurate B1 measurement as well as consistent B1calibration curves among different experiments with slightly different RF coil setup. For
example, differences in the distance between the surface RF coil and the mouse brain
may significantly alter the range of B1 values throughout the brain. Therefore, future
applications involving the B1-correction of AACID CEST data require a more extensive
investigation of the B1-dependence of CEST spectra values (at 2.75, 3.50 and 6.0 ppm)
across a larger range of B1 values. The B1-correction step was avoided in the study
presented in Chapter 4 by using a volume RF coil that provides high B1-homogeneity.
Application of the AACID technique in humans is possible. AACID is immediately
applicable for ultra-high field strength (≥ 7T) human MRI scanners.

Further

investigation is required to determine the utility of AACID for absolute pH measurements
using clinical field strength (≤ 3T) human scanners. The major obstacle at lower field
strength will be to detect any amine CEST effects at 2.75 ppm. The amine protons are
expected to approach the fast-exchange regime at clinical field strengths.

Human

AACID-pH calibration represents another obstacle to overcome before the AACID
technique is available in the clinic. However, high-resolution

31

P MRS using chemical

shift imaging approaches may represent a feasible approach to registering AACID ratios
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with absolute pHi measurements. Furthermore, the conventional fast spin-echo (FSE)
pulse sequence requires long acquisition times. However, several fast pulse sequences
that are modified for CEST have recently been described in the literature [4-6]. Such
rapid CEST pulse sequences are needed to enable rapid AACID-pH measurements in the
clinic.
A key assumption of the AACID technique is that the ratio of amine and amide proton
concentrations is constant throughout the tissue. This assumption may limit oncology
applications of AACID if amine/amide proton concentration ratio changes in tumor
tissue. However, ongoing experiments indicate that the AACID-pH relation is identical
in tumor tissue and normal tissue. Therefore, the AACID pH measurement technique
appears to be valid for investigating both stroke and cancer patients.

5.3 Measuring tumor acidosis following chemotherapy
using APT* and AACID
The study presented in Chapter 4 investigated the application of CEST MRI for
monitoring tumor response to a chemotherapy agent immediately after treatment. A
chemotherapy agent called lonidamine (LND) is known to cause tumor intracellular
acidification. Therefore, we compared the sensitivity of AACID and APT* to LND
treatment. The most important finding in this study was that CEST imaging is capable of
monitoring changes in pHi due to pharmacologically altered metabolism. Significant
changes were observed in tumor regions in both the AACID and APT* maps, while no
changes were observed in the T1-, T2-, and diffusion-weighted MR images. Overall, no
significant difference in sensitivity to LND treatment was measured between AACID and
APT*.
One drawback of the LND-CEST experiments is the duration of the experiment. The
experiment requires both pre- and post-injection CEST maps, which takes approximately
2 hours of MR imaging. In addition, LND effects are not observed until approximately
50 minutes post-injection. This would be an expensive protocol in the clinic and most
cancer patients would not be fit to remain in the scanner for such a long time. Therefore,
future experiments should be optimized using more modern and faster pulse sequences.
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It should be noted that clinical protocols for metabolic imaging using positron emission
tomography (PET) also require several hours.

Another obstacle of the LND-CEST

experiment is the susceptibility to motion artifacts. When subtracting pre- and postinjection CEST maps, it is assumed that the maps were acquired from identical slices.
The most efficient solution to eliminate any motion artifacts would be to acquire threedimensional CEST maps and if necessary, employ an image registration protocol prior to
CEST data processing. One modern CEST pulse sequence is capable of acquiring a
three-dimensional whole brain volume in just over 10 seconds per saturation frequency
([4]). Finally, the LND-CEST experiment is currently not clinically translatable since the
LND proved to be fatal to all of the animals. The toxic effects of LND have led our
group to begin investigating other chemotherapy agents that known to alter tumor
metabolism.
This study demonstrates that CEST imaging can detect tumor response to treatment
within one hour of LND treatment. Interestingly, LND causes tumor acidification by
blocking lactate efflux from the cell. Therefore, the level of LND-induced tumor acidosis
is thought to be dependent on the rate of glycolysis (i.e. lactate production). Further
experiments are required to investigate whether the LND-induced CEST contrast could
be used to probe tumor metabolic activity. In this case, LND-induced contrast maps could
be used to differentiate necrosis from recurrent tumor tissue. Furthermore, LND-induced
contrast maps (both AACID and APT*) proved to be effective in localizing tumor tissue.
In the case that LND-toxicity can be avoided either using a different solvent solution [7,
8] or using liposomes [9], the LND-CEST experiment potentially offers several exciting
clinical applications.

5.4 Future Work
Each of the three studies presented in this thesis offer a novel technique to measure
temperature, pH, or treatment-induced pH changes.

Future work will focus on

optimizing and employing the presented techniques to answer the central questions
regarding the role to pH and temperature in diseases such as cancer and stroke.
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New PARACEST agents are currently being strategically synthesized to have greater
detection sensitivity in vivo.

Using optimized PARACEST agents, the linewidth

technique will be calibrated using either in vivo or in vitro phantoms with physiological
MT effects to improve linewidth-pH calibration. Animal models will be used to
investigate potential clinical applications of PARACEST agents that would motivate
potential clinical trials. For applications in cancer, the linewidth technique will be used
to investigate pHe and temperature signatures throughout the growth period
(approximately 2-3 weeks in mice) of different tumor types (i.e. low- and high-grade
gliomas). Further analysis would evaluate if the tumor pHe and/or temperature could be
used to predict tumor outcomes such as tumor growth rate, volume, metastatic migration,
and necrosis. Furthermore, the linewidth technique will be applied to study the effect of
different anti-cancer treatment routines on pHe and temperature. For example, different
subsets of animals will undergo specific protocols involving chemotherapy and/or
radiation therapy. Tumor temperature and pHe maps acquired before, during and after
therapy could be used to monitor tumor response. Again, retrospective analysis would
evaluate whether pre-treatment maps could be used to predict treatment response.
Another interesting application would be to monitor tumor pHe after treatment with
sodium bicarbonate (NaHCO3) [10]. NaHCO3 is an alkaline compound that has been
hypothesized to neutralize the acidic extracellular tumor microenvironment. pH mapping
using PARACEST MRI presents a novel noninvasive technique to test this hypothesis by
monitoring tumor pHe throughout NaHCO3 treatment.
Future experiments to measure absolute pHi in small animals will aim to investigate pHi
in cancer and stroke. For example, in stroke, the hypothesis that a pHi threshold exists
that can be used to predict areas of irreversible neuronal damage. To test this hypothesis,
focal ischemia will be induced by middle cerebral artery occlusion (MCAO) for a set of
occlusion times followed by reperfusion. Occlusion times should range from 0 to 2 hours
in order to achieve varying sizes of infarct lesions [11]. Quantitative pHi maps will be
acquired immediately after MCAO surgery. Animals will be sacrificed immediately after
pHi map acquisition and processed for histology. A spatial analysis of pHi maps and
histology stained for neuronal damage would enable evaluation of a pHi threshold that
may predict neuronal death. If a pHi threshold is calculated, then further studies should
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be developed to employ pHi maps to guide administration of tissue plasminogen activator
(tPA) in mice after stroke.
Similar to pHe maps derived using the linewidth technique, pHi maps should be measured
in animals with different types of tumors throughout the tumor growth period.
Quantitative analysis should investigate whether tumor pHi can act as a biomarker to
predict any clinical parameters such as metastasis, treatment response, and survival.
Furthermore, the clinical significance of pHi heterogeneity throughout tumors should also
be investigated. In all cases, histology should be performed to spatially correlate tumor
pHi distribution with morphological markers such as necrosis, vasculature and
inflammation. In addition, the intracellular to extracellular tumor pH gradient can be
investigated by applying the AACID (pHi) and linewidth (pHe) techniques in the same
experiment. Tumor pH gradient must be investigated for different tumor types and
treatment strategies to investigate whether any clinical advantage exists when acquiring
both pHi and pHe compared to only pHi or pHe.
Future application of the LND-CEST experiment must first eliminate the lethal toxicity in
order to ensure clinical utility. Pilot experiments must test different solvents [7-9] and/or
different tumor-specific metabolism altering drugs [7, 12]. To study the hypothesis that
LND-induced contrast is a biomarker of glucose metabolic activity, the LND-induced
contrast maps should be compared to radiolabeled

18

F deoxyglucose (FDG) uptake

measured using PET imaging in mouse brain tumors.

Further investigation should

determine if LND-induced contrast signifies tumor grade and growth rate. Finally, the
sensitivity of LND-induced contrast maps for localizing small tumors should be tested.
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